XML 30 R9.htm IDEA: XBRL DOCUMENT
v3.24.0.1

CONSOLIDATED SCHEDULE OF INVESTMENTS £ in Thousands | 12 Months Ended |  |
--- | --- | --- | ---
Dec. 31, 2023 USD ($) shares | Dec. 31, 2022 USD ($) shares | Dec. 31, 2023 GBP (£) shares | Dec. 31, 2022 GBP (£) shares
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Basis spread variable rate |  | 8.50% |  |  |  | 8.50% |  |  |
Investment cost |  | $ 3,247,033,000 |  | $ 3,005,696,000 |  |  |  |  |
Investments, at fair value: |  | 3,248,046,000 |  | $ 2,963,955,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [1],[2] | 237,000 |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 184,000 |  |  |  |  |  |  |
Acquisition date | [1],[3] | Dec. 27, 2022 |  |  |  |  |  |  |
Shares | shares | [1] | 69,239 |  |  |  | 69,239 |  |  |
Investment, Identifier [Axis]: Debt Investments (169.59%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 169.59% |  |  |  | 169.59% |  |  |
Investment cost | [2] | $ 3,058,370,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 3,057,299,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments (199.47%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 199.47% |  |  |  | 199.47% |
Investment cost | [6] |  |  | $ 2,818,060,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 2,795,444,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (2.02%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | 47,010,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 48,027,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (2.31%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 2.31% |  |  |  | 2.31% |
Investment cost | [6] |  |  | $ 32,339,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 32,339,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (2.66%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 2.66% |  |  |  | 2.66% |  |  |
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and Alamar Biosciences, Inc. Senior Secured, Maturity Date June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7] |  |  | 2026-06 |  |  |  | 2026-06 |
Basis spread variable rate | [7],[8] |  |  | 3.00% |  |  |  | 3.00% |
Interest rate floor | [7],[8] |  |  | 6.50% |  |  |  | 6.50% |
Interest rate paid in kind | [7],[8] |  |  | 1.00% |  |  |  | 1.00% |
Exit fee rate | [7],[8] |  |  | 5.95% |  |  |  | 5.95% |
Principal amount | [7] |  |  | $ 5,000,000 |  |  |  |  |
Investment cost | [6],[7] |  |  | 4,951,000 |  |  |  |  |
Investments, at fair value: | [7] |  |  | $ 4,951,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and Alamar Biosciences, Inc., Senior Secured, June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[10] | 2026-06 |  |  |  | 2026-06 |  |  |
Basis spread variable rate | [9],[10],[11] | 3.00% |  |  |  | 3.00% |  |  |
Interest rate floor | [9],[10],[11] | 6.50% |  |  |  | 6.50% |  |  |
Interest rate paid in kind | [9],[10],[11] | 1.00% |  |  |  | 1.00% |  |  |
Exit fee rate | [9],[10],[11] | 5.95% |  |  |  | 5.95% |  |  |
Principal amount | [9],[10] | $ 15,049,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[10] | 15,069,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10] | $ 15,508,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, January 2027, Prime + 2.15%, Floor rate 9.15%, 9.81% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [12] | 2027-01 |  |  |  | 2027-01 |  |  |
Basis spread variable rate | [11],[12] | 2.15% |  |  |  | 2.15% |  |  |
Interest rate floor | [11],[12] | 9.15% |  |  |  | 9.15% |  |  |
Exit fee rate | [11],[12] | 9.81% |  |  |  | 9.81% |  |  |
Principal amount | [12] | $ 32,000,000 |  |  |  |  |  |  |
Investment cost | [2],[12] | 31,941,000 |  |  |  |  |  |  |
Investments, at fair value: | [12] | $ 32,519,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, Maturity Date January 2027, Prime + 2.15%, Floor rate 9.15%, 11.21% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7] |  |  | 2027-01 |  |  |  | 2027-01 |
Basis spread variable rate | [7],[8] |  |  | 2.15% |  |  |  | 2.15% |
Interest rate floor | [7],[8] |  |  | 9.15% |  |  |  | 9.15% |
Exit fee rate | [7],[8] |  |  | 11.21% |  |  |  | 11.21% |
Principal amount | [7] |  |  | $ 28,000,000 |  |  |  |  |
Investment cost | [6],[7] |  |  | 27,388,000 |  |  |  |  |
Investments, at fair value: | [7] |  |  | $ 27,388,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Communications & Networking (7.26%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 7.26% |  |  |  | 7.26% |
Investment cost | [6] |  |  | $ 99,167,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 101,734,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Aryaka Networks, Inc. Senior Secured, Maturity Date July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[13],[14] |  |  | 2026-07 |  |  |  | 2026-07 |
Basis spread variable rate | [7],[8],[13],[14] |  |  | 3.25% |  |  |  | 3.25% |
Interest rate floor | [7],[8],[13],[14] |  |  | 6.75% |  |  |  | 6.75% |
Interest rate paid in kind | [7],[8],[13],[14] |  |  | 1.05% |  |  |  | 1.05% |
Exit fee rate | [7],[8],[13],[14] |  |  | 3.55% |  |  |  | 3.55% |
Principal amount | [7],[13],[14] |  |  | $ 5,023,000 |  |  |  |  |
Investment cost | [6],[7],[13],[14] |  |  | 4,969,000 |  |  |  |  |
Investments, at fair value: | [7],[13],[14] |  |  | $ 5,053,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Cytracom Holdings LLC Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.31%, Floor rate 10.31% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[15],[16] |  |  | 2025-02 |  |  |  | 2025-02 |
Basis spread variable rate | [7],[8],[15],[16] |  |  | 9.31% |  |  |  | 9.31% |
Interest rate floor | [7],[8],[15],[16] |  |  | 10.31% |  |  |  | 10.31% |
Principal amount | [7],[15],[16] |  |  | $ 8,910,000 |  |  |  |  |
Investment cost | [6],[7],[15],[16] |  |  | 8,768,000 |  |  |  |  |
Investments, at fair value: | [7],[15],[16] |  |  | $ 8,748,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Rocket Lab Global Services, LLC Senior Secured, Maturity Date June 2024, Prime + 4.90%, Floor rate 8.15%, PIK Interest 1.25%, 3.25% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[15],[17],[18],[19] |  |  | 2024-06 |  |  |  | 2024-06 |
Basis spread variable rate | [8],[14],[15],[17],[18],[19] |  |  | 4.90% |  |  |  | 4.90% |
Interest rate floor | [8],[14],[15],[17],[18],[19] |  |  | 8.15% |  |  |  | 8.15% |
Interest rate paid in kind | [8],[14],[15],[17],[18],[19] |  |  | 1.25% |  |  |  | 1.25% |
Exit fee rate | [8],[14],[15],[17],[18],[19] |  |  | 3.25% |  |  |  | 3.25% |
Principal amount | [14],[15],[17],[18],[19] |  |  | $ 84,581,000 |  |  |  |  |
Investment cost | [6],[14],[15],[17],[18],[19] |  |  | 85,430,000 |  |  |  |  |
Investments, at fair value: | [14],[15],[17],[18],[19] |  |  | $ 87,933,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Communications and Networking and Aryaka Networks, Inc., Senior Secured, July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[12],[20] | 2026-07 |  |  |  | 2026-07 |  |  |
Basis spread variable rate | [9],[11],[12],[20] | 3.25% |  |  |  | 3.25% |  |  |
Interest rate floor | [9],[11],[12],[20] | 6.75% |  |  |  | 6.75% |  |  |
Interest rate paid in kind | [9],[11],[12],[20] | 1.05% |  |  |  | 1.05% |  |  |
Exit fee rate | [9],[11],[12],[20] | 3.55% |  |  |  | 3.55% |  |  |
Principal amount | [9],[12],[20] | $ 25,153,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[12],[20] | 24,943,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[12],[20] | $ 26,000,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Communications and Networking and Cytracom Holdings LLC, Senior Secured, February 2025, 3-month SOFR + 9.72%, Floor rate 10.62% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [21],[22],[23] | 2025-02 |  |  |  | 2025-02 |  |  |
Basis spread variable rate | [11],[21],[22],[23] | 9.72% |  |  |  | 9.72% |  |  |
Interest rate floor | [11],[21],[22],[23] | 10.62% |  |  |  | 10.62% |  |  |
Principal amount | [21],[22],[23] | $ 3,267,000 |  |  |  |  |  |  |
Investment cost | [2],[21],[22],[23] | 3,239,000 |  |  |  |  |  |  |
Investments, at fair value: | [21],[22],[23] | $ 3,272,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (28.24%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 28.24% |  |  |  | 28.24% |  |  |
Investment cost | [2] | $ 507,063,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 509,053,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (30.59%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 30.59% |  |  |  | 30.59% |
Investment cost | [6] |  |  | $ 444,703,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 428,750,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Altumint, Inc., Senior Secured, December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1],[22] | 2027-12 |  |  |  | 2027-12 |  |  |
Basis spread variable rate | [1],[11],[22] | 3.65% |  |  |  | 3.65% |  |  |
Interest rate floor | [1],[11],[22] | 12.15% |  |  |  | 12.15% |  |  |
Exit fee rate | [1],[11],[22] | 2.50% |  |  |  | 2.50% |  |  |
Principal amount | [1],[22] | $ 10,000,000 |  |  |  |  |  |  |
Investment cost | [1],[2],[22] | 9,905,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[22] | $ 9,905,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and AppDirect, Inc. Senior Secured, Maturity Date April 2026, Prime + 5.50%, Floor rate 8.8%, 8.29% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[18] |  |  | 2026-04 |  |  |  | 2026-04 |
Basis spread variable rate | [7],[8],[18] |  |  | 5.50% |  |  |  | 5.50% |
Interest rate floor | [7],[8],[18] |  |  | 8.75% |  |  |  | 8.75% |
Exit fee rate | [7],[8],[18] |  |  | 8.29% |  |  |  | 8.29% |
Principal amount | [7],[18] |  |  | $ 40,790,000 |  |  |  |  |
Investment cost | [6],[7],[18] |  |  | 41,856,000 |  |  |  |  |
Investments, at fair value: | [7],[18] |  |  | $ 42,426,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and AppDirect, Inc., Senior Secured, April 2026, Prime + 5.50%, Floor rate 8.75%, 7.12% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [12] | 2026-04 |  |  |  | 2026-04 |  |  |
Basis spread variable rate | [11],[12] | 5.50% |  |  |  | 5.50% |  |  |
Interest rate floor | [11],[12] | 8.75% |  |  |  | 8.75% |  |  |
Exit fee rate | [11],[12] | 7.12% |  |  |  | 7.12% |  |  |
Principal amount | [12] | $ 55,790,000 |  |  |  |  |  |  |
Investment cost | [2],[12] | 57,653,000 |  |  |  |  |  |  |
Investments, at fair value: | [12] | $ 59,507,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Carwow LTD Senior Secured, Maturity Date December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[24],[25] |  |  | 2024-12 |  |  |  | 2024-12 |
Basis spread variable rate | [8],[14],[24],[25] |  |  | 4.70% |  |  |  | 4.70% |
Interest rate floor | [8],[14],[24],[25] |  |  | 7.95% |  |  |  | 7.95% |
Interest rate paid in kind | [8],[14],[24],[25] |  |  | 1.45% |  |  |  | 1.45% |
Exit fee rate | [8],[14],[24],[25] |  |  | 4.95% |  |  |  | 4.95% |
Principal amount | £ | [14],[24],[25] |  |  |  |  |  |  | £ 18,890 |
Investment cost | [6],[14],[24],[25] |  |  | $ 26,024,000 |  |  |  |  |
Investments, at fair value: | [14],[24],[25] |  |  | $ 22,971,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Carwow LTD, Senior Secured, December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[26],[27] | 2024-12 |  |  |  | 2024-12 |  |  |
Basis spread variable rate | [9],[11],[26],[27] | 4.70% |  |  |  | 4.70% |  |  |
Interest rate floor | [9],[11],[26],[27] | 7.95% |  |  |  | 7.95% |  |  |
Interest rate paid in kind | [9],[11],[26],[27] | 1.45% |  |  |  | 1.45% |  |  |
Exit fee rate | [9],[11],[26],[27] | 4.95% |  |  |  | 4.95% |  |  |
Principal amount | £ | [9],[26],[27] |  |  |  |  | £ 19,146 |  |  |
Investment cost | [2],[9],[26],[27] | $ 26,834,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[26],[27] | $ 25,157,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 5.50% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[28] |  |  | 2028-05 |  |  |  | 2028-05 |
Interest rate paid in kind | [8],[14],[28] |  |  | 5.50% |  |  |  | 5.50% |
Principal amount | [14],[28] |  |  | $ 21,853,000 |  |  |  |  |
Investment cost | [6],[14],[28] |  |  | 21,853,000 |  |  |  |  |
Investments, at fair value: | [14],[28] |  |  | $ 20,356,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc., Convertible Debt, May 2028, PIK Interest 8.50% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[29] | 2028-05 |  |  |  | 2028-05 |  |  |
Interest rate paid in kind | [9],[11],[29] | 8.50% |  |  |  | 8.50% |  |  |
Principal amount | [9],[29] | $ 23,340,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[29] | 23,340,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[29] | $ 23,244,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date February 2025, 1-month SOFR + 8.86%, Floor rate 9.75%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [24],[25] |  |  | 2025-02 |  |  |  | 2025-02 |
Basis spread variable rate | [8],[24],[25] |  |  | 8.86% |  |  |  | 8.86% |
Interest rate floor | [8],[24],[25] |  |  | 9.75% |  |  |  | 9.75% |
Exit fee rate | [8],[24],[25] |  |  | 3.00% |  |  |  | 3.00% |
Principal amount | [24],[25] |  |  | $ 14,000,000 |  |  |  |  |
Investment cost | [6],[24],[25] |  |  | 13,853,000 |  |  |  |  |
Investments, at fair value: | [24],[25] |  |  | $ 13,904,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc., Senior Secured, February 2025, 1-month SOFR + 8.86% Floor rate 9.75%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [26],[27] | 2025-02 |  |  |  | 2025-02 |  |  |
Basis spread variable rate | [11],[26],[27] | 8.86% |  |  |  | 8.86% |  |  |
Interest rate floor | [11],[26],[27] | 9.75% |  |  |  | 9.75% |  |  |
Exit fee rate | [11],[26],[27] | 3.00% |  |  |  | 3.00% |  |  |
Principal amount | [26],[27] | $ 14,000,000 |  |  |  |  |  |  |
Investment cost | [2],[26],[27] | 14,095,000 |  |  |  |  |  |  |
Investments, at fair value: | [26],[27] | $ 14,259,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Plentific Ltd, Senior Secured, October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22],[26],[27] | 2026-10 |  |  |  | 2026-10 |  |  |
Basis spread variable rate | [11],[22],[26],[27] | 2.55% |  |  |  | 2.55% |  |  |
Interest rate floor | [11],[22],[26],[27] | 11.05% |  |  |  | 11.05% |  |  |
Exit fee rate | [11],[22],[26],[27] | 2.95% |  |  |  | 2.95% |  |  |
Principal amount | [22],[26],[27] | $ 875,000 |  |  |  |  |  |  |
Investment cost | [2],[22],[26],[27] | 853,000 |  |  |  |  |  |  |
Investments, at fair value: | [22],[26],[27] | $ 853,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Provi, Senior Secured, December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1] | 2026-12 |  |  |  | 2026-12 |  |  |
Basis spread variable rate | [1],[11] | 4.40% |  |  |  | 4.40% |  |  |
Interest rate floor | [1],[11] | 10.65% |  |  |  | 10.65% |  |  |
Exit fee rate | [1],[11] | 2.95% |  |  |  | 2.95% |  |  |
Principal amount | [1] | $ 15,000,000 |  |  |  |  |  |  |
Investment cost | [1],[2] | 14,904,000 |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 15,046,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Provi, Senior Secured, Maturity Date December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [30] |  |  | 2026-12 |  |  |  | 2026-12 |
Basis spread variable rate | [8],[30] |  |  | 4.40% |  |  |  | 4.40% |
Interest rate floor | [8],[30] |  |  | 10.65% |  |  |  | 10.65% |
Exit fee rate | [8],[30] |  |  | 2.95% |  |  |  | 2.95% |
Principal amount | [30] |  |  | $ 15,000,000 |  |  |  |  |
Investment cost | [6],[30] |  |  | 14,739,000 |  |  |  |  |
Investments, at fair value: | [30] |  |  | $ 14,739,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1],[9],[10] | 2026-12 |  |  |  | 2026-12 |  |  |
Basis spread variable rate | [1],[9],[10],[11] | 5.50% |  |  |  | 5.50% |  |  |
Interest rate floor | [1],[9],[10],[11] | 6.50% |  |  |  | 6.50% |  |  |
Interest rate paid in kind | [1],[9],[10],[11] | 4.00% |  |  |  | 4.00% |  |  |
Principal amount | [1],[9],[10] | $ 28,876,000 |  |  |  |  |  |  |
Investment cost | [1],[2],[9],[10] | 28,404,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[9],[10] | $ 28,888,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month LIBOR + 5.50%, Floor rate 6.50%, PIK Interest 4.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[14],[17],[30] |  |  | 2026-12 |  |  |  | 2026-12 |
Basis spread variable rate | [7],[8],[14],[17],[30] |  |  | 5.50% |  |  |  | 5.50% |
Interest rate floor | [7],[8],[14],[17],[30] |  |  | 6.50% |  |  |  | 6.50% |
Interest rate paid in kind | [7],[8],[14],[17],[30] |  |  | 4.00% |  |  |  | 4.00% |
Principal amount | [7],[14],[17],[30] |  |  | $ 27,730,000 |  |  |  |  |
Investment cost | [6],[7],[14],[17],[30] |  |  | 27,265,000 |  |  |  |  |
Investments, at fair value: | [7],[14],[17],[30] |  |  | $ 27,256,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Rhino Labs, Inc. Senior Secured, Maturity Date March 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[30] |  |  | 2024-03 |  |  |  | 2024-03 |
Basis spread variable rate | [8],[14],[30] |  |  | 5.50% |  |  |  | 5.50% |
Interest rate floor | [8],[14],[30] |  |  | 8.75% |  |  |  | 8.75% |
Interest rate paid in kind | [8],[14],[30] |  |  | 2.25% |  |  |  | 2.25% |
Principal amount | [14],[30] |  |  | $ 16,500,000 |  |  |  |  |
Investment cost | [6],[14],[30] |  |  | 16,328,000 |  |  |  |  |
Investments, at fair value: | [14],[30] |  |  | $ 16,496,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Rhino Labs, Inc., Senior Secured, June 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1],[9] | 2024-06 |  |  |  | 2024-06 |  |  |
Basis spread variable rate | [1],[9],[11] | 5.50% |  |  |  | 5.50% |  |  |
Interest rate floor | [1],[9],[11] | 8.75% |  |  |  | 8.75% |  |  |
Interest rate paid in kind | [1],[9],[11] | 2.25% |  |  |  | 2.25% |  |  |
Principal amount | [1],[9] | $ 4,710,000 |  |  |  |  |  |  |
Investment cost | [1],[2],[9] | 4,704,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[9] | $ 4,704,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Riviera Partners LLC, Senior Secured, April 2027, 3-month SOFR + 8.26%, Floor rate 9.26% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22],[23] | 2027-04 |  |  |  | 2027-04 |  |  |
Basis spread variable rate | [11],[22],[23] | 8.26% |  |  |  | 8.26% |  |  |
Interest rate floor | [11],[22],[23] | 9.26% |  |  |  | 9.26% |  |  |
Principal amount | [22],[23] | $ 36,868,000 |  |  |  |  |  |  |
Investment cost | [2],[22],[23] | 36,339,000 |  |  |  |  |  |  |
Investments, at fair value: | [22],[23] | $ 34,659,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Seat Geek, Inc., Senior Secured, July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[12],[31] | 2026-07 |  |  |  | 2026-07 |  |  |
Basis spread variable rate | [9],[11],[12],[31] | 2.50% |  |  |  | 2.50% |  |  |
Interest rate floor | [9],[11],[12],[31] | 10.75% |  |  |  | 10.75% |  |  |
Interest rate paid in kind | [9],[11],[12],[31] | 0.50% |  |  |  | 0.50% |  |  |
Exit fee rate | [9],[11],[12],[31] | 3.00% |  |  |  | 3.00% |  |  |
Principal amount | [9],[12],[31] | $ 77,642,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[12],[31] | 77,170,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[12],[31] | $ 79,119,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date June 2023, Prime + 5.00%, Floor rate 10.50%, PIK Interest 0.50% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[17],[18],[19] |  |  | 2023-06 |  |  |  | 2023-06 |
Basis spread variable rate | [8],[14],[17],[18],[19] |  |  | 5.00% |  |  |  | 5.00% |
Interest rate floor | [8],[14],[17],[18],[19] |  |  | 10.50% |  |  |  | 10.50% |
Interest rate paid in kind | [8],[14],[17],[18],[19] |  |  | 0.50% |  |  |  | 0.50% |
Principal amount | [14],[17],[18],[19] |  |  | $ 60,915,000 |  |  |  |  |
Investment cost | [6],[14],[17],[18],[19] |  |  | 60,721,000 |  |  |  |  |
Investments, at fair value: | [14],[17],[18],[19] |  |  | $ 60,721,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[15],[19] |  |  | 2026-05 |  |  |  | 2026-05 |
Basis spread variable rate | [8],[14],[15],[19] |  |  | 7.00% |  |  |  | 7.00% |
Interest rate floor | [8],[14],[15],[19] |  |  | 10.50% |  |  |  | 10.50% |
Interest rate paid in kind | [8],[14],[15],[19] |  |  | 0.50% |  |  |  | 0.50% |
Principal amount | [14],[15],[19] |  |  | $ 25,071,000 |  |  |  |  |
Investment cost | [6],[14],[15],[19] |  |  | 24,912,000 |  |  |  |  |
Investments, at fair value: | [14],[15],[19] |  |  | $ 25,823,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc., Senior Secured, May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[21],[31] | 2026-05 |  |  |  | 2026-05 |  |  |
Basis spread variable rate | [9],[11],[21],[31] | 7.00% |  |  |  | 7.00% |  |  |
Interest rate floor | [9],[11],[21],[31] | 10.50% |  |  |  | 10.50% |  |  |
Interest rate paid in kind | [9],[11],[21],[31] | 0.50% |  |  |  | 0.50% |  |  |
Exit fee rate | [9],[11],[21],[31] | 4.00% |  |  |  | 4.00% |  |  |
Principal amount | [9],[21],[31] | $ 25,199,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[21],[31] | 25,126,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[21],[31] | $ 25,869,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Skyword, Inc. Senior Secured, Maturity Date November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[17] |  |  | 2026-11 |  |  |  | 2026-11 |
Basis spread variable rate | [8],[14],[17] |  |  | 2.75% |  |  |  | 2.75% |
Interest rate floor | [8],[14],[17] |  |  | 9.25% |  |  |  | 9.25% |
Interest rate paid in kind | [8],[14],[17] |  |  | 1.75% |  |  |  | 1.75% |
Exit fee rate | [8],[14],[17] |  |  | 3.00% |  |  |  | 3.00% |
Principal amount | [14],[17] |  |  | $ 9,007,000 |  |  |  |  |
Investment cost | [6],[14],[17] |  |  | 8,918,000 |  |  |  |  |
Investments, at fair value: | [14],[17] |  |  | $ 8,870,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Skyword, Inc., Senior Secured, November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[10] | 2026-11 |  |  |  | 2026-11 |  |  |
Basis spread variable rate | [9],[10],[11] | 2.75% |  |  |  | 2.75% |  |  |
Interest rate floor | [9],[10],[11] | 9.25% |  |  |  | 9.25% |  |  |
Interest rate paid in kind | [9],[10],[11] | 1.75% |  |  |  | 1.75% |  |  |
Exit fee rate | [9],[10],[11] | 3.00% |  |  |  | 3.00% |  |  |
Principal amount | [9],[10] | $ 9,169,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[10] | 9,189,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10] | $ 9,311,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, July 2024, FIXED 8.25% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [32] | 2024-07 |  |  |  | 2024-07 |  |  |
Interest rate paid in cash | [11],[32] | 8.25% |  |  |  | 8.25% |  |  |
Principal amount | [32] | $ 8,250,000 |  |  |  |  |  |  |
Investment cost | [2],[32] | 8,250,000 |  |  |  |  |  |  |
Investments, at fair value: | [32] | $ 8,250,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 One, PIK Interest 5.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[33],[34] |  |  | 2024-07 |  |  |  | 2024-07 |
Interest rate paid in kind | [8],[14],[33],[34] |  |  | 5.00% |  |  |  | 5.00% |
Principal amount | [14],[33],[34] |  |  | $ 10,680,000 |  |  |  |  |
Investment cost | [6],[14],[33],[34] |  |  | 240,000 |  |  |  |  |
Investments, at fair value: | [14],[33],[34] |  |  | $ 0 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 Two, PIK Interest 5.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[33],[34] |  |  | 2024-07 |  |  |  | 2024-07 |
Interest rate paid in kind | [8],[14],[33],[34] |  |  | 5.00% |  |  |  | 5.00% |
Principal amount | [14],[33],[34] |  |  | $ 13,023,000 |  |  |  |  |
Investment cost | [6],[14],[33],[34] |  |  | 13,023,000 |  |  |  |  |
Investments, at fair value: | [14],[33],[34] |  |  | $ 0 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024, FIXED 8.25% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[33],[34] |  |  | 2024-07 |  |  |  | 2024-07 |
Interest rate paid in cash | [8],[14],[33],[34] |  |  | 8.25% |  |  |  | 8.25% |
Principal amount | [14],[33],[34] |  |  | $ 8,250,000 |  |  |  |  |
Investment cost | [6],[14],[33],[34] |  |  | 8,250,000 |  |  |  |  |
Investments, at fair value: | [14],[33],[34] |  |  | $ 8,042,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Thumbtack, Inc. Senior Secured, Maturity Date April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[14],[18] |  |  | 2026-04 |  |  |  | 2026-04 |
Basis spread variable rate | [7],[8],[14],[18] |  |  | 4.95% |  |  |  | 4.95% |
Interest rate floor | [7],[8],[14],[18] |  |  | 8.20% |  |  |  | 8.20% |
Interest rate paid in kind | [7],[8],[14],[18] |  |  | 1.50% |  |  |  | 1.50% |
Exit fee rate | [7],[8],[14],[18] |  |  | 3.95% |  |  |  | 3.95% |
Principal amount | [7],[14],[18] |  |  | $ 10,103,000 |  |  |  |  |
Investment cost | [6],[7],[14],[18] |  |  | 10,050,000 |  |  |  |  |
Investments, at fair value: | [7],[14],[18] |  |  | $ 10,167,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Thumbtack, Inc., Senior Secured, April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[12],[22] | 2026-04 |  |  |  | 2026-04 |  |  |
Basis spread variable rate | [9],[11],[12],[22] | 4.95% |  |  |  | 4.95% |  |  |
Interest rate floor | [9],[11],[12],[22] | 8.20% |  |  |  | 8.20% |  |  |
Interest rate paid in kind | [9],[11],[12],[22] | 1.50% |  |  |  | 1.50% |  |  |
Exit fee rate | [9],[11],[12],[22] | 3.95% |  |  |  | 3.95% |  |  |
Principal amount | [9],[12],[22] | $ 10,258,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[12],[22] | 10,317,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[12],[22] | 10,639,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Total SeatGeek, Inc., Senior Secured |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Principal amount |  | 102,841,000 |  |  |  |  |  |  |
Investment cost | [2] | 102,296,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 104,988,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Total Veem, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Principal amount |  | 10,217,000 |  |  |  |  |  |  |
Investment cost | [2] | 10,365,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 10,516,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Total Worldremit Group Limited |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Principal amount |  | 94,500,000 |  |  |  |  |  |  |
Investment cost | [2] | 95,626,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 95,997,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Udacity, Inc. Senior Secured, Maturity Date September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[18] |  |  | 2024-09 |  |  |  | 2024-09 |
Basis spread variable rate | [8],[14],[18] |  |  | 4.50% |  |  |  | 4.50% |
Interest rate floor | [8],[14],[18] |  |  | 7.75% |  |  |  | 7.75% |
Interest rate paid in kind | [8],[14],[18] |  |  | 2.00% |  |  |  | 2.00% |
Exit fee rate | [8],[14],[18] |  |  | 3.00% |  |  |  | 3.00% |
Principal amount | [14],[18] |  |  | $ 51,937,000 |  |  |  |  |
Investment cost | [6],[14],[18] |  |  | 52,265,000 |  |  |  |  |
Investments, at fair value: | [14],[18] |  |  | $ 52,976,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Udacity, Inc., Senior Secured, September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[12] | 2024-09 |  |  |  | 2024-09 |  |  |
Basis spread variable rate | [9],[11],[12] | 4.50% |  |  |  | 4.50% |  |  |
Interest rate floor | [9],[11],[12] | 7.75% |  |  |  | 7.75% |  |  |
Interest rate paid in kind | [9],[11],[12] | 2.00% |  |  |  | 2.00% |  |  |
Exit fee rate | [9],[11],[12] | 3.00% |  |  |  | 3.00% |  |  |
Principal amount | [9],[12] | $ 53,000,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[12] | 53,989,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[12] | $ 53,130,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[17] |  |  | 2025-03 |  |  |  | 2025-03 |
Basis spread variable rate | [8],[14],[17] |  |  | 4.00% |  |  |  | 4.00% |
Interest rate floor | [8],[14],[17] |  |  | 7.25% |  |  |  | 7.25% |
Interest rate paid in kind | [8],[14],[17] |  |  | 1.25% |  |  |  | 1.25% |
Exit fee rate | [8],[14],[17] |  |  | 4.50% |  |  |  | 4.50% |
Principal amount | [14],[17] |  |  | $ 5,043,000 |  |  |  |  |
Investment cost | [6],[14],[17] |  |  | 5,000,000 |  |  |  |  |
Investments, at fair value: | [14],[17] |  |  | $ 5,042,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14] |  |  | 2025-03 |  |  |  | 2025-03 |
Basis spread variable rate | [8],[14] |  |  | 4.70% |  |  |  | 4.70% |
Interest rate floor | [8],[14] |  |  | 7.95% |  |  |  | 7.95% |
Interest rate paid in kind | [8],[14] |  |  | 1.50% |  |  |  | 1.50% |
Exit fee rate | [8],[14] |  |  | 4.50% |  |  |  | 4.50% |
Principal amount | [14] |  |  | $ 5,033,000 |  |  |  |  |
Investment cost | [6],[14] |  |  | 4,988,000 |  |  |  |  |
Investments, at fair value: | [14] |  |  | $ 5,124,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[10] | 2025-03 |  |  |  | 2025-03 |  |  |
Basis spread variable rate | [9],[10],[11] | 4.00% |  |  |  | 4.00% |  |  |
Interest rate floor | [9],[10],[11] | 7.25% |  |  |  | 7.25% |  |  |
Interest rate paid in kind | [9],[10],[11] | 1.25% |  |  |  | 1.25% |  |  |
Exit fee rate | [9],[10],[11] | 4.50% |  |  |  | 4.50% |  |  |
Principal amount | [9],[10] | $ 5,107,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[10] | 5,176,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10] | $ 5,230,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[12] | 2025-03 |  |  |  | 2025-03 |  |  |
Basis spread variable rate | [9],[11],[12] | 4.70% |  |  |  | 4.70% |  |  |
Interest rate floor | [9],[11],[12] | 7.95% |  |  |  | 7.95% |  |  |
Interest rate paid in kind | [9],[11],[12] | 1.50% |  |  |  | 1.50% |  |  |
Exit fee rate | [9],[11],[12] | 4.50% |  |  |  | 4.50% |  |  |
Principal amount | [9],[12] | $ 5,110,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[12] | 5,189,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[12] | $ 5,286,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 1-month SOFR + 9.35%, Floor rate 10.25%, 3.20% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [20],[26],[27],[31] | 2025-02 |  |  |  | 2025-02 |  |  |
Basis spread variable rate | [11],[20],[26],[27],[31] | 9.35% |  |  |  | 9.35% |  |  |
Interest rate floor | [11],[20],[26],[27],[31] | 10.25% |  |  |  | 10.25% |  |  |
Exit fee rate | [11],[20],[26],[27],[31] | 3.20% |  |  |  | 3.20% |  |  |
Principal amount | [20],[26],[27],[31] | $ 6,250,000 |  |  |  |  |  |  |
Investment cost | [2],[20],[26],[27],[31] | 6,308,000 |  |  |  |  |  |  |
Investments, at fair value: | [20],[26],[27],[31] | $ 6,344,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 3-month SOFR + 9.40%, Floor rate 10.25%, 3.20% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [12],[20],[21],[26],[27],[31] | 2025-02 |  |  |  | 2025-02 |  |  |
Basis spread variable rate | [11],[12],[20],[21],[26],[27],[31] | 9.40% |  |  |  | 9.40% |  |  |
Interest rate floor | [11],[12],[20],[21],[26],[27],[31] | 10.25% |  |  |  | 10.25% |  |  |
Exit fee rate | [11],[12],[20],[21],[26],[27],[31] | 3.20% |  |  |  | 3.20% |  |  |
Principal amount | [12],[20],[21],[26],[27],[31] | $ 88,250,000 |  |  |  |  |  |  |
Investment cost | [2],[12],[20],[21],[26],[27],[31] | 89,318,000 |  |  |  |  |  |  |
Investments, at fair value: | [12],[20],[21],[26],[27],[31] | $ 89,653,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.25%, Floor rate 10.25%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [13],[15],[18],[19],[24],[25] |  |  | 2025-02 |  |  |  | 2025-02 |
Basis spread variable rate | [8],[13],[15],[18],[19],[24],[25] |  |  | 9.25% |  |  |  | 9.25% |
Interest rate floor | [8],[13],[15],[18],[19],[24],[25] |  |  | 10.25% |  |  |  | 10.25% |
Exit fee rate | [8],[13],[15],[18],[19],[24],[25] |  |  | 3.00% |  |  |  | 3.00% |
Principal amount | [13],[15],[18],[19],[24],[25] |  |  | $ 94,500,000 |  |  |  |  |
Investment cost | [6],[13],[15],[18],[19],[24],[25] |  |  | 94,418,000 |  |  |  |  |
Investments, at fair value: | [13],[15],[18],[19],[24],[25] |  |  | 93,837,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, SeatGeek, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Principal amount |  |  |  | 85,986,000 |  |  |  |  |
Investment cost | [6] |  |  | 85,633,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 86,544,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, Tectura Corporation |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Principal amount |  |  |  | 31,953,000 |  |  |  |  |
Investment cost | [6] |  |  | 21,513,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 8,042,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, Veem, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Principal amount |  |  |  | 10,076,000 |  |  |  |  |
Investment cost | [6] |  |  | 9,988,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 10,166,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (2.40%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 2.40% |  |  |  | 2.40% |
Investment cost | [6] |  |  | $ 36,567,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 33,700,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (3.17%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 3.17% |  |  |  | 3.17% |  |  |
Investment cost | [2] | $ 56,764,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 57,096,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Principal amount |  | 35,000,000 |  |  |  |  |  |  |
Investment cost | [2] | 34,478,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 34,478,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), UnSecured, Maturity Date September 2026, FIXED + 11.95% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [32],[35] | 2026-09 |  |  |  | 2026-09 |  |  |
Interest rate paid in cash | [11],[32],[35] | 11.95% |  |  |  | 11.95% |  |  |
Principal amount | [32],[35] | $ 10,000,000 |  |  |  |  |  |  |
Investment cost | [2],[32],[35] | 9,815,000 |  |  |  |  |  |  |
Investments, at fair value: | [32],[35] | $ 9,815,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, Maturity Date September 2026, FIXED 11.50% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [32],[35] | 2026-09 |  |  |  | 2026-09 |  |  |
Interest rate paid in cash | [11],[32],[35] | 11.50% |  |  |  | 11.50% |  |  |
Principal amount | [32],[35] | $ 25,000,000 |  |  |  |  |  |  |
Investment cost | [2],[32],[35] | 24,663,000 |  |  |  |  |  |  |
Investments, at fair value: | [32],[35] | $ 24,663,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 11.50% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [34] |  |  | 2026-09 |  |  |  | 2026-09 |
Interest rate paid in cash | [8],[34] |  |  | 11.50% |  |  |  | 11.50% |
Principal amount | [34] |  |  | $ 10,000,000 |  |  |  |  |
Investment cost | [6],[34] |  |  | 9,852,000 |  |  |  |  |
Investments, at fair value: | [34] |  |  | $ 8,898,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 14.50% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [34] |  |  | 2026-09 |  |  |  | 2026-09 |
Interest rate paid in cash | [8],[34] |  |  | 14.50% |  |  |  | 14.50% |
Principal amount | [34] |  |  | $ 15,000,000 |  |  |  |  |
Investment cost | [6],[34] |  |  | 14,715,000 |  |  |  |  |
Investments, at fair value: | [34] |  |  | $ 12,802,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2025-06 | [32],[36] | 2025-06 | [34] | 2025-06 | [32],[36] | 2025-06 | [34]
Interest rate paid in cash |  | 5.00% | [11],[32],[36] | 5.00% | [8],[34] | 5.00% | [11],[32],[36] | 5.00% | [8],[34]
Principal amount |  | $ 12,000,000 | [32],[36] | $ 12,000,000 | [34] |  |  |  |
Investment cost |  | 12,000,000 | [2],[32],[36] | 12,000,000 | [6],[34] |  |  |  |
Investments, at fair value: |  | $ 12,000,000 | [32],[36] | 12,000,000 | [34] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Next Insurance, Inc, Senior Secured, Maturity Date February 2028, Prime + -1.50%, Floor rate 4.75%, PIK Interest 5.50% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[20],[22] | 2028-02 |  |  |  | 2028-02 |  |  |
Basis spread variable rate | [9],[11],[20],[22] | (1.50%) |  |  |  | (1.50%) |  |  |
Interest rate floor | [9],[11],[20],[22] | 4.75% |  |  |  | 4.75% |  |  |
Interest rate paid in kind | [9],[11],[20],[22] | 5.50% |  |  |  | 5.50% |  |  |
Principal amount | [9],[20],[22] | $ 10,469,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[20],[22] | 10,286,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[20],[22] | $ 10,618,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services, Gibraltar Business Capital, LLC, Unsecured |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Principal amount |  |  |  | 25,000,000 |  |  |  |  |
Investment cost | [6] |  |  | 24,567,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 21,700,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (66.60%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 66.60% |  |  |  | 66.60% |  |  |
Investment cost | [2] | $ 1,184,022,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 1,200,667,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (78.59%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 78.59% |  |  |  | 78.59% |
Investment cost | [6] |  |  | $ 1,107,352,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 1,101,430,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V. Senior Secured, Maturity Date August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-08 | [26],[27] | 2026-08 | [24],[25] | 2026-08 | [26],[27] | 2026-08 | [24],[25]
Basis spread variable rate |  | 4.55% | [11],[26],[27] | 4.55% | [8],[24],[25] | 4.55% | [11],[26],[27] | 4.55% | [8],[24],[25]
Interest rate floor |  | 8.55% | [11],[26],[27] | 8.55% | [8],[24],[25] | 8.55% | [11],[26],[27] | 8.55% | [8],[24],[25]
Exit fee rate |  | 6.95% | [11],[26],[27] | 6.95% | [8],[24],[25] | 6.95% | [11],[26],[27] | 6.95% | [8],[24],[25]
Principal amount |  | $ 10,500,000 | [26],[27] | $ 10,500,000 | [24],[25] |  |  |  |
Investment cost |  | 10,695,000 | [2],[26],[27] | 10,513,000 | [6],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 10,904,000 | [26],[27] | $ 10,513,000 | [24],[25] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date January 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-01 | [10],[22],[26] | 2027-01 | [7],[17],[24] | 2027-01 | [10],[22],[26] | 2027-01 | [7],[17],[24]
Basis spread variable rate |  | 3.65% | [10],[11],[22],[26] | 3.65% | [7],[8],[17],[24] | 3.65% | [10],[11],[22],[26] | 3.65% | [7],[8],[17],[24]
Interest rate floor |  | 7.65% | [10],[11],[22],[26] | 7.65% | [7],[8],[17],[24] | 7.65% | [10],[11],[22],[26] | 7.65% | [7],[8],[17],[24]
Exit fee rate |  | 5.85% | [10],[11],[22],[26] | 5.85% | [7],[8],[17],[24] | 5.85% | [10],[11],[22],[26] | 5.85% | [7],[8],[17],[24]
Principal amount |  | $ 12,500,000 | [10],[22],[26] | $ 5,000,000 | [7],[17],[24] |  |  |  |
Investment cost |  | 12,525,000 | [2],[10],[22],[26] | 4,986,000 | [6],[7],[17],[24] |  |  |  |
Investments, at fair value: |  | $ 13,065,000 | [10],[22],[26] | $ 5,039,000 | [7],[17],[24] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2024-10 | [21] | 2024-10 | [15] | 2024-10 | [21] | 2024-10 | [15]
Basis spread variable rate |  | 3.10% | [11],[21] | 3.10% | [8],[15] | 3.10% | [11],[21] | 3.10% | [8],[15]
Interest rate floor |  | 8.60% | [11],[21] | 8.60% | [8],[15] | 8.60% | [11],[21] | 8.60% | [8],[15]
Exit fee rate |  | 8.90% | [11],[21] | 8.90% | [8],[15] | 8.90% | [11],[21] | 8.90% | [8],[15]
Principal amount |  | $ 15,000,000 | [21] | $ 15,000,000 | [15] |  |  |  |
Investment cost |  | 15,152,000 | [2],[21] | 15,879,000 | [6],[15] |  |  |  |
Investments, at fair value: |  | $ 15,152,000 | [21] | $ 15,974,000 | [15] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 10.60% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[17] |  |  | 2026-09 |  |  |  | 2026-09 |
Basis spread variable rate | [7],[8],[17] |  |  | 3.65% |  |  |  | 3.65% |
Interest rate floor | [7],[8],[17] |  |  | 8.40% |  |  |  | 8.40% |
Interest rate cap | [7],[8],[17] |  |  | 10.90% |  |  |  | 10.90% |
Exit fee rate | [7],[8],[17] |  |  | 10.60% |  |  |  | 10.60% |
Principal amount | [7],[17] |  |  | $ 15,000,000 |  |  |  |  |
Investment cost | [6],[7],[17] |  |  | 14,920,000 |  |  |  |  |
Investments, at fair value: | [7],[17] |  |  | $ 14,920,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 5.30% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10] | 2026-09 |  |  |  | 2026-09 |  |  |
Basis spread variable rate | [10],[11] | 3.65% |  |  |  | 3.65% |  |  |
Interest rate floor | [10],[11] | 8.40% |  |  |  | 8.40% |  |  |
Interest rate cap | [10],[11] | 10.90% |  |  |  | 10.90% |  |  |
Exit fee rate | [10],[11] | 5.30% |  |  |  | 5.30% |  |  |
Principal amount | [10] | $ 35,000,000 |  |  |  |  |  |  |
Investment cost | [2],[10] | 35,173,000 |  |  |  |  |  |  |
Investments, at fair value: | [10] | $ 36,855,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-01 | [1] | 2027-01 | [30] | 2027-01 | [1] | 2027-01 | [30]
Basis spread variable rate |  | 2.50% | [1],[11] | 2.50% | [8],[30] | 2.50% | [1],[11] | 2.50% | [8],[30]
Interest rate floor |  | 9.50% | [1],[11] | 9.50% | [8],[30] | 9.50% | [1],[11] | 9.50% | [8],[30]
Interest rate cap |  | 10.75% | [1],[11] | 10.75% | [8],[30] | 10.75% | [1],[11] | 10.75% | [8],[30]
Exit fee rate |  | 5.85% | [1],[11] | 5.85% | [8],[30] | 5.85% | [1],[11] | 5.85% | [8],[30]
Principal amount |  | $ 24,000,000 | [1] | $ 24,000,000 | [30] |  |  |  |
Investment cost |  | 24,120,000 | [1],[2] | 23,663,000 | [6],[30] |  |  |  |
Investments, at fair value: |  | $ 24,514,000 | [1] | $ 23,663,000 | [30] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc. Senior Secured, Maturity Date September 2024, Prime + 6.40%, Floor rate 9.65%, Cap rate 15.00%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [15],[30] |  |  | 2024-09 |  |  |  | 2024-09 |
Basis spread variable rate | [8],[15],[30] |  |  | 6.40% |  |  |  | 6.40% |
Interest rate floor | [8],[15],[30] |  |  | 9.65% |  |  |  | 9.65% |
Interest rate cap | [8],[15],[30] |  |  | 15.00% |  |  |  | 15.00% |
Exit fee rate | [8],[15],[30] |  |  | 6.95% |  |  |  | 6.95% |
Principal amount | [15],[30] |  |  | $ 40,000,000 |  |  |  |  |
Investment cost | [6],[15],[30] |  |  | 41,644,000 |  |  |  |  |
Investments, at fair value: | [15],[30] |  |  | $ 43,183,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date January 2028 Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [12],[21],[26],[31] | 2028-01 |  |  |  | 2028-01 |  |  |
Basis spread variable rate | [11],[12],[21],[26],[31] | 2.20% |  |  |  | 2.20% |  |  |
Interest rate floor | [11],[12],[21],[26],[31] | 9.95% |  |  |  | 9.95% |  |  |
Interest rate cap | [11],[12],[21],[26],[31] | 10.70% |  |  |  | 10.70% |  |  |
Exit fee rate | [11],[12],[21],[26],[31] | 5.78% |  |  |  | 5.78% |  |  |
Principal amount | [12],[21],[26],[31] | $ 143,350,000 |  |  |  |  |  |  |
Investment cost | [2],[12],[21],[26],[31] | 143,646,000 |  |  |  |  |  |  |
Investments, at fair value: | [12],[21],[26],[31] | $ 150,255,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 5.70%, Floor rate 8.95%, Cap rate 10.70%, 5.31% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[15],[18],[19],[24] |  |  | 2026-10 |  |  |  | 2026-10 |
Basis spread variable rate | [7],[8],[15],[18],[19],[24] |  |  | 5.70% |  |  |  | 5.70% |
Interest rate floor | [7],[8],[15],[18],[19],[24] |  |  | 8.95% |  |  |  | 8.95% |
Interest rate cap | [7],[8],[15],[18],[19],[24] |  |  | 10.70% |  |  |  | 10.70% |
Exit fee rate | [7],[8],[15],[18],[19],[24] |  |  | 5.31% |  |  |  | 5.31% |
Principal amount | [7],[15],[18],[19],[24] |  |  | $ 81,725,000 |  |  |  |  |
Investment cost | [6],[7],[15],[18],[19],[24] |  |  | 81,631,000 |  |  |  |  |
Investments, at fair value: | [7],[15],[18],[19],[24] |  |  | $ 78,074,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, Maturity Date July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2025-07 | [12],[21],[26],[27] | 2025-07 | [15],[18],[24],[25] | 2025-07 | [12],[21],[26],[27] | 2025-07 | [15],[18],[24],[25]
Basis spread variable rate |  | 4.55% | [11],[12],[21],[26],[27] | 4.55% | [8],[15],[18],[24],[25] | 4.55% | [11],[12],[21],[26],[27] | 4.55% | [8],[15],[18],[24],[25]
Interest rate floor |  | 8.05% | [11],[12],[21],[26],[27] | 8.05% | [8],[15],[18],[24],[25] | 8.05% | [11],[12],[21],[26],[27] | 8.05% | [8],[15],[18],[24],[25]
Interest rate cap |  | 9.05% | [11],[12],[21],[26],[27] | 9.05% | [8],[15],[18],[24],[25] | 9.05% | [11],[12],[21],[26],[27] | 9.05% | [8],[15],[18],[24],[25]
Exit fee rate |  | 5.00% | [11],[12],[21],[26],[27] | 5.00% | [8],[15],[18],[24],[25] | 5.00% | [11],[12],[21],[26],[27] | 5.00% | [8],[15],[18],[24],[25]
Principal amount |  | $ 11,500,000 | [12],[21],[26],[27] | $ 11,500,000 | [15],[18],[24],[25] |  |  |  |
Investment cost |  | 11,880,000 | [2],[12],[21],[26],[27] | 11,757,000 | [6],[15],[18],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 11,783,000 | [12],[21],[26],[27] | $ 11,435,000 | [15],[18],[24],[25] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and BiomX, INC, Senior Secured, Maturity Date September 2025, Prime + 5.70%, Floor rate 8.95%, 6.55% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2025-09 | [21],[26],[27] | 2025-09 | [15],[24],[25] | 2025-09 | [21],[26],[27] | 2025-09 | [15],[24],[25]
Basis spread variable rate |  | 5.70% | [11],[21],[26],[27] | 5.70% | [8],[15],[24],[25] | 5.70% | [11],[21],[26],[27] | 5.70% | [8],[15],[24],[25]
Interest rate floor |  | 8.95% | [11],[21],[26],[27] | 8.95% | [8],[15],[24],[25] | 8.95% | [11],[21],[26],[27] | 8.95% | [8],[15],[24],[25]
Exit fee rate |  | 6.55% | [11],[21],[26],[27] | 6.55% | [8],[15],[24],[25] | 6.55% | [11],[21],[26],[27] | 6.55% | [8],[15],[24],[25]
Principal amount |  | $ 6,448,000 | [21],[26],[27] | $ 9,000,000 | [15],[24],[25] |  |  |  |
Investment cost |  | 6,807,000 | [2],[21],[26],[27] | 9,174,000 | [6],[15],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 6,790,000 | [21],[26],[27] | $ 9,052,000 | [15],[24],[25] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Basis spread variable rate | [9],[11] | 2.45% |  |  |  | 2.45% |  |  |
Interest rate floor | [9],[11] | 10.95% |  |  |  | 10.95% |  |  |
Interest rate paid in kind | [9],[11] | 1.10% |  |  |  | 1.10% |  |  |
Exit fee rate | [9],[11] | 5.45% |  |  |  | 5.45% |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9] | 2028-10 |  |  |  | 2028-10 |  |  |
Principal amount | [9] | $ 52,601,000 |  |  |  |  |  |  |
Investment cost | [2],[9] | 52,185,000 |  |  |  |  |  |  |
Investments, at fair value: | [9] | $ 52,185,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and BridgeBio Pharma, Inc. Senior Secured, Maturity Date November 2026, FIXED 9.00%, 2.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-11 | [9],[10],[12] | 2026-11 | [14],[17],[18] | 2026-11 | [9],[10],[12] | 2026-11 | [14],[17],[18]
Interest rate paid in cash |  | 9.00% | [9],[10],[11],[12] | 9.00% | [8],[14],[17],[18] | 9.00% | [9],[10],[11],[12] | 9.00% | [8],[14],[17],[18]
Exit fee rate |  | 2.00% | [9],[10],[11],[12] | 2.00% | [8],[14],[17],[18] | 2.00% | [9],[10],[11],[12] | 2.00% | [8],[14],[17],[18]
Principal amount |  | $ 38,167,000 | [9],[10],[12] | $ 37,312,000 | [14],[17],[18] |  |  |  |
Investment cost |  | 38,124,000 | [2],[9],[10],[12] | 37,039,000 | [6],[14],[17],[18] |  |  |  |
Investments, at fair value: |  | $ 35,498,000 | [9],[10],[12] | $ 33,344,000 | [14],[17],[18] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and COMPASS Pathways plc Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[26],[27] | 2027-07 |  |  |  | 2027-07 |  |  |
Basis spread variable rate | [9],[11],[26],[27] | 1.50% |  |  |  | 1.50% |  |  |
Interest rate floor | [9],[11],[26],[27] | 9.75% |  |  |  | 9.75% |  |  |
Interest rate paid in kind | [9],[11],[26],[27] | 1.40% |  |  |  | 1.40% |  |  |
Exit fee rate | [9],[11],[26],[27] | 4.75% |  |  |  | 4.75% |  |  |
Principal amount | [9],[26],[27] | $ 24,144,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[26],[27] | 23,798,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[26],[27] | $ 24,601,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Cellarity, Inc. Senior Secured, Maturity Date June 2026, Prime + 5.70%, Floor rate 8.95%, 3.75% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-06 | [1],[10] | 2026-06 | [17],[30] | 2026-06 | [1],[10] | 2026-06 | [17],[30]
Basis spread variable rate |  | 5.70% | [1],[10],[11] | 5.70% | [8],[17],[30] | 5.70% | [1],[10],[11] | 5.70% | [8],[17],[30]
Interest rate floor |  | 8.95% | [1],[10],[11] | 8.95% | [8],[17],[30] | 8.95% | [1],[10],[11] | 8.95% | [8],[17],[30]
Exit fee rate |  | 3.75% | [1],[10],[11] | 3.75% | [8],[17],[30] | 3.75% | [1],[10],[11] | 3.75% | [8],[17],[30]
Principal amount |  | $ 29,193,000 | [1],[10] | $ 30,000,000 | [17],[30] |  |  |  |
Investment cost |  | 29,482,000 | [1],[2],[10] | 29,841,000 | [6],[17],[30] |  |  |  |
Investments, at fair value: |  | $ 30,051,000 | [1],[10] | $ 30,097,000 | [17],[30] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Century Therapeutics, Inc. Senior Secured, Maturity Date April 2024, Prime + 6.30%, Floor rate 9.55%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [15] |  |  | 2024-04 |  |  |  | 2024-04 |
Basis spread variable rate | [8],[15] |  |  | 6.30% |  |  |  | 6.30% |
Interest rate floor | [8],[15] |  |  | 9.55% |  |  |  | 9.55% |
Exit fee rate | [8],[15] |  |  | 3.95% |  |  |  | 3.95% |
Principal amount | [15] |  |  | $ 10,000,000 |  |  |  |  |
Investment cost | [6],[15] |  |  | 10,235,000 |  |  |  |  |
Investments, at fair value: | [15] |  |  | $ 10,292,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Codiak Biosciences, Inc. Senior Secured, Maturity Date October 2025, Prime + 5.00%, Floor rate 8.25%, 5.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [15] |  |  | 2025-10 |  |  |  | 2025-10 |
Basis spread variable rate | [8],[15] |  |  | 5.00% |  |  |  | 5.00% |
Interest rate floor | [8],[15] |  |  | 8.25% |  |  |  | 8.25% |
Exit fee rate | [8],[15] |  |  | 5.50% |  |  |  | 5.50% |
Principal amount | [15] |  |  | $ 25,000,000 |  |  |  |  |
Investment cost | [6],[15] |  |  | 25,759,000 |  |  |  |  |
Investments, at fair value: | [15] |  |  | $ 25,177,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-09 | [10],[31] | 2026-09 | [17],[19] | 2026-09 | [10],[31] | 2026-09 | [17],[19]
Basis spread variable rate |  | 5.70% | [10],[11],[31] | 5.70% | [8],[17],[19] | 5.70% | [10],[11],[31] | 5.70% | [8],[17],[19]
Interest rate floor |  | 8.95% | [10],[11],[31] | 8.95% | [8],[17],[19] | 8.95% | [10],[11],[31] | 8.95% | [8],[17],[19]
Exit fee rate |  | 7.75% | [10],[11],[31] | 7.75% | [8],[17],[19] | 7.75% | [10],[11],[31] | 7.75% | [8],[17],[19]
Principal amount |  | $ 105,225,000 | [10],[31] | $ 132,675,000 | [17],[19] |  |  |  |
Investment cost |  | 107,667,000 | [2],[10],[31] | 133,557,000 | [6],[17],[19] |  |  |  |
Investments, at fair value: |  | $ 108,545,000 | [10],[31] | $ 135,619,000 | [17],[19] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Curevo, Inc. Senior Secured, Maturity Date June 2027 Prime + 1.70%, Floor rate 9.70%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1] | 2027-06 |  |  |  | 2027-06 |  |  |
Basis spread variable rate | [1],[11] | 1.70% |  |  |  | 1.70% |  |  |
Interest rate floor | [1],[11] | 9.70% |  |  |  | 9.70% |  |  |
Exit fee rate | [1],[11] | 6.95% |  |  |  | 6.95% |  |  |
Principal amount | [1] | $ 10,000,000 |  |  |  |  |  |  |
Investment cost | [1],[2] | 9,821,000 |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 10,076,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 6.55% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2025-04 | [1] | 2025-04 | [30] | 2025-04 | [1] | 2025-04 | [30]
Basis spread variable rate |  | 6.25% | [1],[11] | 6.25% | [8],[30] | 6.25% | [1],[11] | 6.25% | [8],[30]
Interest rate floor |  | 9.50% | [1],[11] | 9.50% | [8],[30] | 9.50% | [1],[11] | 9.50% | [8],[30]
Exit fee rate |  | 6.55% | [1],[11] | 6.55% | [8],[30] | 6.55% | [1],[11] | 6.55% | [8],[30]
Principal amount |  | $ 3,099,000 | [1] | $ 12,500,000 | [30] |  |  |  |
Investment cost |  | 3,789,000 | [1],[2] | 12,753,000 | [6],[30] |  |  |  |
Investments, at fair value: |  | $ 3,731,000 | [1] | $ 12,535,000 | [30] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Finch Therapeutics Group, Inc. Senior Secured, Maturity Date November 2026, Prime + 4.05%, Floor rate 7.55%, Cap rate 8.80%, 5.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  |  |  | 2026-11 |  |  |  | 2026-11 |
Basis spread variable rate | [8] |  |  | 4.05% |  |  |  | 4.05% |
Interest rate floor | [8] |  |  | 7.55% |  |  |  | 7.55% |
Interest rate cap | [8] |  |  | 8.80% |  |  |  | 8.80% |
Exit fee rate | [8] |  |  | 5.50% |  |  |  | 5.50% |
Principal amount |  |  |  | $ 15,000,000 |  |  |  |  |
Investment cost | [6] |  |  | 15,012,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 13,940,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc. Senior Secured, Maturity Date November 2026, Prime + 5.90%, Floor rate 9.15%, 9.86% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[15],[18],[30] |  |  | 2026-11 |  |  |  | 2026-11 |
Basis spread variable rate | [7],[8],[15],[18],[30] |  |  | 5.90% |  |  |  | 5.90% |
Interest rate floor | [7],[8],[15],[18],[30] |  |  | 9.15% |  |  |  | 9.15% |
Exit fee rate | [7],[8],[15],[18],[30] |  |  | 9.86% |  |  |  | 9.86% |
Principal amount | [7],[15],[18],[30] |  |  | $ 58,125,000 |  |  |  |  |
Investment cost | [6],[7],[15],[18],[30] |  |  | 58,674,000 |  |  |  |  |
Investments, at fair value: | [7],[15],[18],[30] |  |  | $ 58,407,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc., Senior Secured, Maturity Date November 2026, Prime + 5.65%, Floor rate 9.15%, 11.41% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1],[12],[21] | 2026-11 |  |  |  | 2026-11 |  |  |
Basis spread variable rate | [1],[11],[12],[21] | 5.65% |  |  |  | 5.65% |  |  |
Interest rate floor | [1],[11],[12],[21] | 9.15% |  |  |  | 9.15% |  |  |
Exit fee rate | [1],[11],[12],[21] | 11.41% |  |  |  | 11.41% |  |  |
Principal amount | [1],[12],[21] | $ 38,750,000 |  |  |  |  |  |  |
Investment cost | [1],[2],[12],[21] | 39,679,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[12],[21] | $ 40,421,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date April 2025, Prime + 4.50%, Floor rate 9.00%, 6.55% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10],[12],[26] | 2025-04 |  |  |  | 2025-04 |  |  |
Basis spread variable rate | [10],[11],[12],[26] | 4.50% |  |  |  | 4.50% |  |  |
Interest rate floor | [10],[11],[12],[26] | 9.00% |  |  |  | 9.00% |  |  |
Exit fee rate | [10],[11],[12],[26] | 6.55% |  |  |  | 6.55% |  |  |
Principal amount | [10],[12],[26] | $ 30,200,000 |  |  |  |  |  |  |
Investment cost | [2],[10],[12],[26] | 31,005,000 |  |  |  |  |  |  |
Investments, at fair value: | [10],[12],[26] | $ 31,210,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date October 2024, Prime + 5.75%, Floor rate 9.00%, 6.55% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [17],[18],[24] |  |  | 2024-10 |  |  |  | 2024-10 |
Basis spread variable rate | [8],[17],[18],[24] |  |  | 5.75% |  |  |  | 5.75% |
Interest rate floor | [8],[17],[18],[24] |  |  | 9.00% |  |  |  | 9.00% |
Exit fee rate | [8],[17],[18],[24] |  |  | 6.55% |  |  |  | 6.55% |
Principal amount | [17],[18],[24] |  |  | $ 18,500,000 |  |  |  |  |
Investment cost | [6],[17],[18],[24] |  |  | 19,109,000 |  |  |  |  |
Investments, at fair value: | [17],[18],[24] |  |  | $ 19,174,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Gritstone Bio, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[14] |  |  | 2027-07 |  |  |  | 2027-07 |
Basis spread variable rate | [7],[8],[14] |  |  | 3.15% |  |  |  | 3.15% |
Interest rate floor | [7],[8],[14] |  |  | 7.15% |  |  |  | 7.15% |
Interest rate cap | [7],[8],[14] |  |  | 8.65% |  |  |  | 8.65% |
Interest rate paid in kind | [7],[8],[14] |  |  | 2.00% |  |  |  | 2.00% |
Exit fee rate | [7],[8],[14] |  |  | 5.75% |  |  |  | 5.75% |
Principal amount | [7],[14] |  |  | $ 15,113,000 |  |  |  |  |
Investment cost | [6],[7],[14] |  |  | 15,109,000 |  |  |  |  |
Investments, at fair value: | [7],[14] |  |  | $ 15,109,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Gritstone Bio, Inc., Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[10] | 2027-07 |  |  |  | 2027-07 |  |  |
Basis spread variable rate | [9],[10],[11] | 3.15% |  |  |  | 3.15% |  |  |
Interest rate floor | [9],[10],[11] | 7.15% |  |  |  | 7.15% |  |  |
Interest rate cap | [9],[10],[11] | 8.65% |  |  |  | 8.65% |  |  |
Interest rate paid in kind | [9],[10],[11] | 2.00% |  |  |  | 2.00% |  |  |
Exit fee rate | [9],[10],[11] | 5.75% |  |  |  | 5.75% |  |  |
Principal amount | [9],[10] | $ 30,532,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[10] | 30,717,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10] | $ 30,909,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc., Senior Secured, Maturity Date February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1],[9],[22] | 2026-02 |  |  |  | 2026-02 |  |  |
Basis spread variable rate | [1],[9],[11],[22] | 1.70% |  |  |  | 1.70% |  |  |
Interest rate floor | [1],[9],[11],[22] | 9.95% |  |  |  | 9.95% |  |  |
Interest rate paid in kind | [1],[9],[11],[22] | 1.50% |  |  |  | 1.50% |  |  |
Exit fee rate | [1],[9],[11],[22] | 3.00% |  |  |  | 3.00% |  |  |
Principal amount | [1],[9],[22] | $ 20,095,000 |  |  |  |  |  |  |
Investment cost | [1],[2],[9],[22] | 19,788,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[9],[22] | $ 19,788,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Hibercell, Inc. Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [17],[30] |  |  | 2025-05 |  |  |  | 2025-05 |
Basis spread variable rate | [8],[17],[30] |  |  | 5.40% |  |  |  | 5.40% |
Interest rate floor | [8],[17],[30] |  |  | 8.65% |  |  |  | 8.65% |
Exit fee rate | [8],[17],[30] |  |  | 4.95% |  |  |  | 4.95% |
Principal amount | [17],[30] |  |  | $ 17,000,000 |  |  |  |  |
Investment cost | [6],[17],[30] |  |  | 17,313,000 |  |  |  |  |
Investments, at fair value: | [17],[30] |  |  | $ 17,265,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Hibercell, Inc., Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1],[10] | 2025-05 |  |  |  | 2025-05 |  |  |
Basis spread variable rate | [1],[10],[11] | 5.40% |  |  |  | 5.40% |  |  |
Interest rate floor | [1],[10],[11] | 8.65% |  |  |  | 8.65% |  |  |
Exit fee rate | [1],[10],[11] | 4.95% |  |  |  | 4.95% |  |  |
Principal amount | [1],[10] | $ 12,535,000 |  |  |  |  |  |  |
Investment cost | [1],[2],[10] | 13,117,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[10] | $ 13,181,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and HilleVax, Inc. Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[14],[30] |  |  | 2027-05 |  |  |  | 2027-05 |
Basis spread variable rate | [7],[8],[14],[30] |  |  | 1.05% |  |  |  | 1.05% |
Interest rate floor | [7],[8],[14],[30] |  |  | 4.55% |  |  |  | 4.55% |
Interest rate cap | [7],[8],[14],[30] |  |  | 6.05% |  |  |  | 6.05% |
Interest rate paid in kind | [7],[8],[14],[30] |  |  | 2.85% |  |  |  | 2.85% |
Exit fee rate | [7],[8],[14],[30] |  |  | 7.15% |  |  |  | 7.15% |
Principal amount | [7],[14],[30] |  |  | $ 12,072,000 |  |  |  |  |
Investment cost | [6],[7],[14],[30] |  |  | 12,043,000 |  |  |  |  |
Investments, at fair value: | [7],[14],[30] |  |  | $ 11,333,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and HilleVax, Inc., Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1],[9] | 2027-05 |  |  |  | 2027-05 |  |  |
Basis spread variable rate | [1],[9],[11] | 1.05% |  |  |  | 1.05% |  |  |
Interest rate floor | [1],[9],[11] | 4.55% |  |  |  | 4.55% |  |  |
Interest rate cap | [1],[9],[11] | 6.05% |  |  |  | 6.05% |  |  |
Interest rate paid in kind | [1],[9],[11] | 2.85% |  |  |  | 2.85% |  |  |
Exit fee rate | [1],[9],[11] | 7.15% |  |  |  | 7.15% |  |  |
Principal amount | [1],[9] | $ 20,524,000 |  |  |  |  |  |  |
Investment cost | [1],[2],[9] | 20,685,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[9] | $ 20,335,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Iveric Bio, Inc. Senior Secured, Maturity Date August 2027, Prime + 4.00%, Floor rate 8.75%, Cap rate 10.25%, 4.25% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [18],[24] |  |  | 2027-08 |  |  |  | 2027-08 |
Basis spread variable rate | [8],[18],[24] |  |  | 4.00% |  |  |  | 4.00% |
Interest rate floor | [8],[18],[24] |  |  | 8.75% |  |  |  | 8.75% |
Interest rate cap | [8],[18],[24] |  |  | 10.25% |  |  |  | 10.25% |
Exit fee rate | [8],[18],[24] |  |  | 4.25% |  |  |  | 4.25% |
Principal amount | [18],[24] |  |  | $ 49,500,000 |  |  |  |  |
Investment cost | [6],[18],[24] |  |  | 49,090,000 |  |  |  |  |
Investments, at fair value: | [18],[24] |  |  | $ 49,090,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[24],[30] |  |  | 2027-11 |  |  |  | 2027-11 |
Basis spread variable rate | [7],[8],[24],[30] |  |  | 2.40% |  |  |  | 2.40% |
Interest rate floor | [7],[8],[24],[30] |  |  | 8.65% |  |  |  | 8.65% |
Exit fee rate | [7],[8],[24],[30] |  |  | 15.13% |  |  |  | 15.13% |
Principal amount | [7],[24],[30] |  |  | $ 5,500,000 |  |  |  |  |
Investment cost | [6],[7],[24],[30] |  |  | 5,448,000 |  |  |  |  |
Investments, at fair value: | [7],[24],[30] |  |  | $ 5,448,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1],[22],[26] | 2027-11 |  |  |  | 2027-11 |  |  |
Basis spread variable rate | [1],[11],[22],[26] | 2.40% |  |  |  | 2.40% |  |  |
Interest rate floor | [1],[11],[22],[26] | 8.65% |  |  |  | 8.65% |  |  |
Exit fee rate | [1],[11],[22],[26] | 15.13% |  |  |  | 15.13% |  |  |
Principal amount | [1],[22],[26] | $ 5,500,000 |  |  |  |  |  |  |
Investment cost | [1],[2],[22],[26] | 5,532,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[22],[26] | $ 5,752,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Locus Biosciences, Inc. Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [30] |  |  | 2025-07 |  |  |  | 2025-07 |
Basis spread variable rate | [8],[30] |  |  | 6.10% |  |  |  | 6.10% |
Interest rate floor | [8],[30] |  |  | 9.35% |  |  |  | 9.35% |
Exit fee rate | [8],[30] |  |  | 4.95% |  |  |  | 4.95% |
Principal amount | [30] |  |  | $ 8,000,000 |  |  |  |  |
Investment cost | [6],[30] |  |  | 8,120,000 |  |  |  |  |
Investments, at fair value: | [30] |  |  | $ 8,085,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Locus Biosciences, Inc., Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1] | 2025-07 |  |  |  | 2025-07 |  |  |
Basis spread variable rate | [1],[11] | 6.10% |  |  |  | 6.10% |  |  |
Interest rate floor | [1],[11] | 9.35% |  |  |  | 9.35% |  |  |
Exit fee rate | [1],[11] | 4.95% |  |  |  | 4.95% |  |  |
Principal amount | [1] | $ 5,399,000 |  |  |  |  |  |  |
Investment cost | [1],[2] | 5,651,000 |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 5,686,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2026, Prime + 3.95%, Floor rate 7.45%, 5.35% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[24] |  |  | 2026-05 |  |  |  | 2026-05 |
Basis spread variable rate | [7],[8],[24] |  |  | 3.95% |  |  |  | 3.95% |
Interest rate floor | [7],[8],[24] |  |  | 7.45% |  |  |  | 7.45% |
Exit fee rate | [7],[8],[24] |  |  | 5.35% |  |  |  | 5.35% |
Principal amount | [7],[24] |  |  | $ 34,000,000 |  |  |  |  |
Investment cost | [6],[7],[24] |  |  | 33,945,000 |  |  |  |  |
Investments, at fair value: | [7],[24] |  |  | $ 33,987,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Senior Secured, Maturity Date May 2026, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [26] | 2026-05 |  |  |  | 2026-05 |  |  |
Basis spread variable rate | [11],[26] | 2.45% |  |  |  | 2.45% |  |  |
Interest rate floor | [11],[26] | 8.25% |  |  |  | 8.25% |  |  |
Exit fee rate | [11],[26] | 5.35% |  |  |  | 5.35% |  |  |
Principal amount | [26] | $ 78,200,000 |  |  |  |  |  |  |
Investment cost | [2],[26] | 78,728,000 |  |  |  |  |  |  |
Investments, at fair value: | [26] | $ 81,945,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Nabriva Therapeutics, Senior Secured, Maturity Date June 2023, Prime + 4.30%, Floor rate 9.80%, 9.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [17],[24],[25] |  |  | 2023-06 |  |  |  | 2023-06 |
Basis spread variable rate | [8],[17],[24],[25] |  |  | 4.30% |  |  |  | 4.30% |
Interest rate floor | [8],[17],[24],[25] |  |  | 9.80% |  |  |  | 9.80% |
Exit fee rate | [8],[17],[24],[25] |  |  | 9.95% |  |  |  | 9.95% |
Principal amount | [17],[24],[25] |  |  | $ 2,079,000 |  |  |  |  |
Investment cost | [6],[17],[24],[25] |  |  | 2,734,000 |  |  |  |  |
Investments, at fair value: | [17],[24],[25] |  |  | $ 2,804,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc. Senior Secured, Maturity Date October 2026, Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.35%, 7.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[14],[18],[19],[24],[30],[37] |  |  | 2026-10 |  |  |  | 2026-10 |
Basis spread variable rate | [7],[8],[14],[18],[19],[24],[30],[37] |  |  | 2.25% |  |  |  | 2.25% |
Interest rate floor | [7],[8],[14],[18],[19],[24],[30],[37] |  |  | 5.50% |  |  |  | 5.50% |
Interest rate paid in kind | [7],[8],[14],[18],[19],[24],[30],[37] |  |  | 3.35% |  |  |  | 3.35% |
Exit fee rate | [7],[8],[14],[18],[19],[24],[30],[37] |  |  | 7.50% |  |  |  | 7.50% |
Principal amount | [7],[14],[18],[19],[24],[30],[37] |  |  | $ 94,737,000 |  |  |  |  |
Investment cost | [6],[7],[14],[18],[19],[24],[30],[37] |  |  | 95,032,000 |  |  |  |  |
Investments, at fair value: | [7],[14],[18],[19],[24],[30],[37] |  |  | $ 93,916,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.15%, 7.29% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1],[9],[12],[22],[26],[31],[38] | 2027-12 |  |  |  | 2027-12 |  |  |
Basis spread variable rate | [1],[9],[11],[12],[22],[26],[31],[38] | 1.35% |  |  |  | 1.35% |  |  |
Interest rate floor | [1],[9],[11],[12],[22],[26],[31],[38] | 9.85% |  |  |  | 9.85% |  |  |
Interest rate paid in kind | [1],[9],[11],[12],[22],[26],[31],[38] | 2.15% |  |  |  | 2.15% |  |  |
Exit fee rate | [1],[9],[11],[12],[22],[26],[31],[38] | 7.29% |  |  |  | 7.29% |  |  |
Principal amount | [1],[9],[12],[22],[26],[31],[38] | $ 129,699,000 |  |  |  |  |  |  |
Investment cost | [1],[2],[9],[12],[22],[26],[31],[38] | 130,934,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[9],[12],[22],[26],[31],[38] | $ 128,326,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Provention Bio, Inc. Senior Secured, Maturity Date September 2027, Prime + 2.70%, Floor rate 8.20%, 6.60% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7] |  |  | 2027-09 |  |  |  | 2027-09 |
Basis spread variable rate | [7],[8] |  |  | 2.70% |  |  |  | 2.70% |
Interest rate floor | [7],[8] |  |  | 8.20% |  |  |  | 8.20% |
Exit fee rate | [7],[8] |  |  | 6.60% |  |  |  | 6.60% |
Principal amount | [7] |  |  | $ 25,000,000 |  |  |  |  |
Investment cost | [6],[7] |  |  | 24,670,000 |  |  |  |  |
Investments, at fair value: | [7] |  |  | $ 24,670,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc. Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [30] |  |  | 2026-01 |  |  |  | 2026-01 |
Basis spread variable rate | [8],[30] |  |  | 4.25% |  |  |  | 4.25% |
Interest rate floor | [8],[30] |  |  | 7.50% |  |  |  | 7.50% |
Exit fee rate | [8],[30] |  |  | 3.80% |  |  |  | 3.80% |
Principal amount | [30] |  |  | $ 5,000,000 |  |  |  |  |
Investment cost | [6],[30] |  |  | 4,957,000 |  |  |  |  |
Investments, at fair value: | [30] |  |  | $ 4,946,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc., Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1] | 2026-01 |  |  |  | 2026-01 |  |  |
Basis spread variable rate | [1],[11] | 4.25% |  |  |  | 4.25% |  |  |
Interest rate floor | [1],[11] | 7.50% |  |  |  | 7.50% |  |  |
Exit fee rate | [1],[11] | 3.80% |  |  |  | 3.80% |  |  |
Principal amount | [1] | $ 5,000,000 |  |  |  |  |  |  |
Investment cost | [1],[2] | 5,047,000 |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 5,119,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc. Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[14],[24] |  |  | 2027-10 |  |  |  | 2027-10 |
Basis spread variable rate | [7],[8],[14],[24] |  |  | 1.75% |  |  |  | 1.75% |
Interest rate floor | [7],[8],[14],[24] |  |  | 7.25% |  |  |  | 7.25% |
Interest rate cap | [7],[8],[14],[24] |  |  | 9.00% |  |  |  | 9.00% |
Interest rate paid in kind | [7],[8],[14],[24] |  |  | 1.50% |  |  |  | 1.50% |
Exit fee rate | [7],[8],[14],[24] |  |  | 4.95% |  |  |  | 4.95% |
Principal amount | [7],[14],[24] |  |  | $ 20,754,000 |  |  |  |  |
Investment cost | [6],[7],[14],[24] |  |  | 20,656,000 |  |  |  |  |
Investments, at fair value: | [7],[14],[24] |  |  | $ 20,656,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc., Senior Secured, Maturity Date October 2026, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[12],[26] | 2027-10 |  |  |  | 2027-10 |  |  |
Basis spread variable rate | [9],[11],[12],[26] | 1.75% |  |  |  | 1.75% |  |  |
Interest rate floor | [9],[11],[12],[26] | 7.25% |  |  |  | 7.25% |  |  |
Interest rate cap | [9],[11],[12],[26] | 9.00% |  |  |  | 9.00% |  |  |
Interest rate paid in kind | [9],[11],[12],[26] | 1.50% |  |  |  | 1.50% |  |  |
Exit fee rate | [9],[11],[12],[26] | 4.95% |  |  |  | 4.95% |  |  |
Principal amount | [9],[12],[26] | $ 31,416,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[12],[26] | 31,450,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[12],[26] | $ 32,702,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Scynexis, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.80%, Floor rate 9.05%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [17],[18] |  |  | 2025-03 |  |  |  | 2025-03 |
Basis spread variable rate | [8],[17],[18] |  |  | 5.80% |  |  |  | 5.80% |
Interest rate floor | [8],[17],[18] |  |  | 9.05% |  |  |  | 9.05% |
Exit fee rate | [8],[17],[18] |  |  | 3.95% |  |  |  | 3.95% |
Principal amount | [17],[18] |  |  | $ 18,667,000 |  |  |  |  |
Investment cost | [6],[17],[18] |  |  | 18,675,000 |  |  |  |  |
Investments, at fair value: | [17],[18] |  |  | $ 18,698,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Seres Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 6.40%, Floor rate 9.65%, 4.98% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [17],[18] |  |  | 2024-10 |  |  |  | 2024-10 |
Basis spread variable rate | [8],[17],[18] |  |  | 6.40% |  |  |  | 6.40% |
Interest rate floor | [8],[17],[18] |  |  | 9.65% |  |  |  | 9.65% |
Exit fee rate | [8],[17],[18] |  |  | 4.98% |  |  |  | 4.98% |
Principal amount | [17],[18] |  |  | $ 37,500,000 |  |  |  |  |
Investment cost | [6],[17],[18] |  |  | 38,638,000 |  |  |  |  |
Investments, at fair value: | [17],[18] |  |  | $ 38,816,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and TG Therapeutics, Inc. Senior Secured, Maturity Date January 2026, Prime + 2.15%, Floor rate 5.40%, PIK Interest 3.45%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[15],[18],[24] |  |  | 2026-01 |  |  |  | 2026-01 |
Basis spread variable rate | [8],[14],[15],[18],[24] |  |  | 2.15% |  |  |  | 2.15% |
Interest rate floor | [8],[14],[15],[18],[24] |  |  | 5.40% |  |  |  | 5.40% |
Interest rate paid in kind | [8],[14],[15],[18],[24] |  |  | 3.45% |  |  |  | 3.45% |
Exit fee rate | [8],[14],[15],[18],[24] |  |  | 5.95% |  |  |  | 5.95% |
Principal amount | [14],[15],[18],[24] |  |  | $ 47,983,000 |  |  |  |  |
Investment cost | [6],[14],[15],[18],[24] |  |  | 47,889,000 |  |  |  |  |
Investments, at fair value: | [14],[15],[18],[24] |  |  | $ 48,649,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and TG Therapeutics, Inc., Senior Secured, Maturity Date January 2026, Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[12],[21],[26] | 2026-01 |  |  |  | 2026-01 |  |  |
Basis spread variable rate | [9],[11],[12],[21],[26] | 1.20% |  |  |  | 1.20% |  |  |
Interest rate floor | [9],[11],[12],[21],[26] | 8.95% |  |  |  | 8.95% |  |  |
Interest rate paid in kind | [9],[11],[12],[21],[26] | 2.25% |  |  |  | 2.25% |  |  |
Exit fee rate | [9],[11],[12],[21],[26] | 5.69% |  |  |  | 5.69% |  |  |
Principal amount | [9],[12],[21],[26] | $ 65,770,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[12],[21],[26] | 66,439,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[12],[21],[26] | $ 67,610,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc. Senior Secured, Maturity Date February 2027, Prime + 5.20%, Floor rate 8.45%, 4.75% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[17],[24] |  |  | 2027-02 |  |  |  | 2027-02 |
Basis spread variable rate | [7],[8],[17],[24] |  |  | 5.20% |  |  |  | 5.20% |
Interest rate floor | [7],[8],[17],[24] |  |  | 8.45% |  |  |  | 8.45% |
Exit fee rate | [7],[8],[17],[24] |  |  | 4.75% |  |  |  | 4.75% |
Principal amount | [7],[17],[24] |  |  | $ 8,250,000 |  |  |  |  |
Investment cost | [6],[7],[17],[24] |  |  | 8,274,000 |  |  |  |  |
Investments, at fair value: | [7],[17],[24] |  |  | $ 8,423,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Senior Secured, Maturity Date February 2027, Prime + 4.45%, Floor rate 8.45%, Cap rate 11.45%, 4.75% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10],[22],[26] | 2027-02 |  |  |  | 2027-02 |  |  |
Basis spread variable rate | [10],[11],[22],[26] | 4.45% |  |  |  | 4.45% |  |  |
Interest rate floor | [10],[11],[22],[26] | 8.45% |  |  |  | 8.45% |  |  |
Interest rate cap | [10],[11],[22],[26] | 11.45% |  |  |  | 11.45% |  |  |
Exit fee rate | [10],[11],[22],[26] | 4.75% |  |  |  | 4.75% |  |  |
Principal amount | [10],[22],[26] | $ 12,375,000 |  |  |  |  |  |  |
Investment cost | [2],[10],[22],[26] | 12,488,000 |  |  |  |  |  |  |
Investments, at fair value: | [10],[22],[26] | $ 12,916,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Unity Biotechnology, Inc. Senior Secured, Maturity Date August 2024, Prime + 6.10%, Floor rate 9.35%, 6.25% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [17] |  |  | 2024-08 |  |  |  | 2024-08 |
Basis spread variable rate | [8],[17] |  |  | 6.10% |  |  |  | 6.10% |
Interest rate floor | [8],[17] |  |  | 9.35% |  |  |  | 9.35% |
Exit fee rate | [8],[17] |  |  | 6.25% |  |  |  | 6.25% |
Principal amount | [17] |  |  | $ 20,000,000 |  |  |  |  |
Investment cost | [6],[17] |  |  | 21,079,000 |  |  |  |  |
Investments, at fair value: | [17] |  |  | $ 20,967,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Valo Health, LLC, Senior Secured, Maturity Date May 2024, Prime + 6.45%, Floor rate 9.70%, 3.85% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2024-05 | [10],[21] | 2024-05 | [15],[17] | 2024-05 | [10],[21] | 2024-05 | [15],[17]
Basis spread variable rate |  | 6.45% | [10],[11],[21] | 6.45% | [8],[15],[17] | 6.45% | [10],[11],[21] | 6.45% | [8],[15],[17]
Interest rate floor |  | 9.70% | [10],[11],[21] | 9.70% | [8],[15],[17] | 9.70% | [10],[11],[21] | 9.70% | [8],[15],[17]
Exit fee rate |  | 3.85% | [10],[11],[21] | 3.85% | [8],[15],[17] | 3.85% | [10],[11],[21] | 3.85% | [8],[15],[17]
Principal amount |  | $ 2,396,000 | [10],[21] | $ 8,146,000 | [15],[17] |  |  |  |
Investment cost |  | 2,808,000 | [2],[10],[21] | 8,416,000 | [6],[15],[17] |  |  |  |
Investments, at fair value: |  | $ 2,808,000 | [10],[21] | $ 8,410,000 | [15],[17] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Verona Pharma, Inc., Senior Secured, Maturity Date December 2028, 1-month SOFR + 5.85%, Floor rate 11.19%, Cap rate 13.19%, 3.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [26],[27] | 2028-12 |  |  |  | 2028-12 |  |  |
Basis spread variable rate | [11],[26],[27] | 5.85% |  |  |  | 5.85% |  |  |
Interest rate floor | [11],[26],[27] | 11.19% |  |  |  | 11.19% |  |  |
Interest rate cap | [11],[26],[27] | 13.19% |  |  |  | 13.19% |  |  |
Exit fee rate | [11],[26],[27] | 3.50% |  |  |  | 3.50% |  |  |
Principal amount | [26],[27] | $ 15,750,000 |  |  |  |  |  |  |
Investment cost | [2],[26],[27] | 15,646,000 |  |  |  |  |  |  |
Investments, at fair value: | [26],[27] | $ 15,646,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 4.76% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[17],[24] |  |  | 2026-10 |  |  |  | 2026-10 |
Basis spread variable rate | [7],[8],[17],[24] |  |  | 4.20% |  |  |  | 4.20% |
Interest rate floor | [7],[8],[17],[24] |  |  | 7.45% |  |  |  | 7.45% |
Interest rate cap | [7],[8],[17],[24] |  |  | 8.95% |  |  |  | 8.95% |
Exit fee rate | [7],[8],[17],[24] |  |  | 4.76% |  |  |  | 4.76% |
Principal amount | [7],[17],[24] |  |  | $ 2,000,000 |  |  |  |  |
Investment cost | [6],[7],[17],[24] |  |  | 2,012,000 |  |  |  |  |
Investments, at fair value: | [7],[17],[24] |  |  | $ 1,934,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10],[26] | 2026-10 |  |  |  | 2026-10 |  |  |
Basis spread variable rate | [10],[11],[26] | 4.20% |  |  |  | 4.20% |  |  |
Interest rate floor | [10],[11],[26] | 7.45% |  |  |  | 7.45% |  |  |
Interest rate cap | [10],[11],[26] | 8.95% |  |  |  | 8.95% |  |  |
Exit fee rate | [10],[11],[26] | 6.00% |  |  |  | 6.00% |  |  |
Principal amount | [10],[26] | $ 8,000,000 |  |  |  |  |  |  |
Investment cost | [2],[10],[26] | 8,057,000 |  |  |  |  |  |  |
Investments, at fair value: | [10],[26] | $ 8,023,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date July 2024, Prime + 3.75%, Floor rate 8.75%, 8.80% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [15],[17],[18] |  |  | 2024-07 |  |  |  | 2024-07 |
Basis spread variable rate | [8],[15],[17],[18] |  |  | 3.75% |  |  |  | 3.75% |
Interest rate floor | [8],[15],[17],[18] |  |  | 8.75% |  |  |  | 8.75% |
Exit fee rate | [8],[15],[17],[18] |  |  | 8.80% |  |  |  | 8.80% |
Principal amount | [15],[17],[18] |  |  | $ 32,500,000 |  |  |  |  |
Investment cost | [6],[15],[17],[18] |  |  | 33,705,000 |  |  |  |  |
Investments, at fair value: | [15],[17],[18] |  |  | $ 33,700,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Senior Secured, Maturity Date October 2026, Prime + 3.15%, Floor rate 10.15%, 3.80% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10],[12],[21] | 2026-10 |  |  |  | 2026-10 |  |  |
Basis spread variable rate | [10],[11],[12],[21] | 3.15% |  |  |  | 3.15% |  |  |
Interest rate floor | [10],[11],[12],[21] | 10.15% |  |  |  | 10.15% |  |  |
Exit fee rate | [10],[11],[12],[21] | 3.80% |  |  |  | 3.80% |  |  |
Principal amount | [10],[12],[21] | $ 55,000,000 |  |  |  |  |  |  |
Investment cost | [2],[10],[12],[21] | 54,680,000 |  |  |  |  |  |  |
Investments, at fair value: | [10],[12],[21] | $ 55,417,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [26],[27] | 2028-01 |  |  |  | 2028-01 |  |  |
Basis spread variable rate | [11],[26],[27] | 0.75% |  |  |  | 0.75% |  |  |
Interest rate floor | [11],[26],[27] | 9.25% |  |  |  | 9.25% |  |  |
Interest rate cap | [11],[26],[27] | 9.75% |  |  |  | 9.75% |  |  |
Interest rate paid in kind | [11],[26],[27] | 1.15% |  |  |  | 1.15% |  |  |
Exit fee rate | [11],[26],[27] | 5.50% |  |  |  | 5.50% |  |  |
Principal amount | [26],[27] | $ 15,750,000 |  |  |  |  |  |  |
Investment cost | [2],[26],[27] | 15,550,000 |  |  |  |  |  |  |
Investments, at fair value: | [26],[27] | $ 15,550,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date July 2025, Prime + 5.00%, Floor rate 8.25%, 6.35% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [17],[18],[24],[25] |  |  | 2025-07 |  |  |  | 2025-07 |
Basis spread variable rate | [8],[17],[18],[24],[25] |  |  | 5.00% |  |  |  | 5.00% |
Interest rate floor | [8],[17],[18],[24],[25] |  |  | 8.25% |  |  |  | 8.25% |
Exit fee rate | [8],[17],[18],[24],[25] |  |  | 6.35% |  |  |  | 6.35% |
Principal amount | [17],[18],[24],[25] |  |  | $ 11,000,000 |  |  |  |  |
Investment cost | [6],[17],[18],[24],[25] |  |  | 11,072,000 |  |  |  |  |
Investments, at fair value: | [17],[18],[24],[25] |  |  | $ 11,067,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V. Senior Secured, Maturity Date December 2025, Prime + 4.70%, Floor rate 7.95%, 7.28% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [15],[18],[19],[24],[25] |  |  | 2025-12 |  |  |  | 2025-12 |
Basis spread variable rate | [8],[15],[18],[19],[24],[25] |  |  | 4.70% |  |  |  | 4.70% |
Interest rate floor | [8],[15],[18],[19],[24],[25] |  |  | 7.95% |  |  |  | 7.95% |
Exit fee rate | [8],[15],[18],[19],[24],[25] |  |  | 7.28% |  |  |  | 7.28% |
Principal amount | [15],[18],[19],[24],[25] |  |  | $ 70,000,000 |  |  |  |  |
Investment cost | [6],[15],[18],[19],[24],[25] |  |  | 72,329,000 |  |  |  |  |
Investments, at fair value: | [15],[18],[19],[24],[25] |  |  | $ 73,019,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V., Senior Secured, Maturity Date January 2027, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [12],[21],[26],[27] | 2027-01 |  |  |  | 2027-01 |  |  |
Basis spread variable rate | [11],[12],[21],[26],[27] | 4.70% |  |  |  | 4.70% |  |  |
Interest rate floor | [11],[12],[21],[26],[27] | 7.95% |  |  |  | 7.95% |  |  |
Exit fee rate | [11],[12],[21],[26],[27] | 6.10% |  |  |  | 6.10% |  |  |
Principal amount | [12],[21],[26],[27] | $ 70,000,000 |  |  |  |  |  |  |
Investment cost | [2],[12],[21],[26],[27] | 71,157,000 |  |  |  |  |  |  |
Investments, at fair value: | [12],[21],[26],[27] | $ 73,318,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (1.05%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 1.05% |  |  |  | 1.05% |  |  |
Investment cost | [2] | $ 18,348,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 18,982,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (1.34%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 1.34% |  |  |  | 1.34% |
Investment cost | [6] |  |  | $ 18,171,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 18,723,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Locus Robotics Corp. Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 1.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [13] |  |  | 2026-06 |  |  |  | 2026-06 |
Basis spread variable rate | [8],[13] |  |  | 4.50% |  |  |  | 4.50% |
Interest rate floor | [8],[13] |  |  | 8.00% |  |  |  | 8.00% |
Exit fee rate | [8],[13] |  |  | 1.00% |  |  |  | 1.00% |
Principal amount | [13] |  |  | $ 18,281,000 |  |  |  |  |
Investment cost | [6],[13] |  |  | 18,171,000 |  |  |  |  |
Investments, at fair value: | [13] |  |  | $ 18,723,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Locus Robotics Corp., Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [20] | 2026-06 |  |  |  | 2026-06 |  |  |
Basis spread variable rate | [11],[20] | 4.50% |  |  |  | 4.50% |  |  |
Interest rate floor | [11],[20] | 8.00% |  |  |  | 8.00% |  |  |
Exit fee rate | [11],[20] | 4.00% |  |  |  | 4.00% |  |  |
Principal amount | [20] | $ 18,281,000 |  |  |  |  |  |  |
Investment cost | [2],[20] | 18,348,000 |  |  |  |  |  |  |
Investments, at fair value: | [20] | $ 18,982,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (13.98%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 13.98% |  |  |  | 13.98% |
Investment cost | [6] |  |  | $ 196,342,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 195,855,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (16.56%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 16.56% |  |  |  | 16.56% |  |  |
Investment cost | [2] | $ 301,164,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 298,523,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Better Therapeutics, Inc. Senior Secured, Maturity Date August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [30] |  |  | 2025-08 |  |  |  | 2025-08 |
Basis spread variable rate | [8],[30] |  |  | 5.70% |  |  |  | 5.70% |
Interest rate floor | [8],[30] |  |  | 8.95% |  |  |  | 8.95% |
Exit fee rate | [8],[30] |  |  | 5.95% |  |  |  | 5.95% |
Principal amount | [30] |  |  | $ 12,000,000 |  |  |  |  |
Investment cost | [6],[30] |  |  | 12,162,000 |  |  |  |  |
Investments, at fair value: | [30] |  |  | $ 12,053,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Better Therapeutics, Inc., Senior Secured, Maturity Date August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1] | 2025-08 |  |  |  | 2025-08 |  |  |
Basis spread variable rate | [1],[11] | 5.70% |  |  |  | 5.70% |  |  |
Interest rate floor | [1],[11] | 8.95% |  |  |  | 8.95% |  |  |
Exit fee rate | [1],[11] | 5.95% |  |  |  | 5.95% |  |  |
Principal amount | [1] | $ 10,865,000 |  |  |  |  |  |  |
Investment cost | [1],[2] | 11,285,000 |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 8,455,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 1-month LIBOR + 5.00%, Floor rate 6.00%, PIK Interest 4.45% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[15],[17] |  |  | 2026-11 |  |  |  | 2026-11 |
Basis spread variable rate | [8],[14],[15],[17] |  |  | 5.00% |  |  |  | 5.00% |
Interest rate floor | [8],[14],[15],[17] |  |  | 6.00% |  |  |  | 6.00% |
Interest rate paid in kind | [8],[14],[15],[17] |  |  | 4.45% |  |  |  | 4.45% |
Principal amount | [14],[15],[17] |  |  | $ 51,480,000 |  |  |  |  |
Investment cost | [6],[14],[15],[17] |  |  | 50,813,000 |  |  |  |  |
Investments, at fair value: | [14],[15],[17] |  |  | $ 49,732,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc., Senior Secured, Maturity Date November 2026, 1-month SOFR + 5.11%, Floor rate 6.00%, PIK Interest 4.45% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[10],[21] | 2026-11 |  |  |  | 2026-11 |  |  |
Basis spread variable rate | [9],[10],[11],[21] | 5.11% |  |  |  | 5.11% |  |  |
Interest rate floor | [9],[10],[11],[21] | 6.00% |  |  |  | 6.00% |  |  |
Interest rate paid in kind | [9],[10],[11],[21] | 4.45% |  |  |  | 4.45% |  |  |
Principal amount | [9],[10],[21] | $ 69,032,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[10],[21] | 68,277,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10],[21] | $ 68,393,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [13],[15],[17] |  |  | 2025-03 |  |  |  | 2025-03 |
Basis spread variable rate | [8],[13],[15],[17] |  |  | 5.60% |  |  |  | 5.60% |
Interest rate floor | [8],[13],[15],[17] |  |  | 8.85% |  |  |  | 8.85% |
Exit fee rate | [8],[13],[15],[17] |  |  | 4.61% |  |  |  | 4.61% |
Principal amount | [13],[15],[17] |  |  | $ 46,125,000 |  |  |  |  |
Investment cost | [6],[13],[15],[17] |  |  | 46,552,000 |  |  |  |  |
Investments, at fair value: | [13],[15],[17] |  |  | $ 46,548,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Senior Secured, Maturity Date March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10],[21] | 2025-03 |  |  |  | 2025-03 |  |  |
Basis spread variable rate | [10],[11],[21] | 5.60% |  |  |  | 5.60% |  |  |
Interest rate floor | [10],[11],[21] | 8.85% |  |  |  | 8.85% |  |  |
Exit fee rate | [10],[11],[21] | 4.61% |  |  |  | 4.61% |  |  |
Principal amount | [10],[21] | $ 46,125,000 |  |  |  |  |  |  |
Investment cost | [2],[10],[21] | 47,193,000 |  |  |  |  |  |  |
Investments, at fair value: | [10],[21] | $ 46,242,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-02 | [9],[12],[21] | 2026-02 | [14],[18] | 2026-02 | [9],[12],[21] | 2026-02 | [14],[18]
Basis spread variable rate |  | 6.25% | [9],[11],[12],[21] | 6.25% | [8],[14],[18] | 6.25% | [9],[11],[12],[21] | 6.25% | [8],[14],[18]
Interest rate floor |  | 9.50% | [9],[11],[12],[21] | 9.50% | [8],[14],[18] | 9.50% | [9],[11],[12],[21] | 9.50% | [8],[14],[18]
Interest rate paid in kind |  | 1.55% | [9],[11],[12],[21] | 1.55% | [8],[14],[18] | 1.55% | [9],[11],[12],[21] | 1.55% | [8],[14],[18]
Principal amount |  | $ 54,425,000 | [9],[12],[21] | $ 53,587,000 | [14],[18] |  |  |  |
Investment cost |  | 54,142,000 | [2],[9],[12],[21] | 53,164,000 | [6],[14],[18] |  |  |  |
Investments, at fair value: |  | $ 54,697,000 | [9],[12],[21] | $ 53,871,000 | [14],[18] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Main Street Rural, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1],[22] | 2027-07 |  |  |  | 2027-07 |  |  |
Basis spread variable rate | [1],[11],[22] | 1.95% |  |  |  | 1.95% |  |  |
Interest rate floor | [1],[11],[22] | 9.95% |  |  |  | 9.95% |  |  |
Exit fee rate | [1],[11],[22] | 6.85% |  |  |  | 6.85% |  |  |
Principal amount | [1],[22] | $ 24,500,000 |  |  |  |  |  |  |
Investment cost | [1],[2],[22] | 24,476,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[22] | $ 24,929,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Modern Life, Inc., Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10],[22] | 2027-02 |  |  |  | 2027-02 |  |  |
Basis spread variable rate | [10],[11],[22] | 2.75% |  |  |  | 2.75% |  |  |
Interest rate floor | [10],[11],[22] | 8.75% |  |  |  | 8.75% |  |  |
Exit fee rate | [10],[11],[22] | 5.00% |  |  |  | 5.00% |  |  |
Principal amount | [10],[22] | $ 13,000,000 |  |  |  |  |  |  |
Investment cost | [2],[10],[22] | 12,888,000 |  |  |  |  |  |  |
Investments, at fair value: | [10],[22] | $ 13,111,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Oak Street Health, Inc. Senior Secured, Maturity Date October 2027, Prime + 2.45%, Floor rate 7.95%, Cap rate 9.45%, PIK Interest 1.00%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[14],[24] |  |  | 2027-10 |  |  |  | 2027-10 |
Basis spread variable rate | [7],[8],[14],[24] |  |  | 2.45% |  |  |  | 2.45% |
Interest rate floor | [7],[8],[14],[24] |  |  | 7.95% |  |  |  | 7.95% |
Interest rate cap | [7],[8],[14],[24] |  |  | 9.45% |  |  |  | 9.45% |
Interest rate paid in kind | [7],[8],[14],[24] |  |  | 1.00% |  |  |  | 1.00% |
Exit fee rate | [7],[8],[14],[24] |  |  | 4.95% |  |  |  | 4.95% |
Principal amount | [7],[14],[24] |  |  | $ 33,808,000 |  |  |  |  |
Investment cost | [6],[7],[14],[24] |  |  | 33,651,000 |  |  |  |  |
Investments, at fair value: | [7],[14],[24] |  |  | $ 33,651,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Recover Together, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-07 |  |  |  | 2027-07 |  |  |
Basis spread variable rate | [11] | 1.90% |  |  |  | 1.90% |  |  |
Interest rate floor | [11] | 10.15% |  |  |  | 10.15% |  |  |
Exit fee rate | [11] | 7.50% |  |  |  | 7.50% |  |  |
Principal amount |  | $ 35,000,000 |  |  |  |  |  |  |
Investment cost | [2] | 34,683,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 34,683,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1] | 2027-09 |  |  |  | 2027-09 |  |  |
Basis spread variable rate | [1],[11] | 0.70% |  |  |  | 0.70% |  |  |
Interest rate floor | [1],[11] | 9.20% |  |  |  | 9.20% |  |  |
Exit fee rate | [1],[11] | 5.95% |  |  |  | 5.95% |  |  |
Principal amount | [1] | $ 12,000,000 |  |  |  |  |  |  |
Investment cost | [1],[2] | 11,868,000 |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 11,868,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc., Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [21] | 2026-03 |  |  |  | 2026-03 |  |  |
Basis spread variable rate | [11],[21] | 3.25% |  |  |  | 3.25% |  |  |
Interest rate floor | [11],[21] | 9.20% |  |  |  | 9.20% |  |  |
Interest rate cap | [11],[21] | 10.20% |  |  |  | 10.20% |  |  |
Exit fee rate | [11],[21] | 4.95% |  |  |  | 4.95% |  |  |
Principal amount | [21] | $ 36,500,000 |  |  |  |  |  |  |
Investment cost | [2],[21] | 36,352,000 |  |  |  |  |  |  |
Investments, at fair value: | [21] | $ 36,145,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc., Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee | Minimum |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Basis spread variable rate | [11],[21] | 1.00% |  |  |  | 1.00% |  |  |
Investment, Identifier [Axis]: Debt Investments Information Services (3.72%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 3.72% |  |  |  | 3.72% |
Investment cost | [6] |  |  | $ 52,619,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 52,075,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Information Services (6.65%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 6.65% |  |  |  | 6.65% |  |  |
Investment cost | [2] | $ 117,099,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 119,876,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Information Services and Capella Space Corp. Senior Secured, Maturity Date November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [13],[14],[30] |  |  | 2025-11 |  |  |  | 2025-11 |
Basis spread variable rate | [8],[13],[14],[30] |  |  | 5.00% |  |  |  | 5.00% |
Interest rate floor | [8],[13],[14],[30] |  |  | 8.25% |  |  |  | 8.25% |
Interest rate paid in kind | [8],[13],[14],[30] |  |  | 1.10% |  |  |  | 1.10% |
Exit fee rate | [8],[13],[14],[30] |  |  | 7.00% |  |  |  | 7.00% |
Principal amount | [13],[14],[30] |  |  | $ 20,250,000 |  |  |  |  |
Investment cost | [6],[13],[14],[30] |  |  | 20,506,000 |  |  |  |  |
Investments, at fair value: | [13],[14],[30] |  |  | $ 20,574,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Information Services and Capella Space Corp., Senior Secured, Maturity Date November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1],[9] | 2025-11 |  |  |  | 2025-11 |  |  |
Basis spread variable rate | [1],[9],[11] | 5.00% |  |  |  | 5.00% |  |  |
Interest rate floor | [1],[9],[11] | 8.25% |  |  |  | 8.25% |  |  |
Interest rate paid in kind | [1],[9],[11] | 1.10% |  |  |  | 1.10% |  |  |
Exit fee rate | [1],[9],[11] | 7.00% |  |  |  | 7.00% |  |  |
Principal amount | [1],[9] | $ 20,477,000 |  |  |  |  |  |  |
Investment cost | [1],[2],[9] | 21,166,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[9] | $ 21,351,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Information Services and Checkr Group, Inc., Senior Secured, Maturity Date August 2028, Prime + 1.45%, Floor rate 8.00%, PIK Interest 2.00%, 2.75% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[22] | 2028-08 |  |  |  | 2028-08 |  |  |
Basis spread variable rate | [9],[11],[22] | 1.45% |  |  |  | 1.45% |  |  |
Interest rate floor | [9],[11],[22] | 8.00% |  |  |  | 8.00% |  |  |
Interest rate paid in kind | [9],[11],[22] | 2.00% |  |  |  | 2.00% |  |  |
Exit fee rate | [9],[11],[22] | 2.75% |  |  |  | 2.75% |  |  |
Principal amount | [9],[22] | $ 47,621,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[22] | 47,460,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[22] | $ 49,382,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Information Services and Saama Technologies, LLC, Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[22] | 2027-07 |  |  |  | 2027-07 |  |  |
Basis spread variable rate | [9],[11],[22] | 0.70% |  |  |  | 0.70% |  |  |
Interest rate floor | [9],[11],[22] | 8.95% |  |  |  | 8.95% |  |  |
Interest rate paid in kind | [9],[11],[22] | 2.00% |  |  |  | 2.00% |  |  |
Exit fee rate | [9],[11],[22] | 2.95% |  |  |  | 2.95% |  |  |
Principal amount | [9],[22] | $ 11,725,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[22] | 11,627,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[22] | $ 11,876,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Information Services and Signal Media Limited, Senior Secured, Maturity Date June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2025-06 | [26],[27] | 2025-06 | [7],[24],[25] | 2025-06 | [26],[27] | 2025-06 | [7],[24],[25]
Basis spread variable rate |  | 5.50% | [11],[26],[27] | 5.50% | [7],[8],[24],[25] | 5.50% | [11],[26],[27] | 5.50% | [7],[8],[24],[25]
Interest rate floor |  | 9.00% | [11],[26],[27] | 9.00% | [7],[8],[24],[25] | 9.00% | [11],[26],[27] | 9.00% | [7],[8],[24],[25]
Interest rate cap |  | 12.00% | [11],[26],[27] | 12.00% | [7],[8],[24],[25] | 12.00% | [11],[26],[27] | 12.00% | [7],[8],[24],[25]
Exit fee rate |  | 3.45% | [11],[26],[27] | 3.45% | [7],[8],[24],[25] | 3.45% | [11],[26],[27] | 3.45% | [7],[8],[24],[25]
Principal amount |  | $ 5,400,000 | [26],[27] | $ 750,000 | [7],[24],[25] |  |  |  |
Investment cost |  | 5,364,000 | [2],[26],[27] | 742,000 | [6],[7],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 5,392,000 | [26],[27] | $ 738,000 | [7],[24],[25] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 8.45%, Floor rate 9.35% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22],[23] | 2026-09 |  |  |  | 2026-09 |  |  |
Basis spread variable rate | [11],[22],[23] | 8.45% |  |  |  | 8.45% |  |  |
Interest rate floor | [11],[22],[23] | 9.35% |  |  |  | 9.35% |  |  |
Principal amount | [22],[23] | $ 31,875,000 |  |  |  |  |  |  |
Investment cost | [2],[22],[23] | 31,482,000 |  |  |  |  |  |  |
Investments, at fair value: | [22],[23] | $ 31,875,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 9.08%, Floor rate 10.08% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[16] |  |  | 2026-09 |  |  |  | 2026-09 |
Basis spread variable rate | [7],[8],[16] |  |  | 9.08% |  |  |  | 9.08% |
Interest rate floor | [7],[8],[16] |  |  | 10.08% |  |  |  | 10.08% |
Principal amount | [7],[16] |  |  | $ 31,875,000 |  |  |  |  |
Investment cost | [6],[7],[16] |  |  | 31,371,000 |  |  |  |  |
Investments, at fair value: | [7],[16] |  |  | $ 30,763,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology (0.44%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.44% |  |  |  | 0.44% |  |  |
Investment cost | [2] | $ 8,064,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 8,006,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology (2.99%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 2.99% |  |  |  | 2.99% |
Investment cost | [6] |  |  | $ 41,568,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 41,953,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and Bright Machines, Inc. Senior Secured, Maturity Date April 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [17] |  |  | 2025-04 |  |  |  | 2025-04 |
Basis spread variable rate | [8],[17] |  |  | 4.00% |  |  |  | 4.00% |
Interest rate floor | [8],[17] |  |  | 9.50% |  |  |  | 9.50% |
Exit fee rate | [8],[17] |  |  | 5.00% |  |  |  | 5.00% |
Principal amount | [17] |  |  | $ 11,050,000 |  |  |  |  |
Investment cost | [6],[17] |  |  | 10,832,000 |  |  |  |  |
Investments, at fair value: | [17] |  |  | $ 10,832,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and Bright Machines, Inc., Senior Secured, Maturity Date May 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10] | 2025-05 |  |  |  | 2025-05 |  |  |
Basis spread variable rate | [10],[11] | 4.00% |  |  |  | 4.00% |  |  |
Interest rate floor | [10],[11] | 9.50% |  |  |  | 9.50% |  |  |
Exit fee rate | [10],[11] | 5.00% |  |  |  | 5.00% |  |  |
Principal amount | [10] | $ 7,827,000 |  |  |  |  |  |  |
Investment cost | [2],[10] | 8,064,000 |  |  |  |  |  |  |
Investments, at fair value: | [10] | $ 8,006,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and MacroFab, Inc. Senior Secured, Maturity Date March 2026, Prime + 4.35%, Floor rate 7.60%, PIK Interest 1.25%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[14] |  |  | 2026-03 |  |  |  | 2026-03 |
Basis spread variable rate | [7],[8],[14] |  |  | 4.35% |  |  |  | 4.35% |
Interest rate floor | [7],[8],[14] |  |  | 7.60% |  |  |  | 7.60% |
Interest rate paid in kind | [7],[8],[14] |  |  | 1.25% |  |  |  | 1.25% |
Exit fee rate | [7],[8],[14] |  |  | 4.50% |  |  |  | 4.50% |
Principal amount | [7],[14] |  |  | $ 17,137,000 |  |  |  |  |
Investment cost | [6],[7],[14] |  |  | 16,766,000 |  |  |  |  |
Investments, at fair value: | [7],[14] |  |  | $ 16,917,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and Ouster, Inc. Senior Secured, Maturity Date May 2026, Prime + 6.15%, Floor rate 9.40%, 7.45% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [17],[24] |  |  | 2026-05 |  |  |  | 2026-05 |
Basis spread variable rate | [8],[17],[24] |  |  | 6.15% |  |  |  | 6.15% |
Interest rate floor | [8],[17],[24] |  |  | 9.40% |  |  |  | 9.40% |
Exit fee rate | [8],[17],[24] |  |  | 7.45% |  |  |  | 7.45% |
Principal amount | [17],[24] |  |  | $ 14,000,000 |  |  |  |  |
Investment cost | [6],[17],[24] |  |  | 13,970,000 |  |  |  |  |
Investments, at fair value: | [17],[24] |  |  | $ 14,204,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Media/Content/Info (0.69%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.69% |  |  |  | 0.69% |  |  |
Investment cost | [2] | $ 12,340,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 12,469,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date December 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [20] | 2025-12 |  |  |  | 2025-12 |  |  |
Basis spread variable rate | [11],[20] | 3.50% |  |  |  | 3.50% |  |  |
Interest rate floor | [11],[20] | 9.00% |  |  |  | 9.00% |  |  |
Exit fee rate | [11],[20] | 3.00% |  |  |  | 3.00% |  |  |
Principal amount | [20] | $ 1,333,000 |  |  |  |  |  |  |
Investment cost | [2],[20] | 1,342,000 |  |  |  |  |  |  |
Investments, at fair value: | [20] | $ 1,351,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date June 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [20] | 2026-06 |  |  |  | 2026-06 |  |  |
Basis spread variable rate | [11],[20] | 3.50% |  |  |  | 3.50% |  |  |
Interest rate floor | [11],[20] | 9.00% |  |  |  | 9.00% |  |  |
Exit fee rate | [11],[20] | 3.00% |  |  |  | 3.00% |  |  |
Principal amount | [20] | $ 1,667,000 |  |  |  |  |  |  |
Investment cost | [2],[20] | 1,647,000 |  |  |  |  |  |  |
Investments, at fair value: | [20] | $ 1,653,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [20] | 2026-03 |  |  |  | 2026-03 |  |  |
Basis spread variable rate | [11],[20] | 3.50% |  |  |  | 3.50% |  |  |
Interest rate floor | [11],[20] | 9.00% |  |  |  | 9.00% |  |  |
Exit fee rate | [11],[20] | 3.00% |  |  |  | 3.00% |  |  |
Principal amount | [20] | $ 1,500,000 |  |  |  |  |  |  |
Investment cost | [2],[20] | 1,501,000 |  |  |  |  |  |  |
Investments, at fair value: | [20] | $ 1,509,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date September 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [20] | 2025-09 |  |  |  | 2025-09 |  |  |
Basis spread variable rate | [11],[20] | 3.50% |  |  |  | 3.50% |  |  |
Interest rate floor | [11],[20] | 9.00% |  |  |  | 9.00% |  |  |
Exit fee rate | [11],[20] | 3.00% |  |  |  | 3.00% |  |  |
Principal amount | [20] | $ 1,167,000 |  |  |  |  |  |  |
Investment cost | [2],[20] | 1,178,000 |  |  |  |  |  |  |
Investments, at fair value: | [20] | $ 1,188,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date September 2026, Prime + 3.50%, Floor rate 9.00%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [20] | 2026-09 |  |  |  | 2026-09 |  |  |
Basis spread variable rate | [11],[20] | 3.50% |  |  |  | 3.50% |  |  |
Interest rate floor | [11],[20] | 9.00% |  |  |  | 9.00% |  |  |
Exit fee rate | [11],[20] | 4.00% |  |  |  | 4.00% |  |  |
Principal amount | [20] | $ 6,667,000 |  |  |  |  |  |  |
Investment cost | [2],[20] | 6,672,000 |  |  |  |  |  |  |
Investments, at fair value: | [20] | 6,768,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Total Fever Labs, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Principal amount |  | 12,334,000 |  |  |  |  |  |  |
Investment cost | [2] | 12,340,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 12,469,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment (1.20%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 1.20% |  |  |  | 1.20% |  |  |
Investment cost | [2] | $ 21,572,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 21,572,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc. Maturity Date September 2027, Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22] | 2027-09 |  |  |  | 2027-09 |  |  |
Basis spread variable rate | [11],[22] | 1.40% |  |  |  | 1.40% |  |  |
Interest rate floor | [11],[22] | 9.90% |  |  |  | 9.90% |  |  |
Exit fee rate | [11],[22] | 6.95% |  |  |  | 6.95% |  |  |
Principal amount | [22] | $ 21,875,000 |  |  |  |  |  |  |
Investment cost | [2],[22] | 21,572,000 |  |  |  |  |  |  |
Investments, at fair value: | [22] | $ 21,572,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Semiconductors (1.51%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 1.51% |  |  |  | 1.51% |
Investment cost | [6] |  |  | $ 19,639,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 21,192,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Semiconductors and Fungible, Inc. Senior Secured, Maturity Date December 2024, Prime + 5.00%, Floor rate 8.25%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [13],[30] |  |  | 2024-12 |  |  |  | 2024-12 |
Basis spread variable rate | [8],[13],[30] |  |  | 5.00% |  |  |  | 5.00% |
Interest rate floor | [8],[13],[30] |  |  | 8.25% |  |  |  | 8.25% |
Exit fee rate | [8],[13],[30] |  |  | 4.95% |  |  |  | 4.95% |
Principal amount | [13],[30] |  |  | $ 20,000,000 |  |  |  |  |
Investment cost | [6],[13],[30] |  |  | 19,639,000 |  |  |  |  |
Investments, at fair value: | [13],[30] |  |  | $ 21,192,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software (40.39%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 40.39% |  |  |  | 40.39% |  |  |
Investment cost | [2] | $ 751,108,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 728,139,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software (54.28%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 54.28% |  |  |  | 54.28% |
Investment cost | [6] |  |  | $ 762,371,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 760,679,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Principal amount |  | 15,100,000 |  | 13,176,000 |  |  |  |  |
Investment cost |  | 15,017,000 | [2] | 13,035,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 15,089,000 |  | $ 12,998,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 6.57%, Floor rate 7.57% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [16] |  |  | 2025-02 |  |  |  | 2025-02 |
Basis spread variable rate | [8],[16] |  |  | 6.57% |  |  |  | 6.57% |
Interest rate floor | [8],[16] |  |  | 7.57% |  |  |  | 7.57% |
Principal amount | [16] |  |  | $ 2,750,000 |  |  |  |  |
Investment cost | [6],[16] |  |  | 2,744,000 |  |  |  |  |
Investments, at fair value: | [16] |  |  | $ 2,681,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.28%, Floor rate 10.28% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [15],[16] |  |  | 2025-02 |  |  |  | 2025-02 |
Basis spread variable rate | [8],[15],[16] |  |  | 9.28% |  |  |  | 9.28% |
Interest rate floor | [8],[15],[16] |  |  | 10.28% |  |  |  | 10.28% |
Principal amount | [15],[16] |  |  | $ 10,426,000 |  |  |  |  |
Investment cost | [6],[15],[16] |  |  | 10,291,000 |  |  |  |  |
Investments, at fair value: | [15],[16] |  |  | $ 10,317,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 6.88%, Floor rate 7.78% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22],[23] | 2025-02 |  |  |  | 2025-02 |  |  |
Basis spread variable rate | [11],[22],[23] | 6.88% |  |  |  | 6.88% |  |  |
Interest rate floor | [11],[22],[23] | 7.78% |  |  |  | 7.78% |  |  |
Principal amount | [22],[23] | $ 1,990,000 |  |  |  |  |  |  |
Investment cost | [2],[22],[23] | 1,988,000 |  |  |  |  |  |  |
Investments, at fair value: | [22],[23] | $ 1,986,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 9.70%, Floor rate 10.60% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [21],[22],[23] | 2025-02 |  |  |  | 2025-02 |  |  |
Basis spread variable rate | [11],[21],[22],[23] | 9.70% |  |  |  | 9.70% |  |  |
Interest rate floor | [11],[21],[22],[23] | 10.60% |  |  |  | 10.60% |  |  |
Principal amount | [21],[22],[23] | $ 13,110,000 |  |  |  |  |  |  |
Investment cost | [2],[21],[22],[23] | 13,029,000 |  |  |  |  |  |  |
Investments, at fair value: | [21],[22],[23] | $ 13,103,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Agilence, Inc. Senior Secured, Maturity Date October 2026, 1-month BSBY + 9.00%, Floor rate 10.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-10 | [12],[22],[23] | 2026-10 | [7],[16],[18] | 2026-10 | [12],[22],[23] | 2026-10 | [7],[16],[18]
Basis spread variable rate |  | 9.00% | [11],[12],[22],[23] | 9.00% | [7],[8],[16],[18] | 9.00% | [11],[12],[22],[23] | 9.00% | [7],[8],[16],[18]
Interest rate floor |  | 10.00% | [11],[12],[22],[23] | 10.00% | [7],[8],[16],[18] | 10.00% | [11],[12],[22],[23] | 10.00% | [7],[8],[16],[18]
Principal amount |  | $ 9,212,000 | [12],[22],[23] | $ 9,306,000 | [7],[16],[18] |  |  |  |
Investment cost |  | 9,040,000 | [2],[12],[22],[23] | 9,088,000 | [6],[7],[16],[18] |  |  |  |
Investments, at fair value: |  | $ 9,212,000 | [12],[22],[23] | $ 8,977,000 | [7],[16],[18] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 7.89%, Floor rate 8.89% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[16] |  |  | 2028-05 |  |  |  | 2028-05 |
Basis spread variable rate | [7],[8],[16] |  |  | 7.89% |  |  |  | 7.89% |
Interest rate floor | [7],[8],[16] |  |  | 8.89% |  |  |  | 8.89% |
Principal amount | [7],[16] |  |  | $ 20,463,000 |  |  |  |  |
Investment cost | [6],[7],[16] |  |  | 19,999,000 |  |  |  |  |
Investments, at fair value: | [7],[16] |  |  | $ 20,123,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10],[22],[23] | 2028-05 |  |  |  | 2028-05 |  |  |
Basis spread variable rate | [10],[11],[22],[23] | 8.14% |  |  |  | 8.14% |  |  |
Interest rate floor | [10],[11],[22],[23] | 9.14% |  |  |  | 9.14% |  |  |
Principal amount | [10],[22],[23] | $ 20,908,000 |  |  |  |  |  |  |
Investment cost | [2],[10],[22],[23] | 20,508,000 |  |  |  |  |  |  |
Investments, at fair value: | [10],[22],[23] | $ 21,297,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 6-month SOFR + 7.25%, Floor rate 8.25% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22] | 2029-09 |  |  |  | 2029-09 |  |  |
Basis spread variable rate | [11],[22] | 7.25% |  |  |  | 7.25% |  |  |
Interest rate floor | [11],[22] | 8.25% |  |  |  | 8.25% |  |  |
Principal amount | [22] | $ 36,410,000 |  |  |  |  |  |  |
Investment cost | [2],[22] | 35,530,000 |  |  |  |  |  |  |
Investments, at fair value: | [22] | $ 35,530,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 8.99%, Floor rate 10.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[17] |  |  | 2027-02 |  |  |  | 2027-02 |
Basis spread variable rate | [7],[8],[17] |  |  | 8.99% |  |  |  | 8.99% |
Interest rate floor | [7],[8],[17] |  |  | 10.00% |  |  |  | 10.00% |
Principal amount | [7],[17] |  |  | $ 8,500,000 |  |  |  |  |
Investment cost | [6],[7],[17] |  |  | 8,292,000 |  |  |  |  |
Investments, at fair value: | [7],[17] |  |  | $ 8,176,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 9.41%, Floor rate 10.41% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10],[22] | 2027-02 |  |  |  | 2027-02 |  |  |
Basis spread variable rate | [10],[11],[22] | 9.41% |  |  |  | 9.41% |  |  |
Interest rate floor | [10],[11],[22] | 10.41% |  |  |  | 10.41% |  |  |
Principal amount | [10],[22] | $ 9,823,000 |  |  |  |  |  |  |
Investment cost | [2],[10],[22] | 9,649,000 |  |  |  |  |  |  |
Investments, at fair value: | [10],[22] | $ 9,761,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 2.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[13],[15] |  |  | 2027-09 |  |  |  | 2027-09 |
Basis spread variable rate | [7],[8],[13],[15] |  |  | 4.25% |  |  |  | 4.25% |
Interest rate floor | [7],[8],[13],[15] |  |  | 9.00% |  |  |  | 9.00% |
Exit fee rate | [7],[8],[13],[15] |  |  | 2.50% |  |  |  | 2.50% |
Principal amount | [7],[13],[15] |  |  | $ 19,600,000 |  |  |  |  |
Investment cost | [6],[7],[13],[15] |  |  | 19,059,000 |  |  |  |  |
Investments, at fair value: | [7],[13],[15] |  |  | $ 19,059,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [20],[21],[22] | 2027-09 |  |  |  | 2027-09 |  |  |
Basis spread variable rate | [11],[20],[21],[22] | 4.25% |  |  |  | 4.25% |  |  |
Interest rate floor | [11],[20],[21],[22] | 9.00% |  |  |  | 9.00% |  |  |
Exit fee rate | [11],[20],[21],[22] | 4.50% |  |  |  | 4.50% |  |  |
Principal amount | [20],[21],[22] | $ 19,600,000 |  |  |  |  |  |  |
Investment cost | [2],[20],[21],[22] | 19,345,000 |  |  |  |  |  |  |
Investments, at fair value: | [20],[21],[22] | $ 20,269,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 7.89%, Floor rate 8.89% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-12 | [1],[22],[23] | 2027-12 | [7],[16],[30] | 2027-12 | [1],[22],[23] | 2027-12 | [7],[16],[30]
Basis spread variable rate |  | 7.89% | [1],[11],[22],[23] | 7.89% | [7],[8],[16],[30] | 7.89% | [1],[11],[22],[23] | 7.89% | [7],[8],[16],[30]
Interest rate floor |  | 8.89% | [1],[11],[22],[23] | 8.89% | [7],[8],[16],[30] | 8.89% | [1],[11],[22],[23] | 8.89% | [7],[8],[16],[30]
Principal amount |  | $ 45,000,000 | [1],[22],[23] | $ 45,000,000 | [7],[16],[30] |  |  |  |
Investment cost |  | 43,983,000 | [1],[2],[22],[23] | 43,801,000 | [6],[7],[16],[30] |  |  |  |
Investments, at fair value: |  | $ 44,928,000 | [1],[22],[23] | $ 43,801,000 | [7],[16],[30] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2025, PRIME + 3.70%, Floor rate 6.95%, PIK Interest 1.00%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[14],[17],[30] |  |  | 2025-04 |  |  |  | 2025-04 |
Basis spread variable rate | [7],[8],[14],[17],[30] |  |  | 3.70% |  |  |  | 3.70% |
Interest rate floor | [7],[8],[14],[17],[30] |  |  | 6.95% |  |  |  | 6.95% |
Interest rate paid in kind | [7],[8],[14],[17],[30] |  |  | 1.00% |  |  |  | 1.00% |
Exit fee rate | [7],[8],[14],[17],[30] |  |  | 3.95% |  |  |  | 3.95% |
Principal amount | [7],[14],[17],[30] |  |  | $ 20,166,000 |  |  |  |  |
Investment cost | [6],[7],[14],[17],[30] |  |  | 20,242,000 |  |  |  |  |
Investments, at fair value: | [7],[14],[17],[30] |  |  | $ 20,138,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2026, Prime + 3.70%, Floor rate 9.20%, PIK Interest 1.00%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1],[9],[10],[22] | 2026-04 |  |  |  | 2026-04 |  |  |
Basis spread variable rate | [1],[9],[10],[11],[22] | 3.70% |  |  |  | 3.70% |  |  |
Interest rate floor | [1],[9],[10],[11],[22] | 9.20% |  |  |  | 9.20% |  |  |
Interest rate paid in kind | [1],[9],[10],[11],[22] | 1.00% |  |  |  | 1.00% |  |  |
Exit fee rate | [1],[9],[10],[11],[22] | 3.95% |  |  |  | 3.95% |  |  |
Principal amount | [1],[9],[10],[22] | $ 30,415,000 |  |  |  |  |  |  |
Investment cost | [1],[2],[9],[10],[22] | 30,678,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[9],[10],[22] | $ 30,989,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.05%, Floor rate 9.90% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10],[20] | 2025-11 |  |  |  | 2025-11 |  |  |
Basis spread variable rate | [10],[11],[20] | 9.05% |  |  |  | 9.05% |  |  |
Interest rate floor | [10],[11],[20] | 9.90% |  |  |  | 9.90% |  |  |
Principal amount | [10],[20] | $ 33,000,000 |  |  |  |  |  |  |
Investment cost | [2],[10],[20] | 32,706,000 |  |  |  |  |  |  |
Investments, at fair value: | [10],[20] | $ 33,000,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 6-month SOFR + 8.90%, Floor rate 9.90% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [13],[17] |  |  | 2025-11 |  |  |  | 2025-11 |
Basis spread variable rate | [8],[13],[17] |  |  | 8.90% |  |  |  | 8.90% |
Interest rate floor | [8],[13],[17] |  |  | 9.90% |  |  |  | 9.90% |
Principal amount | [13],[17] |  |  | $ 33,000,000 |  |  |  |  |
Investment cost | [6],[13],[17] |  |  | 32,578,000 |  |  |  |  |
Investments, at fair value: | [13],[17] |  |  | $ 33,000,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date June 2026, 3-month SOFR + 8.86%, Floor rate 9.76% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [16] |  |  | 2026-06 |  |  |  | 2026-06 |
Basis spread variable rate | [8],[16] |  |  | 8.86% |  |  |  | 8.86% |
Interest rate floor | [8],[16] |  |  | 9.76% |  |  |  | 9.76% |
Principal amount | [16] |  |  | $ 10,175,000 |  |  |  |  |
Investment cost | [6],[16] |  |  | 9,980,000 |  |  |  |  |
Investments, at fair value: | [16] |  |  | $ 9,996,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.41%, Floor rate 11.81% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [23] | 2025-11 |  |  |  | 2025-11 |  |  |
Basis spread variable rate | [11],[23] | 9.41% |  |  |  | 9.41% |  |  |
Interest rate floor | [11],[23] | 11.81% |  |  |  | 11.81% |  |  |
Principal amount | [23] | $ 10,073,000 |  |  |  |  |  |  |
Investment cost | [2],[23] | 9,931,000 |  |  |  |  |  |  |
Investments, at fair value: | [23] | $ 9,940,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 6-month LIBOR + 8.99%, Floor rate 9.89% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22],[23] | 2026-09 |  |  |  | 2026-09 |  |  |
Basis spread variable rate | [11],[22],[23] | 8.99% |  |  |  | 8.99% |  |  |
Interest rate floor | [11],[22],[23] | 9.89% |  |  |  | 9.89% |  |  |
Principal amount | [22],[23] | $ 22,867,000 |  |  |  |  |  |  |
Investment cost | [2],[22],[23] | 22,498,000 |  |  |  |  |  |  |
Investments, at fair value: | [22],[23] | $ 23,075,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 6-month LIBOR + 9.67%, Floor rate 10.67% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[16] |  |  | 2026-09 |  |  |  | 2026-09 |
Basis spread variable rate | [7],[8],[16] |  |  | 9.67% |  |  |  | 9.67% |
Interest rate floor | [7],[8],[16] |  |  | 10.67% |  |  |  | 10.67% |
Principal amount | [7],[16] |  |  | $ 21,445,000 |  |  |  |  |
Investment cost | [6],[7],[16] |  |  | 21,003,000 |  |  |  |  |
Investments, at fair value: | [7],[16] |  |  | $ 21,050,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and CloudBolt Software, Inc., Senior Secured, Maturity Date October 2024, Prime + 6.70%, Floor rate 9.95%, 3.45% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [13],[15] |  |  | 2024-10 |  |  |  | 2024-10 |
Basis spread variable rate | [8],[13],[15] |  |  | 6.70% |  |  |  | 6.70% |
Interest rate floor | [8],[13],[15] |  |  | 9.95% |  |  |  | 9.95% |
Exit fee rate | [8],[13],[15] |  |  | 3.45% |  |  |  | 3.45% |
Principal amount | [13],[15] |  |  | $ 10,000,000 |  |  |  |  |
Investment cost | [6],[13],[15] |  |  | 10,069,000 |  |  |  |  |
Investments, at fair value: | [13],[15] |  |  | $ 10,498,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Constructor Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10],[22],[23] | 2027-07 |  |  |  | 2027-07 |  |  |
Basis spread variable rate | [10],[11],[22],[23] | 8.44% |  |  |  | 8.44% |  |  |
Interest rate floor | [10],[11],[22],[23] | 9.44% |  |  |  | 9.44% |  |  |
Principal amount | [10],[22],[23] | $ 4,688,000 |  |  |  |  |  |  |
Investment cost | [2],[10],[22],[23] | 4,592,000 |  |  |  |  |  |  |
Investments, at fair value: | [10],[22],[23] | $ 4,790,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Constructor.io Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[16] |  |  | 2027-07 |  |  |  | 2027-07 |
Basis spread variable rate | [7],[8],[16] |  |  | 8.44% |  |  |  | 8.44% |
Interest rate floor | [7],[8],[16] |  |  | 9.44% |  |  |  | 9.44% |
Principal amount | [7],[16] |  |  | $ 4,688,000 |  |  |  |  |
Investment cost | [6],[7],[16] |  |  | 4,573,000 |  |  |  |  |
Investments, at fair value: | [7],[16] |  |  | $ 4,573,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Convoy, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-03 | [9],[20],[39] | 2026-03 | [13],[14],[19] | 2026-03 | [9],[20],[39] | 2026-03 | [13],[14],[19]
Basis spread variable rate |  | 3.20% | [9],[11],[20],[39] | 3.20% | [8],[13],[14],[19] | 3.20% | [9],[11],[20],[39] | 3.20% | [8],[13],[14],[19]
Interest rate floor |  | 6.45% | [9],[11],[20],[39] | 6.45% | [8],[13],[14],[19] | 6.45% | [9],[11],[20],[39] | 6.45% | [8],[13],[14],[19]
Interest rate paid in kind |  | 1.95% | [9],[11],[20],[39] | 1.95% | [8],[13],[14],[19] | 1.95% | [9],[11],[20],[39] | 1.95% | [8],[13],[14],[19]
Exit fee rate |  | 4.55% | [9],[11],[20],[39] | 4.55% | [8],[13],[14],[19] | 4.55% | [9],[11],[20],[39] | 4.55% | [8],[13],[14],[19]
Principal amount |  | $ 31,049,000 | [9],[20],[39] | $ 73,987,000 | [13],[14],[19] |  |  |  |
Investment cost |  | 30,916,000 | [2],[9],[20],[39] | 73,060,000 | [6],[13],[14],[19] |  |  |  |
Investments, at fair value: |  | $ 0 | [9],[20],[39] | $ 73,498,000 | [13],[14],[19] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 3.96% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[21] | 2025-03 |  |  |  | 2025-03 |  |  |
Basis spread variable rate | [9],[11],[21] | 4.50% |  |  |  | 4.50% |  |  |
Interest rate floor | [9],[11],[21] | 8.25% |  |  |  | 8.25% |  |  |
Interest rate cap | [9],[11],[21] | 10.25% |  |  |  | 10.25% |  |  |
Interest rate paid in kind | [9],[11],[21] | 1.95% |  |  |  | 1.95% |  |  |
Exit fee rate | [9],[11],[21] | 3.96% |  |  |  | 3.96% |  |  |
Principal amount | [9],[21] | $ 9,141,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[21] | 9,307,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[21] | $ 9,153,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[15] |  |  | 2025-03 |  |  |  | 2025-03 |
Basis spread variable rate | [8],[14],[15] |  |  | 4.50% |  |  |  | 4.50% |
Interest rate floor | [8],[14],[15] |  |  | 8.25% |  |  |  | 8.25% |
Interest rate cap | [8],[14],[15] |  |  | 10.25% |  |  |  | 10.25% |
Interest rate paid in kind | [8],[14],[15] |  |  | 1.95% |  |  |  | 1.95% |
Exit fee rate | [8],[14],[15] |  |  | 4.50% |  |  |  | 4.50% |
Principal amount | [14],[15] |  |  | $ 10,144,000 |  |  |  |  |
Investment cost | [6],[14],[15] |  |  | 10,150,000 |  |  |  |  |
Investments, at fair value: | [14],[15] |  |  | $ 9,820,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2025-10 | [12],[22],[26],[27] | 2025-10 | [7],[18],[24],[25] | 2025-10 | [12],[22],[26],[27] | 2025-10 | [7],[18],[24],[25]
Basis spread variable rate |  | 5.20% | [11],[12],[22],[26],[27] | 5.20% | [7],[8],[18],[24],[25] | 5.20% | [11],[12],[22],[26],[27] | 5.20% | [7],[8],[18],[24],[25]
Interest rate floor |  | 9.95% | [11],[12],[22],[26],[27] | 9.95% | [7],[8],[18],[24],[25] | 9.95% | [11],[12],[22],[26],[27] | 9.95% | [7],[8],[18],[24],[25]
Exit fee rate |  | 4.95% | [11],[12],[22],[26],[27] | 4.95% | [7],[8],[18],[24],[25] | 4.95% | [11],[12],[22],[26],[27] | 4.95% | [7],[8],[18],[24],[25]
Principal amount |  | $ 5,500,000 | [12],[22],[26],[27] | $ 5,000,000 | [7],[18],[24],[25] |  |  |  |
Investment cost |  | 5,544,000 | [2],[12],[22],[26],[27] | 4,949,000 | [6],[7],[18],[24],[25] |  |  |  |
Investments, at fair value: |  | 5,715,000 | [12],[22],[26],[27] | $ 4,949,000 | [7],[18],[24],[25] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Principal amount |  | 10,501,000 |  |  |  |  |  |  |
Investment cost | [2] | 10,324,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 10,334,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 12.36%, Floor rate 13.11% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22] | 2026-08 |  |  |  | 2026-08 |  |  |
Basis spread variable rate | [11],[22] | 12.36% |  |  |  | 12.36% |  |  |
Interest rate floor | [11],[22] | 13.11% |  |  |  | 13.11% |  |  |
Principal amount | [22] | $ 2,546,000 |  |  |  |  |  |  |
Investment cost | [2],[22] | 2,494,000 |  |  |  |  |  |  |
Investments, at fair value: | [22] | $ 2,556,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 8.63%, Floor rate 9.38% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10],[22] | 2026-08 |  |  |  | 2026-08 |  |  |
Basis spread variable rate | [10],[11],[22] | 8.63% |  |  |  | 8.63% |  |  |
Interest rate floor | [10],[11],[22] | 9.38% |  |  |  | 9.38% |  |  |
Principal amount | [10],[22] | $ 7,955,000 |  |  |  |  |  |  |
Investment cost | [2],[10],[22] | 7,830,000 |  |  |  |  |  |  |
Investments, at fair value: | [10],[22] | $ 7,778,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 9.53%, Floor rate 10.28% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[17] |  |  | 2026-08 |  |  |  | 2026-08 |
Basis spread variable rate | [7],[8],[17] |  |  | 9.53% |  |  |  | 9.53% |
Interest rate floor | [7],[8],[17] |  |  | 10.28% |  |  |  | 10.28% |
Principal amount | [7],[17] |  |  | $ 10,528,000 |  |  |  |  |
Investment cost | [6],[7],[17] |  |  | 10,298,000 |  |  |  |  |
Investments, at fair value: | [7],[17] |  |  | $ 10,114,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date July 2025, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 7.26% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [10],[20],[21],[22] | 2027-12 |  |  |  | 2027-12 |  |  |
Basis spread variable rate | [10],[11],[20],[21],[22] | 3.05% |  |  |  | 3.05% |  |  |
Interest rate floor | [10],[11],[20],[21],[22] | 11.55% |  |  |  | 11.55% |  |  |
Interest rate paid in kind | [10],[11],[20],[21],[22] | 1.10% |  |  |  | 1.10% |  |  |
Exit fee rate | [10],[11],[20],[21],[22] | 7.26% |  |  |  | 7.26% |  |  |
Principal amount | [10],[20],[21],[22] | $ 42,863,000 |  |  |  |  |  |  |
Investment cost | [2],[10],[20],[21],[22] | 43,087,000 |  |  |  |  |  |  |
Investments, at fair value: | [10],[20],[21],[22] | $ 43,087,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date July 2025, Prime + 3.05%, Floor rate 7.55%, PIK Interest 1.10%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[13],[14],[15],[17] |  |  | 2025-07 |  |  |  | 2025-07 |
Basis spread variable rate | [7],[8],[13],[14],[15],[17] |  |  | 3.05% |  |  |  | 3.05% |
Interest rate floor | [7],[8],[13],[14],[15],[17] |  |  | 7.55% |  |  |  | 7.55% |
Interest rate paid in kind | [7],[8],[13],[14],[15],[17] |  |  | 1.10% |  |  |  | 1.10% |
Exit fee rate | [7],[8],[13],[14],[15],[17] |  |  | 4.95% |  |  |  | 4.95% |
Principal amount | [7],[13],[14],[15],[17] |  |  | $ 31,930,000 |  |  |  |  |
Investment cost | [6],[7],[13],[14],[15],[17] |  |  | 32,346,000 |  |  |  |  |
Investments, at fair value: | [7],[13],[14],[15],[17] |  |  | $ 32,012,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Demandbase, Inc., Senior Secured, Maturity Date August 2025, Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.00%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[13],[14],[17] |  |  | 2025-08 |  |  |  | 2025-08 |
Basis spread variable rate | [7],[8],[13],[14],[17] |  |  | 2.25% |  |  |  | 2.25% |
Interest rate floor | [7],[8],[13],[14],[17] |  |  | 5.50% |  |  |  | 5.50% |
Interest rate paid in kind | [7],[8],[13],[14],[17] |  |  | 3.00% |  |  |  | 3.00% |
Exit fee rate | [7],[8],[13],[14],[17] |  |  | 5.00% |  |  |  | 5.00% |
Principal amount | [7],[13],[14],[17] |  |  | $ 28,503,000 |  |  |  |  |
Investment cost | [6],[7],[13],[14],[17] |  |  | 28,442,000 |  |  |  |  |
Investments, at fair value: | [7],[13],[14],[17] |  |  | $ 28,664,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Dispatch Technologies, Inc., Senior Secured, Maturity Date April 2028, 3-month SOFR + 8.01%, Floor rate 8.76% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2028-04 | [22],[23] | 2028-04 | [7],[16] | 2028-04 | [22],[23] | 2028-04 | [7],[16]
Basis spread variable rate |  | 8.01% | [11],[22],[23] | 8.01% | [7],[8],[16] | 8.01% | [11],[22],[23] | 8.01% | [7],[8],[16]
Interest rate floor |  | 8.76% | [11],[22],[23] | 8.76% | [7],[8],[16] | 8.76% | [11],[22],[23] | 8.76% | [7],[8],[16]
Principal amount |  | $ 8,125,000 | [22],[23] | $ 7,500,000 | [7],[16] |  |  |  |
Investment cost |  | 7,949,000 | [2],[22],[23] | 7,295,000 | [6],[7],[16] |  |  |  |
Investments, at fair value: |  | $ 8,127,000 | [22],[23] | $ 7,339,000 | [7],[16] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and DroneDeploy, Inc., Senior Secured, Maturity Date July 2026, Prime + 4.50%, Floor rate 8.75%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22] | 2026-07 |  |  |  | 2026-07 |  |  |
Basis spread variable rate | [11],[22] | 4.50% |  |  |  | 4.50% |  |  |
Interest rate floor | [11],[22] | 8.75% |  |  |  | 8.75% |  |  |
Exit fee rate | [11],[22] | 4.00% |  |  |  | 4.00% |  |  |
Principal amount | [22] | $ 6,250,000 |  |  |  |  |  |  |
Investment cost | [2],[22] | 6,083,000 |  |  |  |  |  |  |
Investments, at fair value: | [22] | $ 6,153,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Eigen Technologies Ltd., Senior Secured, Maturity Date April 2025, Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2025-04 | [26],[27] | 2025-04 | [24],[25] | 2025-04 | [26],[27] | 2025-04 | [24],[25]
Basis spread variable rate |  | 5.10% | [11],[26],[27] | 5.10% | [8],[24],[25] | 5.10% | [11],[26],[27] | 5.10% | [8],[24],[25]
Interest rate floor |  | 8.35% | [11],[26],[27] | 8.35% | [8],[24],[25] | 8.35% | [11],[26],[27] | 8.35% | [8],[24],[25]
Exit fee rate |  | 2.95% | [11],[26],[27] | 2.95% | [8],[24],[25] | 2.95% | [11],[26],[27] | 2.95% | [8],[24],[25]
Principal amount |  | $ 3,750,000 | [26],[27] | $ 3,750,000 | [24],[25] |  |  |  |
Investment cost |  | 3,801,000 | [2],[26],[27] | 3,744,000 | [6],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 3,730,000 | [26],[27] | $ 3,746,000 | [24],[25] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-03 | [9],[20],[22] | 2026-03 | [7],[13],[14] | 2026-03 | [9],[20],[22] | 2026-03 | [7],[13],[14]
Basis spread variable rate |  | 4.25% | [9],[11],[20],[22] | 4.25% | [7],[8],[13],[14] | 4.25% | [9],[11],[20],[22] | 4.25% | [7],[8],[13],[14]
Interest rate floor |  | 9.00% | [9],[11],[20],[22] | 9.00% | [7],[8],[13],[14] | 9.00% | [9],[11],[20],[22] | 9.00% | [7],[8],[13],[14]
Interest rate paid in kind |  | 1.95% | [9],[11],[20],[22] | 1.95% | [7],[8],[13],[14] | 1.95% | [9],[11],[20],[22] | 1.95% | [7],[8],[13],[14]
Exit fee rate |  | 3.95% | [9],[11],[20],[22] | 3.95% | [7],[8],[13],[14] | 3.95% | [9],[11],[20],[22] | 3.95% | [7],[8],[13],[14]
Principal amount |  | $ 12,629,000 | [9],[20],[22] | $ 5,021,000 | [7],[13],[14] |  |  |  |
Investment cost |  | 12,253,000 | [2],[9],[20],[22] | 4,839,000 | [6],[7],[13],[14] |  |  |  |
Investments, at fair value: |  | $ 12,692,000 | [9],[20],[22] | $ 4,839,000 | [7],[13],[14] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Enmark Systems, Inc., Senior Secured, Maturity Date September 2026, 3-month LIBOR + 6.77%, Floor rate 7.77%, PIK Interest 2.16% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[14],[15],[16] |  |  | 2026-09 |  |  |  | 2026-09 |
Basis spread variable rate | [7],[8],[14],[15],[16] |  |  | 6.77% |  |  |  | 6.77% |
Interest rate floor | [7],[8],[14],[15],[16] |  |  | 7.77% |  |  |  | 7.77% |
Interest rate paid in kind | [7],[8],[14],[15],[16] |  |  | 2.16% |  |  |  | 2.16% |
Principal amount | [7],[14],[15],[16] |  |  | $ 8,223,000 |  |  |  |  |
Investment cost | [6],[7],[14],[15],[16] |  |  | 8,054,000 |  |  |  |  |
Investments, at fair value: | [7],[14],[15],[16] |  |  | $ 8,043,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Enmark Systems, Inc., Senior Secured, Maturity Date September 2026, 3-month SOFR + 6.73%, Floor rate 7.73%, PIK Interest 2.13% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[21],[22],[23] | 2026-09 |  |  |  | 2026-09 |  |  |
Basis spread variable rate | [9],[11],[21],[22],[23] | 6.73% |  |  |  | 6.73% |  |  |
Interest rate floor | [9],[11],[21],[22],[23] | 7.73% |  |  |  | 7.73% |  |  |
Interest rate paid in kind | [9],[11],[21],[22],[23] | 2.13% |  |  |  | 2.13% |  |  |
Principal amount | [9],[21],[22],[23] | $ 8,363,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[21],[22],[23] | 8,230,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[21],[22],[23] | $ 8,363,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Esentire, Inc., Senior Secured, Maturity Date May 2024, 3-month LIBOR + 9.96%, Floor rate 10.96% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [15],[16],[24],[25] |  |  | 2024-05 |  |  |  | 2024-05 |
Basis spread variable rate | [8],[15],[16],[24],[25] |  |  | 9.96% |  |  |  | 9.96% |
Interest rate floor | [8],[15],[16],[24],[25] |  |  | 10.96% |  |  |  | 10.96% |
Principal amount | [15],[16],[24],[25] |  |  | $ 8,436,000 |  |  |  |  |
Investment cost | [6],[15],[16],[24],[25] |  |  | 8,361,000 |  |  |  |  |
Investments, at fair value: | [15],[16],[24],[25] |  |  | $ 8,376,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Esme Learning Solutions, Inc., Senior Secured, Maturity Date February 2025, Prime + 5.50%, Floor rate 8.75%, PIK Interest 1.50%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[33] |  |  | 2025-02 |  |  |  | 2025-02 |
Basis spread variable rate | [8],[14],[33] |  |  | 5.50% |  |  |  | 5.50% |
Interest rate floor | [8],[14],[33] |  |  | 8.75% |  |  |  | 8.75% |
Interest rate paid in kind | [8],[14],[33] |  |  | 1.50% |  |  |  | 1.50% |
Exit fee rate | [8],[14],[33] |  |  | 3.00% |  |  |  | 3.00% |
Principal amount | [14],[33] |  |  | $ 4,892,000 |  |  |  |  |
Investment cost | [6],[14],[33] |  |  | 4,737,000 |  |  |  |  |
Investments, at fair value: | [14],[33] |  |  | $ 1,671,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.79%, Floor rate 8.70% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[16] |  |  | 2027-10 |  |  |  | 2027-10 |
Basis spread variable rate | [7],[8],[16] |  |  | 7.79% |  |  |  | 7.79% |
Interest rate floor | [7],[8],[16] |  |  | 8.70% |  |  |  | 8.70% |
Principal amount | [7],[16] |  |  | $ 5,948,000 |  |  |  |  |
Investment cost | [6],[7],[16] |  |  | 5,771,000 |  |  |  |  |
Investments, at fair value: | [7],[16] |  |  | $ 5,771,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.80%, Floor rate 8.70% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22],[23] | 2027-10 |  |  |  | 2027-10 |  |  |
Basis spread variable rate | [11],[22],[23] | 7.80% |  |  |  | 7.80% |  |  |
Interest rate floor | [11],[22],[23] | 8.70% |  |  |  | 8.70% |  |  |
Principal amount | [22],[23] | $ 6,587,000 |  |  |  |  |  |  |
Investment cost | [2],[22],[23] | 6,420,000 |  |  |  |  |  |  |
Investments, at fair value: | [22],[23] | $ 6,553,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 6-month SOFR + 7.64%, Floor rate 8.54% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [21],[22],[23] | 2027-12 |  |  |  | 2027-12 |  |  |
Basis spread variable rate | [11],[21],[22],[23] | 7.64% |  |  |  | 7.64% |  |  |
Interest rate floor | [11],[21],[22],[23] | 8.54% |  |  |  | 8.54% |  |  |
Principal amount | [21],[22],[23] | $ 7,000,000 |  |  |  |  |  |  |
Investment cost | [2],[21],[22],[23] | 6,851,000 |  |  |  |  |  |  |
Investments, at fair value: | [21],[22],[23] | $ 6,910,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 6-month SOFR + 7.79%, Floor rate 8.54% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[16] |  |  | 2027-12 |  |  |  | 2027-12 |
Basis spread variable rate | [7],[8],[16] |  |  | 7.79% |  |  |  | 7.79% |
Interest rate floor | [7],[8],[16] |  |  | 8.54% |  |  |  | 8.54% |
Principal amount | [7],[16] |  |  | $ 7,000,000 |  |  |  |  |
Investment cost | [6],[7],[16] |  |  | 6,824,000 |  |  |  |  |
Investments, at fair value: | [7],[16] |  |  | $ 6,824,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Ikon Science Limited, Senior Secured, Maturity Date October 2024, 3-month Eurodollar + 9.00%, Floor rate 10.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[16],[24],[25] |  |  | 2024-10 |  |  |  | 2024-10 |
Basis spread variable rate | [7],[8],[16],[24],[25] |  |  | 9.00% |  |  |  | 9.00% |
Interest rate floor | [7],[8],[16],[24],[25] |  |  | 10.00% |  |  |  | 10.00% |
Principal amount | [7],[16],[24],[25] |  |  | $ 6,563,000 |  |  |  |  |
Investment cost | [6],[7],[16],[24],[25] |  |  | 6,422,000 |  |  |  |  |
Investments, at fair value: | [7],[16],[24],[25] |  |  | $ 6,484,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Ikon Science Limited, Senior Secured, Maturity Date October 2024, 3-month SOFR + 9.26%, Floor rate 10.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22],[23],[26],[27] | 2024-10 |  |  |  | 2024-10 |  |  |
Basis spread variable rate | [11],[22],[23],[26],[27] | 9.26% |  |  |  | 9.26% |  |  |
Interest rate floor | [11],[22],[23],[26],[27] | 10.00% |  |  |  | 10.00% |  |  |
Principal amount | [22],[23],[26],[27] | $ 6,213,000 |  |  |  |  |  |  |
Investment cost | [2],[22],[23],[26],[27] | 6,148,000 |  |  |  |  |  |  |
Investments, at fair value: | [22],[23],[26],[27] | $ 6,148,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Imperva, Inc., Senior Secured, Maturity Date January 2027, 3-month LIBOR + 7.75%, Floor rate 8.75% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [13] |  |  | 2027-01 |  |  |  | 2027-01 |
Basis spread variable rate | [8],[13] |  |  | 7.75% |  |  |  | 7.75% |
Interest rate floor | [8],[13] |  |  | 8.75% |  |  |  | 8.75% |
Principal amount | [13] |  |  | $ 20,000,000 |  |  |  |  |
Investment cost | [6],[13] |  |  | 19,875,000 |  |  |  |  |
Investments, at fair value: | [13] |  |  | $ 20,200,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.), Senior Secured, Maturity Date July 2023, 3-month SOFR + 10.14%, Floor rate 11.14% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [16] |  |  | 2023-07 |  |  |  | 2023-07 |
Basis spread variable rate | [8],[16] |  |  | 10.14% |  |  |  | 10.14% |
Interest rate floor | [8],[16] |  |  | 11.14% |  |  |  | 11.14% |
Principal amount | [16] |  |  | $ 10,681,000 |  |  |  |  |
Investment cost | [6],[16] |  |  | 10,593,000 |  |  |  |  |
Investments, at fair value: | [16] |  |  | $ 10,593,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Khoros (p.k.a Lithium Technologies), Senior Secured, Maturity Date January 2024, 3-month SOFR + 8.00%, Floor rate 9.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7] |  |  | 2024-01 |  |  |  | 2024-01 |
Basis spread variable rate | [7],[8] |  |  | 8.00% |  |  |  | 8.00% |
Interest rate floor | [7],[8] |  |  | 9.00% |  |  |  | 9.00% |
Principal amount | [7] |  |  | $ 56,208,000 |  |  |  |  |
Investment cost | [6],[7] |  |  | 56,062,000 |  |  |  |  |
Investments, at fair value: | [7] |  |  | $ 55,520,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Khoros (p.k.a Lithium Technologies), Senior Secured, Maturity Date January 2025, 3-month SOFR + 4.50%, Floor rate 5.50%, PIK Interest 4.50% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9] | 2025-01 |  |  |  | 2025-01 |  |  |
Basis spread variable rate | [9],[11] | 4.50% |  |  |  | 4.50% |  |  |
Interest rate floor | [9],[11] | 5.50% |  |  |  | 5.50% |  |  |
Interest rate paid in kind | [9],[11] | 4.50% |  |  |  | 4.50% |  |  |
Principal amount | [9] | $ 57,770,000 |  |  |  |  |  |  |
Investment cost | [2],[9] | 57,730,000 |  |  |  |  |  |  |
Investments, at fair value: | [9] | $ 56,293,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Leapwork ApS., Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.25%, PIK Interest 1.95%, 2.70% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[12],[22],[26],[27] | 2026-02 |  |  |  | 2026-02 |  |  |
Basis spread variable rate | [9],[11],[12],[22],[26],[27] | 0.25% |  |  |  | 0.25% |  |  |
Interest rate floor | [9],[11],[12],[22],[26],[27] | 7.25% |  |  |  | 7.25% |  |  |
Interest rate paid in kind | [9],[11],[12],[22],[26],[27] | 1.95% |  |  |  | 1.95% |  |  |
Exit fee rate | [9],[11],[12],[22],[26],[27] | 2.70% |  |  |  | 2.70% |  |  |
Principal amount | [9],[12],[22],[26],[27] | $ 3,813,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[12],[22],[26],[27] | 3,810,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[12],[22],[26],[27] | $ 3,907,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and LinenMaster, LLC., Senior Secured, Maturity Date August 2028 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[22] | 2028-08 |  |  |  | 2028-08 |  |  |
Basis spread variable rate | [9],[11],[22] | 6.25% |  |  |  | 6.25% |  |  |
Interest rate floor | [9],[11],[22] | 7.25% |  |  |  | 7.25% |  |  |
Interest rate paid in kind | [9],[11],[22] | 2.15% |  |  |  | 2.15% |  |  |
Principal amount | [9],[22] | $ 15,083,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[22] | 14,799,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[22] | $ 14,799,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22],[23] | 2028-03 |  |  |  | 2028-03 |  |  |
Basis spread variable rate | [11],[22],[23] | 7.88% |  |  |  | 7.88% |  |  |
Interest rate floor | [11],[22],[23] | 8.88% |  |  |  | 8.88% |  |  |
Principal amount | [22],[23] | $ 26,469,000 |  |  |  |  |  |  |
Investment cost | [2],[22],[23] | 25,897,000 |  |  |  |  |  |  |
Investments, at fair value: | [22],[23] | $ 26,566,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and LogicSource, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.93%, Floor rate 9.93% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-07 | [22],[23] | 2027-07 | [7] | 2027-07 | [22],[23] | 2027-07 | [7]
Basis spread variable rate |  | 8.93% | [11],[22],[23] | 8.93% | [7],[8] | 8.93% | [11],[22],[23] | 8.93% | [7],[8]
Interest rate floor |  | 9.93% | [11],[22],[23] | 9.93% | [7],[8] | 9.93% | [11],[22],[23] | 9.93% | [7],[8]
Principal amount |  | $ 13,300,000 | [22],[23] | $ 13,300,000 | [7] |  |  |  |
Investment cost |  | 13,074,000 | [2],[22],[23] | 13,028,000 | [6],[7] |  |  |  |
Investments, at fair value: |  | $ 13,493,000 | [22],[23] | $ 13,028,000 | [7] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Logicworks, Senior Secured, Maturity Date January 2024, Prime + 7.50%, Floor rate 10.75% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [18] |  |  | 2024-01 |  |  |  | 2024-01 |
Basis spread variable rate | [8],[18] |  |  | 7.50% |  |  |  | 7.50% |
Interest rate floor | [8],[18] |  |  | 10.75% |  |  |  | 10.75% |
Principal amount | [18] |  |  | $ 14,500,000 |  |  |  |  |
Investment cost | [6],[18] |  |  | 14,398,000 |  |  |  |  |
Investments, at fair value: | [18] |  |  | $ 14,473,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 3-month LIBOR + 9.06%, Floor rate 10.06% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[16] |  |  | 2025-12 |  |  |  | 2025-12 |
Basis spread variable rate | [7],[8],[16] |  |  | 9.06% |  |  |  | 9.06% |
Interest rate floor | [7],[8],[16] |  |  | 10.06% |  |  |  | 10.06% |
Principal amount | [7],[16] |  |  | $ 17,915,000 |  |  |  |  |
Investment cost | [6],[7],[16] |  |  | 17,556,000 |  |  |  |  |
Investments, at fair value: | [7],[16] |  |  | $ 17,474,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 3-month SOFR + 9.31%, Floor rate 10.06% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [23] | 2025-12 |  |  |  | 2025-12 |  |  |
Basis spread variable rate | [11],[23] | 9.31% |  |  |  | 9.31% |  |  |
Interest rate floor | [11],[23] | 10.06% |  |  |  | 10.06% |  |  |
Principal amount | [23] | $ 18,366,000 |  |  |  |  |  |  |
Investment cost | [2],[23] | 18,116,000 |  |  |  |  |  |  |
Investments, at fair value: | [23] | $ 18,176,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date November 2030, 3-month SOFR + 6.75%, Floor rate 7.75% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22] | 2030-11 |  |  |  | 2030-11 |  |  |
Basis spread variable rate | [11],[22] | 6.75% |  |  |  | 6.75% |  |  |
Interest rate floor | [11],[22] | 7.75% |  |  |  | 7.75% |  |  |
Principal amount | [22] | $ 20,890,000 |  |  |  |  |  |  |
Investment cost | [2],[22] | 20,375,000 |  |  |  |  |  |  |
Investments, at fair value: | [22] | $ 20,375,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Nextroll, Inc., Senior Secured, Maturity Date July 2023, Prime + 3.75%, Floor rate 7.75%, PIK Interest 2.95%, 1.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[18] |  |  | 2023-07 |  |  |  | 2023-07 |
Basis spread variable rate | [8],[14],[18] |  |  | 3.75% |  |  |  | 3.75% |
Interest rate floor | [8],[14],[18] |  |  | 7.75% |  |  |  | 7.75% |
Interest rate paid in kind | [8],[14],[18] |  |  | 2.95% |  |  |  | 2.95% |
Exit fee rate | [8],[14],[18] |  |  | 1.95% |  |  |  | 1.95% |
Principal amount | [14],[18] |  |  | $ 22,211,000 |  |  |  |  |
Investment cost | [6],[14],[18] |  |  | 22,284,000 |  |  |  |  |
Investments, at fair value: | [14],[18] |  |  | $ 22,284,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Nuvolo Technologies Corporation, Senior Secured, Maturity Date July 2025, Prime + 5.25%, Floor rate 8.50%, 2.42% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[13],[17],[18] |  |  | 2025-07 |  |  |  | 2025-07 |
Basis spread variable rate | [7],[8],[13],[17],[18] |  |  | 5.25% |  |  |  | 5.25% |
Interest rate floor | [7],[8],[13],[17],[18] |  |  | 8.50% |  |  |  | 8.50% |
Exit fee rate | [7],[8],[13],[17],[18] |  |  | 2.42% |  |  |  | 2.42% |
Principal amount | [7],[13],[17],[18] |  |  | $ 22,500,000 |  |  |  |  |
Investment cost | [6],[7],[13],[17],[18] |  |  | 22,508,000 |  |  |  |  |
Investments, at fair value: | [7],[13],[17],[18] |  |  | $ 22,817,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Omeda Holdings, LLC, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.05%, Floor rate 9.05% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-07 | [21],[22],[23] | 2027-07 | [7],[16] | 2027-07 | [21],[22],[23] | 2027-07 | [7],[16]
Basis spread variable rate |  | 8.05% | [11],[21],[22],[23] | 8.05% | [7],[8],[16] | 8.05% | [11],[21],[22],[23] | 8.05% | [7],[8],[16]
Interest rate floor |  | 9.05% | [11],[21],[22],[23] | 9.05% | [7],[8],[16] | 9.05% | [11],[21],[22],[23] | 9.05% | [7],[8],[16]
Principal amount |  | $ 7,706,000 | [21],[22],[23] | $ 7,500,000 | [7],[16] |  |  |  |
Investment cost |  | 7,508,000 | [2],[21],[22],[23] | 7,261,000 | [6],[7],[16] |  |  |  |
Investments, at fair value: |  | $ 7,702,000 | [21],[22],[23] | $ 7,261,000 | [7],[16] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Onna Technologies, Inc., Senior Secured, Maturity Date March 2026, Prime + 1.35%, Floor rate 8.85%, PIK Interest, 1.75%, 4.45% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9] | 2026-03 |  |  |  | 2026-03 |  |  |
Basis spread variable rate | [9],[11] | 1.35% |  |  |  | 1.35% |  |  |
Interest rate floor | [9],[11] | 8.85% |  |  |  | 8.85% |  |  |
Interest rate paid in kind | [9],[11] | 1.75% |  |  |  | 1.75% |  |  |
Exit fee rate | [9],[11] | 4.45% |  |  |  | 4.45% |  |  |
Principal amount | [9] | $ 3,853,000 |  |  |  |  |  |  |
Investment cost | [2],[9] | 3,814,000 |  |  |  |  |  |  |
Investments, at fair value: | [9] | $ 3,810,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Riviera Partners LLC, Senior Secured, Maturity Date April 2027, 6-month SOFR + 7.53%, Floor rate 8.53% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[16] |  |  | 2027-04 |  |  |  | 2027-04 |
Basis spread variable rate | [7],[8],[16] |  |  | 7.53% |  |  |  | 7.53% |
Interest rate floor | [7],[8],[16] |  |  | 8.53% |  |  |  | 8.53% |
Principal amount | [7],[16] |  |  | $ 26,184,000 |  |  |  |  |
Investment cost | [6],[7],[16] |  |  | 25,622,000 |  |  |  |  |
Investments, at fair value: | [7],[16] |  |  | $ 25,487,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Salary.com, LLC, Senior Secured, Maturity Date September 2027, 3-month SOFR + 8.00%, Floor rate 9.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [23] | 2027-09 |  |  |  | 2027-09 |  |  |
Basis spread variable rate | [11],[23] | 8.00% |  |  |  | 8.00% |  |  |
Interest rate floor | [11],[23] | 9.00% |  |  |  | 9.00% |  |  |
Principal amount | [23] | $ 22,185,000 |  |  |  |  |  |  |
Investment cost | [2],[23] | 21,814,000 |  |  |  |  |  |  |
Investments, at fair value: | [23] | $ 22,048,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Salary.com, LLC, Senior Secured, Maturity Date September 2027, 6-month SOFR + 8.00%, Floor rate 9.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [16] |  |  | 2027-09 |  |  |  | 2027-09 |
Basis spread variable rate | [8],[16] |  |  | 8.00% |  |  |  | 8.00% |
Interest rate floor | [8],[16] |  |  | 9.00% |  |  |  | 9.00% |
Principal amount | [16] |  |  | $ 18,000,000 |  |  |  |  |
Investment cost | [6],[16] |  |  | 17,654,000 |  |  |  |  |
Investments, at fair value: | [16] |  |  | $ 17,654,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 3-month LIBOR + 9.00%, Floor rate 10.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[16] |  |  | 2026-12 |  |  |  | 2026-12 |
Basis spread variable rate | [7],[8],[16] |  |  | 9.00% |  |  |  | 9.00% |
Interest rate floor | [7],[8],[16] |  |  | 10.00% |  |  |  | 10.00% |
Principal amount | [7],[16] |  |  | $ 5,985,000 |  |  |  |  |
Investment cost | [6],[7],[16] |  |  | 5,841,000 |  |  |  |  |
Investments, at fair value: | [7],[16] |  |  | $ 5,830,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 6-month SOFR + 9.01%, Floor rate 9.91% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22],[23] | 2026-12 |  |  |  | 2026-12 |  |  |
Basis spread variable rate | [11],[22],[23] | 9.01% |  |  |  | 9.01% |  |  |
Interest rate floor | [11],[22],[23] | 9.91% |  |  |  | 9.91% |  |  |
Principal amount | [22],[23] | $ 6,000,000 |  |  |  |  |  |  |
Investment cost | [2],[22],[23] | 5,883,000 |  |  |  |  |  |  |
Investments, at fair value: | [22],[23] | $ 5,921,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Simon Data, Inc., Senior Secured, Maturity Date March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.92% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[12] | 2027-03 |  |  |  | 2027-03 |  |  |
Basis spread variable rate | [9],[11],[12] | 1.00% |  |  |  | 1.00% |  |  |
Interest rate floor | [9],[11],[12] | 8.75% |  |  |  | 8.75% |  |  |
Interest rate paid in kind | [9],[11],[12] | 1.95% |  |  |  | 1.95% |  |  |
Exit fee rate | [9],[11],[12] | 2.92% |  |  |  | 2.92% |  |  |
Principal amount | [9],[12] | $ 15,065,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[12] | 14,982,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[12] | $ 15,037,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Sisense Ltd., Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[26],[27] | 2027-07 |  |  |  | 2027-07 |  |  |
Basis spread variable rate | [9],[11],[26],[27] | 1.50% |  |  |  | 1.50% |  |  |
Interest rate cap | [9],[11],[26],[27] | 9.50% |  |  |  | 9.50% |  |  |
Interest rate paid in kind | [9],[11],[26],[27] | 1.95% |  |  |  | 1.95% |  |  |
Exit fee rate | [9],[11],[26],[27] | 5.95% |  |  |  | 5.95% |  |  |
Principal amount | [9],[26],[27] | $ 34,830,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[26],[27] | 34,584,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[26],[27] | $ 34,881,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 1-month SOFR + 7.25%, Floor rate 8.25% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22],[23] | 2028-03 |  |  |  | 2028-03 |  |  |
Basis spread variable rate | [11],[22],[23] | 7.25% |  |  |  | 7.25% |  |  |
Interest rate floor | [11],[22],[23] | 8.25% |  |  |  | 8.25% |  |  |
Principal amount | [22],[23] | $ 13,200,000 |  |  |  |  |  |  |
Investment cost | [2],[22],[23] | 12,953,000 |  |  |  |  |  |  |
Investments, at fair value: | [22],[23] | $ 13,327,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date May 2030, 3-month SOFR + 6.50%, Floor rate 7.50% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22] | 2030-05 |  |  |  | 2030-05 |  |  |
Basis spread variable rate | [11],[22] | 6.50% |  |  |  | 6.50% |  |  |
Interest rate floor | [11],[22] | 7.50% |  |  |  | 7.50% |  |  |
Principal amount | [22] | $ 23,000,000 |  |  |  |  |  |  |
Investment cost | [2],[22] | 22,460,000 |  |  |  |  |  |  |
Investments, at fair value: | [22] | $ 23,105,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Suzy, Inc.., Senior Secured, Maturity Date August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [1],[9],[22] | 2027-08 |  |  |  | 2027-08 |  |  |
Basis spread variable rate | [1],[9],[11],[22] | 1.75% |  |  |  | 1.75% |  |  |
Interest rate floor | [1],[9],[11],[22] | 10.00% |  |  |  | 10.00% |  |  |
Interest rate paid in kind | [1],[9],[11],[22] | 1.95% |  |  |  | 1.95% |  |  |
Exit fee rate | [1],[9],[11],[22] | 3.45% |  |  |  | 3.45% |  |  |
Principal amount | [1],[9],[22] | $ 12,064,000 |  |  |  |  |  |  |
Investment cost | [1],[2],[9],[22] | 11,837,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[9],[22] | $ 11,837,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Tact.ai Technologies, Inc., Senior Secured, Maturity Date February 2024, Prime + 4.00%, Floor rate 8.75%, PIK Interest 2.00%, 5.50% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14] |  |  | 2024-02 |  |  |  | 2024-02 |
Basis spread variable rate | [8],[14] |  |  | 4.00% |  |  |  | 4.00% |
Interest rate floor | [8],[14] |  |  | 8.75% |  |  |  | 8.75% |
Interest rate paid in kind | [8],[14] |  |  | 2.00% |  |  |  | 2.00% |
Exit fee rate | [8],[14] |  |  | 5.50% |  |  |  | 5.50% |
Principal amount | [14] |  |  | $ 4,250,000 |  |  |  |  |
Investment cost | [6],[14] |  |  | 4,481,000 |  |  |  |  |
Investments, at fair value: | [14] |  |  | $ 4,446,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 6-month LIBOR + 9.00%, Floor rate 10.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [7],[16] |  |  | 2026-05 |  |  |  | 2026-05 |
Basis spread variable rate | [7],[8],[16] |  |  | 9.00% |  |  |  | 9.00% |
Interest rate floor | [7],[8],[16] |  |  | 10.00% |  |  |  | 10.00% |
Principal amount | [7],[16] |  |  | $ 11,032,000 |  |  |  |  |
Investment cost | [6],[7],[16] |  |  | 10,778,000 |  |  |  |  |
Investments, at fair value: | [7],[16] |  |  | $ 10,793,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 6-month SOFR + 9.25%, Floor rate 10.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [22],[23] | 2026-05 |  |  |  | 2026-05 |  |  |
Basis spread variable rate | [11],[22],[23] | 9.25% |  |  |  | 9.25% |  |  |
Interest rate floor | [11],[22],[23] | 10.00% |  |  |  | 10.00% |  |  |
Principal amount | [22],[23] | $ 10,920,000 |  |  |  |  |  |  |
Investment cost | [2],[22],[23] | 10,730,000 |  |  |  |  |  |  |
Investments, at fair value: | [22],[23] | $ 10,920,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2027, Prime + 0.45%, Floor rate 7.95%, PIK Interest 2.00%, 3.75% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[22],[26],[27] | 2027-04 |  |  |  | 2027-04 |  |  |
Basis spread variable rate | [9],[11],[22],[26],[27] | 0.45% |  |  |  | 0.45% |  |  |
Interest rate floor | [9],[11],[22],[26],[27] | 7.95% |  |  |  | 7.95% |  |  |
Interest rate paid in kind | [9],[11],[22],[26],[27] | 2.00% |  |  |  | 2.00% |  |  |
Exit fee rate | [9],[11],[22],[26],[27] | 3.75% |  |  |  | 3.75% |  |  |
Principal amount | [9],[22],[26],[27] | $ 10,649,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[22],[26],[27] | 10,578,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[22],[26],[27] | $ 10,835,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and VideoAmp, Inc., Senior Secured, Maturity Date February 2025, Prime + 3.70%, Floor rate 6.95%, PIK Interest 1.25%, 5.25% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [13],[14],[30] |  |  | 2025-02 |  |  |  | 2025-02 |
Basis spread variable rate | [8],[13],[14],[30] |  |  | 3.70% |  |  |  | 3.70% |
Interest rate floor | [8],[13],[14],[30] |  |  | 6.95% |  |  |  | 6.95% |
Interest rate paid in kind | [8],[13],[14],[30] |  |  | 1.25% |  |  |  | 1.25% |
Exit fee rate | [8],[13],[14],[30] |  |  | 5.25% |  |  |  | 5.25% |
Principal amount | [13],[14],[30] |  |  | $ 63,187,000 |  |  |  |  |
Investment cost | [6],[13],[14],[30] |  |  | 62,640,000 |  |  |  |  |
Investments, at fair value: | [13],[14],[30] |  |  | $ 63,429,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Zappi, Inc., Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.03%, Floor rate 9.03% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-12 | [10],[22],[23],[26],[27] | 2027-12 | [7],[16],[24],[25] | 2027-12 | [10],[22],[23],[26],[27] | 2027-12 | [7],[16],[24],[25]
Basis spread variable rate |  | 8.03% | [10],[11],[22],[23],[26],[27] | 8.03% | [7],[8],[16],[24],[25] | 8.03% | [10],[11],[22],[23],[26],[27] | 8.03% | [7],[8],[16],[24],[25]
Interest rate floor |  | 9.03% | [10],[11],[22],[23],[26],[27] | 9.03% | [7],[8],[16],[24],[25] | 9.03% | [10],[11],[22],[23],[26],[27] | 9.03% | [7],[8],[16],[24],[25]
Principal amount |  | $ 9,000,000 | [10],[22],[23],[26],[27] | $ 9,000,000 | [7],[16],[24],[25] |  |  |  |
Investment cost |  | 8,816,000 | [2],[10],[22],[23],[26],[27] | 8,779,000 | [6],[7],[16],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 8,967,000 | [10],[22],[23],[26],[27] | $ 8,779,000 | [7],[16],[24],[25] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Zimperium, Inc., Senior Secured, Maturity Date May 2027, 3-month SOFR + 8.31%, Floor rate 9.31% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-05 | [22],[23] | 2027-05 | [7],[16] | 2027-05 | [22],[23] | 2027-05 | [7],[16]
Basis spread variable rate |  | 8.31% | [11],[22],[23] | 8.31% | [7],[8],[16] | 8.31% | [11],[22],[23] | 8.31% | [7],[8],[16]
Interest rate floor |  | 9.31% | [11],[22],[23] | 9.31% | [7],[8],[16] | 9.31% | [11],[22],[23] | 9.31% | [7],[8],[16]
Principal amount |  | $ 16,313,000 | [22],[23] | $ 16,313,000 | [7],[16] |  |  |  |
Investment cost |  | 16,057,000 | [2],[22],[23] | 16,000,000 | [6],[7],[16] |  |  |  |
Investments, at fair value: |  | $ 16,394,000 | [22],[23] | $ 16,072,000 | [7],[16] |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and iGrafx,LLC, Senior Secured, Maturity Date May 2027, 1-month SOFR + 8.66%, Floor rate 9.56% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [23] | 2027-05 |  |  |  | 2027-05 |  |  |
Basis spread variable rate | [11],[23] | 8.66% |  |  |  | 8.66% |  |  |
Interest rate floor | [11],[23] | 9.56% |  |  |  | 9.56% |  |  |
Principal amount | [23] | $ 5,000,000 |  |  |  |  |  |  |
Investment cost | [2],[23] | 4,901,000 |  |  |  |  |  |  |
Investments, at fair value: | [23] | $ 4,901,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Subtotal: Communications & Networking (1.62%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 1.62% |  |  |  | 1.62% |  |  |
Investment cost | [2] | $ 28,182,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 29,272,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (0.31%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.31% |  |  |  | 0.31% |  |  |
Investment cost | [2] | $ 5,634,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 5,617,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (0.50%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.50% |  |  |  | 0.50% |
Investment cost | [6] |  |  | $ 7,222,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 7,014,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.78% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [9],[10] | 2025-05 |  |  |  | 2025-05 |  |  |
Basis spread variable rate | [9],[10],[11] | 4.70% |  |  |  | 4.70% |  |  |
Interest rate floor | [9],[10],[11] | 7.95% |  |  |  | 7.95% |  |  |
Interest rate paid in kind | [9],[10],[11] | 1.45% |  |  |  | 1.45% |  |  |
Exit fee rate | [9],[10],[11] | 3.78% |  |  |  | 3.78% |  |  |
Principal amount | [9],[10] | $ 3,926,000 |  |  |  |  |  |  |
Investment cost | [2],[9],[10] | 3,952,000 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10] | $ 3,939,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14],[17] |  |  | 2025-05 |  |  |  | 2025-05 |
Basis spread variable rate | [8],[14],[17] |  |  | 4.70% |  |  |  | 4.70% |
Interest rate floor | [8],[14],[17] |  |  | 7.95% |  |  |  | 7.95% |
Interest rate paid in kind | [8],[14],[17] |  |  | 1.45% |  |  |  | 1.45% |
Exit fee rate | [8],[14],[17] |  |  | 3.95% |  |  |  | 3.95% |
Principal amount | [14],[17] |  |  | $ 4,037,000 |  |  |  |  |
Investment cost | [6],[14],[17] |  |  | 3,985,000 |  |  |  |  |
Investments, at fair value: | [14],[17] |  |  | $ 4,008,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date December 2024, PIK Interest 10.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [14] |  |  | 2024-12 |  |  |  | 2024-12 |
Interest rate paid in kind | [8],[14] |  |  | 10.00% |  |  |  | 10.00% |
Principal amount | [14] |  |  | $ 3,237,000 |  |  |  |  |
Investment cost | [6],[14] |  |  | 3,237,000 |  |  |  |  |
Investments, at fair value: | [14] |  |  | $ 3,006,000 |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date June 2027, FIXED 10.00% |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Maturity Date | [20] | 2027-06 |  |  |  | 2027-06 |  |  |
Interest rate paid in kind | [11],[20] | 10.00% |  |  |  | 10.00% |  |  |
Principal amount | [20] | $ 1,682,000 |  |  |  |  |  |  |
Investment cost | [2],[20] | 1,682,000 |  |  |  |  |  |  |
Investments, at fair value: | [20] | $ 1,678,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments (8.44%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 8.44% |  |  |  | 8.44% |  |  |
Investment cost | [2] | $ 155,226,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 152,170,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments (9.56%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 9.56% |  |  |  | 9.56% |
Investment cost | [6] |  |  | $ 153,173,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 133,972,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.04%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.04% |  |  |  | 0.04% |
Investment cost | [6] |  |  | $ 663,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 498,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.13%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.13% |  |  |  | 0.13% |  |  |
Investment cost | [2] | $ 1,764,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 2,264,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | 1,229,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 796,000 |  |  |  |  |  |  |
Shares | shares |  | 173,180 |  |  |  | 173,180 |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 128,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 96,000 |  |  |  |  |  |  |
Acquisition date | [3] | Apr. 30, 2010 |  |  |  |  |  |  |
Shares | shares |  | 42,989 |  |  |  | 42,989 |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 7/16/2013, Series Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 1,101,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 700,000 |  |  |  |  |  |  |
Acquisition date | [3] | Jul. 16, 2013 |  |  |  |  |  |  |
Shares | shares |  | 130,191 |  |  |  | 130,191 |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 433,000 | [2],[3] | 433,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 21,000 | [3] | $ 24,000 | [40] |  |  |  |
Acquisition date |  | Apr. 30, 2021 | [3] | Apr. 30, 2021 | [40] |  |  |  |
Shares | shares |  | 12,260 | [3] | 61,300 | [40] | 12,260 | [3] | 61,300 | [40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 13,000 | [2] | $ 13,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 863,000 |  | $ 226,000 |  |  |  |  |
Acquisition date |  | Apr. 30, 2010 | [3] | Apr. 30, 2010 | [40] |  |  |  |
Shares | shares |  | 172,328 |  | 42,137 |  | 172,328 |  | 42,137 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 89,000 | [2] | $ 89,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 584,000 |  | $ 116,000 |  |  |  |  |
Acquisition date |  | Apr. 30, 2010 | [3] | Apr. 30, 2010 | [40] |  |  |  |
Shares | shares |  | 173,180 |  | 42,989 |  | 173,180 |  | 42,989 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and TechStyle, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 128,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 132,000 |  |  |  |  |
Acquisition date | [40] |  |  | Apr. 30, 2010 |  |  |  |  |
Shares | shares |  |  |  | 42,989 |  |  |  | 42,989 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.57%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.57% |  |  |  | 0.57% |
Investment cost | [6] |  |  | $ 13,488,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 7,995,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.70%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.70% |  |  |  | 0.70% |  |  |
Investment cost | [2] | $ 26,145,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 12,703,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-4 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 1,151,000 | [2],[26],[27] | 1,151,000 | [6],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 679,000 | [26],[27] | $ 257,000 | [24],[25] |  |  |  |
Acquisition date |  | Dec. 15, 2021 | [3],[26],[27] | Dec. 15, 2021 | [24],[25],[40] |  |  |  |
Shares | shares |  | 199,742 | [26],[27] | 199,742 | [24],[25] | 199,742 | [26],[27] | 199,742 | [24],[25]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 657,000 | [2],[3] | $ 945,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 5,636,000 | [3] | $ 4,003,000 | [40] |  |  |  |
Acquisition date |  | Dec. 20, 2018 | [3] | Dec. 20, 2018 | [40] |  |  |  |
Shares | shares |  | 56,996 | [3] | 81,996 | [40] | 56,996 | [3] | 81,996 | [40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 5,263,000 | [2],[3] | $ 5,263,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 1,510,000 | [3] | $ 1,110,000 | [40] |  |  |  |
Acquisition date |  | Dec. 26, 2018 | [3] | Dec. 26, 2018 | [40] |  |  |  |
Shares | shares |  | 100,738 | [3] | 100,738 | [40] | 100,738 | [3] | 100,738 | [40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,000,000 | [2],[3] | $ 1,000,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 343,000 | [3] | $ 225,000 | [40] |  |  |  |
Acquisition date |  | Sep. 17, 2021 | [3] | Sep. 17, 2021 | [40] |  |  |  |
Shares | shares |  | 100,000 | [3] | 100,000 | [40] | 100,000 | [3] | 100,000 | [40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,663,000 | [2] | $ 1,663,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 377,000 |  | $ 372,000 |  |  |  |  |
Acquisition date |  | Oct. 25, 2016 | [3] | Oct. 25, 2016 | [40] |  |  |  |
Shares | shares |  | 286,080 |  | 286,080 |  | 286,080 |  | 286,080 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 632,000 | [2] | $ 632,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 143,000 |  | $ 141,000 |  |  |  |  |
Acquisition date |  | Oct. 25, 2016 | [3] | Oct. 25, 2016 | [40] |  |  |  |
Shares | shares |  | 108,710 |  | 108,710 |  | 108,710 |  | 108,710 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 577,000 | [2],[3] | $ 577,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 189,000 | [3] | $ 266,000 | [40] |  |  |  |
Acquisition date |  | Jun. 28, 2013 | [3] | Jun. 28, 2013 | [40] |  |  |  |
Shares | shares |  | 48,365 | [3] | 48,365 | [40] | 48,365 | [3] | 48,365 | [40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 39,000 | [2] | $ 39,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |
Acquisition date |  | Jul. 31, 2020 | [3] | Jul. 31, 2020 | [40] |  |  |  |
Shares | shares |  | 3,095 |  | 3,095 |  | 3,095 |  | 3,095 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 1,000,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 559,000 |  |  |  |  |  |  |
Acquisition date | [3] | Jan. 24, 2022 |  |  |  |  |  |  |
Shares | shares |  | 7,063 |  |  |  | 7,063 |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Preferred Series B-2 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 1,000,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 805,000 |  |  |  |  |
Acquisition date | [40] |  |  | Jan. 24, 2022 |  |  |  |  |
Shares | shares |  |  |  | 7,063 |  |  |  | 7,063 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[32] | $ 13,263,000 |  |  |  |  |  |  |
Investments, at fair value: | [32] | $ 3,251,000 |  |  |  |  |  |  |
Acquisition date | [3],[32] | Dec. 29, 2023 |  |  |  |  |  |  |
Shares | shares | [32] | 3,235,298 |  |  |  | 3,235,298 |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 900,000 | [2],[32] | $ 900,000 | [6],[34] |  |  |  |
Investments, at fair value: |  | $ 4,000 | [32] | $ 0 | [34] |  |  |  |
Acquisition date |  | May 23, 2018 | [3],[32] | May 23, 2018 | [34],[40] |  |  |  |
Shares | shares |  | 414,994,863 | [32] | 414,994,863 | [34] | 414,994,863 | [32] | 414,994,863 | [34]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 0 | [2],[32] | $ 0 | [6],[34] |  |  |  |
Investments, at fair value: |  | $ 12,000 | [32] | $ 0 | [34] |  |  |  |
Acquisition date |  | Jun. 06, 2016 | [3],[32] | Jun. 06, 2016 | [34],[40] |  |  |  |
Shares | shares |  | 1,000,000 | [32] | 1,000,000 | [34] | 1,000,000 | [32] | 1,000,000 | [34]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total OfferUp, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,295,000 | [2] | $ 2,295,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 520,000 |  | $ 513,000 |  |  |  |  |
Shares | shares |  | 394,790 |  | 394,790 |  | 394,790 |  | 394,790 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total Tectura Corporation |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 14,163,000 | [2] | $ 900,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 3,267,000 |  | $ 0 |  |  |  |  |
Shares | shares |  | 419,230,161 |  | 415,994,863 |  | 419,230,161 |  | 415,994,863 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Uber Technologies, Inc., Equity, Acquisition Date 12/1/2020, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 318,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 816,000 |  |  |  |  |
Acquisition date | [40] |  |  | Dec. 01, 2020 |  |  |  |  |
Shares | shares | [40] |  |  | 32,991 |  |  |  | 32,991 |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (2.49%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 2.49% |  |  |  | 2.49% |
Investment cost | [6] |  |  | $ 28,444,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 34,869,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (3.17%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 3.17% |  |  |  | 3.17% |  |  |
Investment cost | [2] | $ 34,444,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 57,072,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Equity, Acquisition Date 3/1/2018, Series Member Units |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[32],[35] | 34,006,000 |  |  |  |  |  |  |
Investments, at fair value: | [32],[35] | $ 28,034,000 |  |  |  |  |  |  |
Acquisition date | [3],[32],[35] | Mar. 01, 2018 |  |  |  |  |  |  |
Shares | shares | [32],[35] | 1 |  |  |  | 1 |  |  |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[34] |  |  | 1,884,000 |  |  |  |  |
Investments, at fair value: | [34] |  |  | $ 1,107,000 |  |  |  |  |
Acquisition date | [34],[40] |  |  | Mar. 01, 2018 |  |  |  |  |
Shares | shares | [34] |  |  | 830,000 |  |  |  | 830,000 |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Preferred Series A |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[34] |  |  | $ 26,122,000 |  |  |  |  |
Investments, at fair value: | [34] |  |  | $ 14,137,000 |  |  |  |  |
Acquisition date | [34],[40] |  |  | Mar. 01, 2018 |  |  |  |  |
Shares | shares | [34] |  |  | 10,602,752 |  |  |  | 10,602,752 |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 35,000 | [2],[32],[36] | $ 35,000 | [6],[34] |  |  |  |
Investments, at fair value: |  | $ 28,713,000 | [32],[36] | $ 19,153,000 | [34] |  |  |  |
Acquisition date |  | Mar. 26, 2021 | [3],[32],[36] | Mar. 26, 2021 | [34],[40] |  |  |  |
Shares | shares |  | 1 | [32],[36] | 1 | [34] | 1 | [32],[36] | 1 | [34]
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 403,000 | [2] | $ 403,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 325,000 |  | $ 472,000 |  |  |  |  |
Acquisition date |  | Sep. 30, 2021 | [3] | Sep. 30, 2021 | [40] |  |  |  |
Shares | shares |  | 210,282 |  | 210,282 |  | 210,282 |  | 210,282 |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services, Gibraltar Business Capital, LLC |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 28,006,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 15,244,000 |  |  |  |  |
Shares | shares |  |  |  | 11,432,752 |  |  |  | 11,432,752 |
Investment, Identifier [Axis]: Equity Investments Drug Delivery (0.00%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.00% |  |  |  | 0.00% |  |  |
Investment cost | [2] | $ 3,638,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 21,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Delivery (0.01%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.01% |  |  |  | 0.01% |
Investment cost | [6] |  |  | $ 3,638,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 89,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Delivery and AcelRx Pharmaceuticals, Inc., Equity, Acquisition Date 12/10/2018, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | 1,329,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 20,000 |  |  |  |  |
Acquisition date | [40] |  |  | Dec. 10, 2018 |  |  |  |  |
Shares | shares | [40] |  |  | 8,836 |  |  |  | 8,836 |
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 1,500,000 | [2],[3] | $ 1,500,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 2,000 | [3] | $ 3,000 | [40] |  |  |  |
Acquisition date |  | Mar. 28, 2014 | [3] | Mar. 28, 2014 | [40] |  |  |  |
Shares | shares |  | 680 | [3] | 13,600 | [40] | 680 | [3] | 13,600 | [40]
Investment, Identifier [Axis]: Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 500,000 | [2] | $ 500,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 33,000 |  |  |  |  |
Acquisition date |  | Dec. 08, 2015 | [3] | Dec. 08, 2015 | [40] |  |  |  |
Shares | shares |  | 165,000 |  | 165,000 |  | 165,000 |  | 165,000 |
Investment, Identifier [Axis]: Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 309,000 | [2],[3] | $ 309,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 12,000 | [3] | $ 33,000 | [40] |  |  |  |
Acquisition date |  | Apr. 06, 2015 | [3] | Apr. 06, 2015 | [40] |  |  |  |
Shares | shares |  | 2,498 | [3] | 2,498 | [40] | 2,498 | [3] | 2,498 | [40]
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Talphera, Inc (p.k.a. AcelRx Pharmaceuticals, Inc. ), Equity, Acquisition Date 12/10/2018, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 1,329,000 |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 7,000 |  |  |  |  |  |  |
Acquisition date | [3] | Dec. 10, 2018 |  |  |  |  |  |  |
Shares | shares | [3] | 8,836 |  |  |  | 8,836 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (2.47%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 2.47% |  |  |  | 2.47% |  |  |
Investment cost | [2] | $ 40,735,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 44,500,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (2.66%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 2.66% |  |  |  | 2.66% |
Investment cost | [6] |  |  | $ 43,971,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 37,315,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 9/19/2022, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[24],[40] |  |  | 1,000,000 |  |  |  |  |
Investments, at fair value: | [24],[40] |  |  | $ 2,108,000 |  |  |  |  |
Acquisition date | [24],[40] |  |  | Sep. 19, 2022 |  |  |  |  |
Shares | shares | [24],[40] |  |  | 38,461 |  |  |  | 38,461 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Albireo Pharma, Inc., Equity, Acquisition Date 9/14/2020, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[24],[40] |  |  | $ 1,000,000 |  |  |  |  |
Investments, at fair value: | [24],[40] |  |  | $ 540,000 |  |  |  |  |
Acquisition date | [24],[40] |  |  | Sep. 14, 2020 |  |  |  |  |
Shares | shares | [24],[40] |  |  | 25,000 |  |  |  | 25,000 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Applied Molecular Transport, Equity, Acquisition Date 4/6/2021, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[24],[40] |  |  | $ 42,000 |  |  |  |  |
Investments, at fair value: | [24],[40] |  |  | $ 0 |  |  |  |  |
Acquisition date | [24],[40] |  |  | Apr. 06, 2021 |  |  |  |  |
Shares | shares | [24],[40] |  |  | 1,000 |  |  |  | 1,000 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, 8/19/2014, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | 1,000,000 |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 0 |  |  |  |  |  |  |
Acquisition date | [3] | Aug. 19, 2014 |  |  |  |  |  |  |
Shares | shares | [3] | 42 |  |  |  | 42 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 1,000,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 50,000 |  |  |  |  |
Acquisition date | [40] |  |  | Aug. 19, 2014 |  |  |  |  |
Shares | shares | [40] |  |  | 9,924 |  |  |  | 9,924 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc., Equity, Acquisition Date 7/31/2011, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 1,715,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 2,843,000 |  |  |  |  |
Acquisition date | [40] |  |  | Jul. 31, 2011 |  |  |  |  |
Shares | shares | [40] |  |  | 190,179 |  |  |  | 190,179 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, 5/9/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[26],[31] | $ 4,165,000 |  |  |  |  |  |  |
Investments, at fair value: | [3],[26],[31] | $ 10,110,000 |  |  |  |  |  |  |
Acquisition date | [3],[26],[31] | May 09, 2022 |  |  |  |  |  |  |
Shares | shares | [3],[26],[31] | 127,021 |  |  |  | 127,021 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[19],[24],[40] |  |  | $ 4,165,000 |  |  |  |  |
Investments, at fair value: | [19],[24],[40] |  |  | $ 9,797,000 |  |  |  |  |
Acquisition date | [19],[24],[40] |  |  | May 09, 2022 |  |  |  |  |
Shares | shares | [19],[24],[40] |  |  | 127,021 |  |  |  | 127,021 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, 10/5/2020, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[26],[27] | $ 1,871,000 |  |  |  |  |  |  |
Investments, at fair value: | [3],[26],[27] | $ 1,774,000 |  |  |  |  |  |  |
Acquisition date | [3],[26],[27] | Oct. 05, 2020 |  |  |  |  |  |  |
Shares | shares | [3],[26],[27] | 98,100 |  |  |  | 98,100 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[24],[25],[40] |  |  | $ 1,871,000 |  |  |  |  |
Investments, at fair value: | [24],[25],[40] |  |  | $ 2,904,000 |  |  |  |  |
Acquisition date | [24],[25],[40] |  |  | Oct. 05, 2020 |  |  |  |  |
Shares | shares | [24],[25],[40] |  |  | 98,100 |  |  |  | 98,100 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, 6/21/2018, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 2,255,000 |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 9,339,000 |  |  |  |  |  |  |
Acquisition date | [3] | Jun. 21, 2018 |  |  |  |  |  |  |
Shares | shares | [3] | 231,329 |  |  |  | 231,329 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Concert Pharmaceuticals, Inc., Equity, Acquisition Date 2/13/2019, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[24],[40] |  |  | $ 1,367,000 |  |  |  |  |
Investments, at fair value: | [24],[40] |  |  | $ 413,000 |  |  |  |  |
Acquisition date | [24],[40] |  |  | Feb. 13, 2019 |  |  |  |  |
Shares | shares | [24],[40] |  |  | 70,796 |  |  |  | 70,796 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc. (p.k.a. Applied Molecular Transport), Equity, 4/6/2021, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[26] | $ 42,000 |  |  |  |  |  |  |
Investments, at fair value: | [3],[26] | $ 0 |  |  |  |  |  |  |
Acquisition date | [3],[26] | Apr. 06, 2021 |  |  |  |  |  |  |
Shares | shares | [3],[26] | 134 |  |  |  | 134 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, 1/8/2015, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 1,000,000 |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 4,000 |  |  |  |  |  |  |
Acquisition date | [3] | Jan. 08, 2015 |  |  |  |  |  |  |
Shares | shares | [3] | 13,550 |  |  |  | 13,550 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 1,000,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 11,000 |  |  |  |  |
Acquisition date | [40] |  |  | Jan. 08, 2015 |  |  |  |  |
Shares | shares | [40] |  |  | 13,550 |  |  |  | 13,550 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, 7/22/2015, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[26] | $ 550,000 |  |  |  |  |  |  |
Investments, at fair value: | [3],[26] | $ 280,000 |  |  |  |  |  |  |
Acquisition date | [3],[26] | Jul. 22, 2015 |  |  |  |  |  |  |
Shares | shares | [3],[26] | 20,000 |  |  |  | 20,000 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[24],[40] |  |  | $ 550,000 |  |  |  |  |
Investments, at fair value: | [24],[40] |  |  | $ 213,000 |  |  |  |  |
Acquisition date | [24],[40] |  |  | Jul. 22, 2015 |  |  |  |  |
Shares | shares | [24],[40] |  |  | 20,000 |  |  |  | 20,000 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, 10/26/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 1,000,000 |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 903,000 |  |  |  |  |  |  |
Acquisition date | [3] | Oct. 26, 2022 |  |  |  |  |  |  |
Shares | shares | [3] | 442,477 |  |  |  | 442,477 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, Acquisition Date 10/26/2022, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 1,000,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 1,527,000 |  |  |  |  |
Acquisition date | [40] |  |  | Oct. 26, 2022 |  |  |  |  |
Shares | shares | [40] |  |  | 442,477 |  |  |  | 442,477 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, 7/25/2015, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 500,000 |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 620,000 |  |  |  |  |  |  |
Acquisition date | [3] | Jul. 25, 2023 |  |  |  |  |  |  |
Shares | shares | [3] | 364,963 |  |  |  | 364,963 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, 5/7/2021, Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [1],[2] | $ 4,250,000 |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 1,834,000 |  |  |  |  |  |  |
Acquisition date | [1],[3] | May 07, 2021 |  |  |  |  |  |  |
Shares | shares | [1] | 3,466,840 |  |  |  | 3,466,840 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[30] |  |  | $ 4,250,000 |  |  |  |  |
Investments, at fair value: | [30] |  |  | $ 2,233,000 |  |  |  |  |
Acquisition date | [30],[40] |  |  | May 07, 2021 |  |  |  |  |
Shares | shares | [30] |  |  | 3,466,840 |  |  |  | 3,466,840 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 4,000,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 3,937,000 |  |  |  |  |
Acquisition date | [40] |  |  | May 03, 2022 |  |  |  |  |
Shares | shares | [40] |  |  | 235,295 |  |  |  | 235,295 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc., Equity, 5/3/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 4,000,000 |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 3,777,000 |  |  |  |  |  |  |
Acquisition date | [3] | May 03, 2022 |  |  |  |  |  |  |
Shares | shares | [3] | 235,295 |  |  |  | 235,295 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, 3/31/2021, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[26] | $ 800,000 |  |  |  |  |  |  |
Investments, at fair value: | [3],[26] | $ 0 |  |  |  |  |  |  |
Acquisition date | [3],[26] | Mar. 31, 2021 |  |  |  |  |  |  |
Shares | shares | [3],[26] | 43,243 |  |  |  | 43,243 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, Acquisition Date 3/31/2021, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[24],[40] |  |  | $ 800,000 |  |  |  |  |
Investments, at fair value: | [24],[40] |  |  | $ 5,000 |  |  |  |  |
Acquisition date | [24],[40] |  |  | Mar. 31, 2021 |  |  |  |  |
Shares | shares | [24],[40] |  |  | 43,243 |  |  |  | 43,243 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, 6/16/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[26] | $ 550,000 |  |  |  |  |  |  |
Investments, at fair value: | [3],[26] | $ 688,000 |  |  |  |  |  |  |
Acquisition date | [3],[26] | Jun. 16, 2023 |  |  |  |  |  |  |
Shares | shares | [3],[26] | 47,826 |  |  |  | 47,826 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, 9/29/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[26] | $ 773,000 |  |  |  |  |  |  |
Investments, at fair value: | [3],[26] | $ 1,180,000 |  |  |  |  |  |  |
Acquisition date | [3],[26] | Sep. 29, 2023 |  |  |  |  |  |  |
Shares | shares | [3],[26] | 5,100 |  |  |  | 5,100 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, 12/15/2021, Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[26],[27] | $ 2,000,000 |  |  |  |  |  |  |
Investments, at fair value: | [26],[27] | $ 1,427,000 |  |  |  |  |  |  |
Acquisition date | [3],[26],[27] | Dec. 15, 2021 |  |  |  |  |  |  |
Shares | shares | [26],[27] | 983 |  |  |  | 983 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[24],[25] |  |  | $ 2,000,000 |  |  |  |  |
Investments, at fair value: | [24],[25] |  |  | $ 1,476,000 |  |  |  |  |
Acquisition date | [24],[25],[40] |  |  | Dec. 15, 2021 |  |  |  |  |
Shares | shares | [24],[25] |  |  | 983 |  |  |  | 983 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Equity, Acquisition Date 2/26/2007, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 2,744,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 143,000 |  |  |  |  |
Acquisition date | [40] |  |  | Feb. 26, 2007 |  |  |  |  |
Shares | shares | [40] |  |  | 76,362 |  |  |  | 76,362 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, 6/9/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[26],[31] | $ 1,730,000 |  |  |  |  |  |  |
Investments, at fair value: | [3],[26],[31] | $ 1,344,000 |  |  |  |  |  |  |
Acquisition date | [3],[26],[31] | Jun. 09, 2023 |  |  |  |  |  |  |
Shares | shares | [3],[26],[31] | 147,233 |  |  |  | 147,233 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, 8/22/2007, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 1,500,000 |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 28,000 |  |  |  |  |  |  |
Acquisition date | [3] | Aug. 22, 2007 |  |  |  |  |  |  |
Shares | shares | [3] | 944 |  |  |  | 944 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 1,500,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 18,000 |  |  |  |  |
Acquisition date | [40] |  |  | Aug. 22, 2007 |  |  |  |  |
Shares | shares | [40] |  |  | 944 |  |  |  | 944 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Savara, Inc., Equity, 8/11/2015, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 203,000 |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 52,000 |  |  |  |  |  |  |
Acquisition date | [3] | Aug. 11, 2015 |  |  |  |  |  |  |
Shares | shares | [3] | 11,119 |  |  |  | 11,119 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 203,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 17,000 |  |  |  |  |
Acquisition date | [40] |  |  | Aug. 11, 2015 |  |  |  |  |
Shares | shares | [40] |  |  | 11,119 |  |  |  | 11,119 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, 2/2/2017, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 1,269,000 |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 6,000 |  |  |  |  |  |  |
Acquisition date | [3] | Feb. 02, 2017 |  |  |  |  |  |  |
Shares | shares | [3] | 16,228 |  |  |  | 16,228 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, Acquisition Date 2/2/2017, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 1,269,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 7,000 |  |  |  |  |
Acquisition date | [40] |  |  | Feb. 02, 2017 |  |  |  |  |
Shares | shares | [40] |  |  | 16,228 |  |  |  | 16,228 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, 5/5/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[26] | $ 2,100,000 |  |  |  |  |  |  |
Investments, at fair value: | [3],[26] | $ 3,150,000 |  |  |  |  |  |  |
Acquisition date | [3],[26] | May 05, 2022 |  |  |  |  |  |  |
Shares | shares | [3],[26] | 155,555 |  |  |  | 155,555 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, Acquisition Date 5/5/2022, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[24],[40] |  |  | $ 2,100,000 |  |  |  |  |
Investments, at fair value: | [24],[40] |  |  | $ 2,280,000 |  |  |  |  |
Acquisition date | [24],[40] |  |  | May 05, 2022 |  |  |  |  |
Shares | shares | [24],[40] |  |  | 155,555 |  |  |  | 155,555 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Total Valo Health, LLC |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 4,000,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 4,098,000 |  |  |  |  |  |  |
Shares | shares |  | 680,410 |  |  |  | 680,410 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Tricida, Inc., Equity, Acquisition Date 2/28/2018, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 863,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 11,000 |  |  |  |  |
Acquisition date | [40] |  |  | Feb. 28, 2018 |  |  |  |  |
Shares | shares | [40] |  |  | 68,816 |  |  |  | 68,816 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, 12/11/2020, Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 3,000,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 2,911,000 |  |  |  |  |  |  |
Acquisition date | [3] | Dec. 11, 2020 |  |  |  |  |  |  |
Shares | shares |  | 510,308 |  |  |  | 510,308 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 1,000,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 1,012,000 |  |  |  |  |
Acquisition date | [40] |  |  | Oct. 31, 2022 |  |  |  |  |
Shares | shares |  |  |  | 170,102 |  |  |  | 170,102 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 3,000,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 2,063,000 |  |  |  |  |
Acquisition date | [40] |  |  | Dec. 11, 2020 |  |  |  |  |
Shares | shares |  |  |  | 510,308 |  |  |  | 510,308 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC., Equity, 10/31/2022, Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 1,000,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 1,187,000 |  |  |  |  |  |  |
Acquisition date | [3] | Oct. 31, 2022 |  |  |  |  |  |  |
Shares | shares |  | 170,102 |  |  |  | 170,102 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, 9/6/2023, Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 1,500,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 1,753,000 |  |  |  |  |  |  |
Acquisition date | [3] | Sep. 06, 2023 |  |  |  |  |  |  |
Shares | shares |  | 208,588 |  |  |  | 208,588 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, 11/6/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[26] | $ 400,000 |  |  |  |  |  |  |
Investments, at fair value: | [3],[26] | $ 704,000 |  |  |  |  |  |  |
Acquisition date | [3],[26] | Nov. 06, 2023 |  |  |  |  |  |  |
Shares | shares | [3],[26] | 32,310 |  |  |  | 32,310 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, 11/26/2019, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 2,945,000 |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 1,313,000 |  |  |  |  |  |  |
Acquisition date | [3] | Nov. 26, 2019 |  |  |  |  |  |  |
Shares | shares | [3] | 1,566,064 |  |  |  | 1,566,064 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 2,945,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 1,555,000 |  |  |  |  |
Acquisition date | [40] |  |  | Nov. 26, 2019 |  |  |  |  |
Shares | shares | [40] |  |  | 1,566,064 |  |  |  | 1,566,064 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and uniQure B.V., Equity, 1/31/2019, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[26],[27] | $ 332,000 |  |  |  |  |  |  |
Investments, at fair value: | [3],[26],[27] | $ 116,000 |  |  |  |  |  |  |
Acquisition date | [3],[26],[27] | Jan. 31, 2019 |  |  |  |  |  |  |
Shares | shares | [3],[26],[27] | 17,175 |  |  |  | 17,175 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[19],[24],[25],[40] |  |  | $ 332,000 |  |  |  |  |
Investments, at fair value: | [19],[24],[25],[40] |  |  | $ 389,000 |  |  |  |  |
Acquisition date | [19],[24],[25],[40] |  |  | Jan. 31, 2019 |  |  |  |  |
Shares | shares | [19],[24],[25],[40] |  |  | 17,175 |  |  |  | 17,175 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development, Valo Health LLC |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 4,000,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 3,075,000 |  |  |  |  |
Shares | shares |  |  |  | 680,410 |  |  |  | 680,410 |
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.05%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.05% |  |  |  | 0.05% |  |  |
Investment cost | [2] | $ 2,150,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 951,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.11%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.11% |  |  |  | 0.11% |
Investment cost | [6] |  |  | $ 2,150,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 1,521,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 650,000 | [2] | 650,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 407,000 |  | $ 606,000 |  |  |  |  |
Acquisition date |  | Nov. 17, 2022 | [3] | Nov. 17, 2022 | [40] |  |  |  |
Shares | shares |  | 15,116 |  | 15,116 |  | 15,116 |  | 15,116 |
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,500,000 | [2] | $ 1,500,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 544,000 |  | $ 915,000 |  |  |  |  |
Acquisition date |  | Mar. 08, 2022 | [3] | Mar. 08, 2022 | [40] |  |  |  |
Shares | shares |  | 248,900 |  | 248,900 |  | 248,900 |  | 248,900 |
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.05%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.05% |  |  |  | 0.05% |  |  |
Investment cost | [2] | $ 6,782,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 960,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.21%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.21% |  |  |  | 0.21% |
Investment cost | [6] |  |  | $ 6,781,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 2,894,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 5,094,000 | [2],[3] | 5,094,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 754,000 | [3] | $ 1,784,000 | [40] |  |  |  |
Acquisition date |  | Mar. 11, 2019 | [3] | Mar. 11, 2019 | [40] |  |  |  |
Shares | shares |  | 825,732 | [3] | 825,732 | [40] | 825,732 | [3] | 825,732 | [40]
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,688,000 | [2] | $ 1,687,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 206,000 |  | $ 1,110,000 |  |  |  |  |
Acquisition date |  | Mar. 30, 2021 | [3] | Mar. 30, 2021 | [40] |  |  |  |
Shares | shares |  | 217,880 |  | 217,880 |  | 217,880 |  | 217,880 |
Investment, Identifier [Axis]: Equity Investments Information Services (0.35%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.35% |  |  |  | 0.35% |  |  |
Investment cost | [2] | $ 4,440,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 6,243,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Information Services (0.58%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.58% |  |  |  | 0.58% |
Investment cost | [6] |  |  | $ 4,440,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 8,175,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 615,000 | [2],[3] | 615,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 1,353,000 | [3] | $ 2,383,000 | [40] |  |  |  |
Acquisition date |  | Jun. 21, 2019 | [3] | Jun. 21, 2019 | [40] |  |  |  |
Shares | shares |  | 547,880 | [3] | 547,880 | [40] | 547,880 | [3] | 547,880 | [40]
Investment, Identifier [Axis]: Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 3,825,000 | [2] | $ 3,825,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 4,890,000 |  | $ 3,375,000 |  |  |  |  |
Acquisition date |  | Dec. 30, 2021 | [3] | Dec. 30, 2021 | [40] |  |  |  |
Shares | shares |  | 41,021 |  | 41,021 |  | 41,021 |  | 41,021 |
Investment, Identifier [Axis]: Equity Investments Information Services and Zeta Global Corp., Equity, Acquisition Date 11/20/2007, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 0 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 2,417,000 |  |  |  |  |
Acquisition date | [40] |  |  | Nov. 20, 2007 |  |  |  |  |
Shares | shares | [40] |  |  | 295,861 |  |  |  | 295,861 |
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment (0.01%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.01% |  |  |  | 0.01% |  |  |
Investment cost | [2] | $ 250,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 262,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment (0.07%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.07% |  |  |  | 0.07% |
Investment cost | [6] |  |  | $ 2,953,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 915,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 0 | [2],[32] | 0 | [6],[34] |  |  |  |
Investments, at fair value: |  | $ 2,000 | [32] | $ 6,000 | [34] |  |  |  |
Acquisition date |  | Oct. 15, 2021 | [3],[32] | Oct. 15, 2021 | [34],[40] |  |  |  |
Shares | shares |  | 180,000 | [32] | 180,000 | [34] | 180,000 | [32] | 180,000 | [34]
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[32] | $ 250,000 |  |  |  |  |  |  |
Investments, at fair value: | [32] | $ 260,000 |  |  |  |  |  |  |
Acquisition date | [3],[32] | Oct. 15, 2021 |  |  |  |  |  |  |
Shares | shares | [32] | 5,000,000 |  |  |  | 5,000,000 |  |  |
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Flowonix Medical Incorporated, Equity, Acquisition Date 11/3/2014, Series Preferred Series AA |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 1,499,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Nov. 03, 2014 |  |  |  |  |
Shares | shares |  |  |  | 221,893 |  |  |  | 221,893 |
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Gelesis, Inc., Equity, Acquisition Date 11/30/2009, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 871,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 433,000 |  |  |  |  |
Acquisition date | [40] |  |  | Nov. 30, 2009 |  |  |  |  |
Shares | shares | [40] |  |  | 1,490,700 |  |  |  | 1,490,700 |
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and ViewRay, Inc., Equity, Acquisition Date 12/16/2013, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 333,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 163,000 |  |  |  |  |
Acquisition date | [40] |  |  | Dec. 16, 2013 |  |  |  |  |
Shares | shares | [40] |  |  | 36,457 |  |  |  | 36,457 |
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment, Coronado Aesthetics, LLC |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 250,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 319,000 |  |  |  |  |
Shares | shares |  |  |  | 5,180,000 |  |  |  | 5,180,000 |
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment, Total Coronado Aesthetics, LLC |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 250,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 262,000 |  |  |  |  |  |  |
Shares | shares |  | 5,180,000 |  |  |  | 5,180,000 |  |  |
Investment, Identifier [Axis]: Equity Investments Semiconductors (0.01%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.01% |  |  |  | 0.01% |
Investment cost | [6] |  |  | $ 160,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 205,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Semiconductors (0.02%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.02% |  |  |  | 0.02% |  |  |
Investment cost | [2] | $ 160,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 394,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 160,000 | [2] | 160,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 394,000 |  | $ 205,000 |  |  |  |  |
Acquisition date |  | Jul. 01, 2011 | [3] | Jul. 01, 2011 | [40] |  |  |  |
Shares | shares |  | 277,995 |  | 277,995 |  | 277,995 |  | 277,995 |
Investment, Identifier [Axis]: Equity Investments Software (1.27%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 1.27% |  |  |  | 1.27% |  |  |
Investment cost | [2] | $ 23,210,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 22,919,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Software (2.07%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 2.07% |  |  |  | 2.07% |
Investment cost | [6] |  |  | $ 32,498,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 28,966,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 1,000,000 | [2] | 1,000,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 863,000 |  | $ 793,000 |  |  |  |  |
Acquisition date |  | Aug. 09, 2021 | [3] | Aug. 09, 2021 | [40] |  |  |  |
Shares | shares |  | 1,000,000 |  | 1,000,000 |  | 1,000,000 |  | 1,000,000 |
Investment, Identifier [Axis]: Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,406,000 | [2],[41] | $ 3,000,000 | [6],[42] |  |  |  |
Investments, at fair value: |  | $ 2,406,000 | [41] | $ 3,000,000 | [42] |  |  |  |
Acquisition date |  | Mar. 24, 2021 | [3],[41] | Mar. 24, 2021 | [40],[42] |  |  |  |
Shares | shares |  | 3 | [41] | 3 | [42] | 3 | [41] | 3 | [42]
Investment, Identifier [Axis]: Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-3 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 51,000 | [2] | $ 51,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 6,000 |  |  |  |  |
Acquisition date |  | Oct. 26, 2012 | [3] | Oct. 26, 2012 | [40] |  |  |  |
Shares | shares |  | 53,614 |  | 53,614 |  | 53,614 |  | 53,614 |
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 500,000 | [2],[26],[27] | $ 500,000 | [6],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 842,000 | [26],[27] | $ 732,000 | [24],[25] |  |  |  |
Acquisition date |  | Nov. 20, 2018 | [3],[26],[27] | Nov. 20, 2018 | [24],[25],[40] |  |  |  |
Shares | shares |  | 108,500 | [26],[27] | 108,500 | [24],[25] | 108,500 | [26],[27] | 108,500 | [24],[25]
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 138,000 | [2],[26],[27] | $ 138,000 | [6],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 303,000 | [26],[27] | $ 258,000 | [24],[25] |  |  |  |
Acquisition date |  | Dec. 22, 2020 | [3],[26],[27] | Dec. 22, 2020 | [24],[25],[40] |  |  |  |
Shares | shares |  | 41,000 | [26],[27] | 41,000 | [24],[25] | 41,000 | [26],[27] | 41,000 | [24],[25]
Investment, Identifier [Axis]: Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 4,284,000 | [2] | $ 4,284,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 636,000 |  | $ 503,000 |  |  |  |  |
Acquisition date |  | Nov. 29, 2018 | [3] | Nov. 29, 2018 | [40] |  |  |  |
Shares | shares |  | 20,000 |  | 20,000 |  | 20,000 |  | 20,000 |
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 2 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,000,000 | [2] | $ 1,000,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 2,752,000 |  | $ 1,764,000 |  |  |  |  |
Acquisition date |  | Oct. 22, 2015 | [3] | Oct. 22, 2015 | [40] |  |  |  |
Shares | shares |  | 458,841 |  | 458,841 |  | 458,841 |  | 458,841 |
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 3 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 300,000 | [2] | $ 300,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 587,000 |  | $ 395,000 |  |  |  |  |
Acquisition date |  | Aug. 24, 2017 | [3] | Aug. 24, 2017 | [40] |  |  |  |
Shares | shares |  | 93,620 |  | 93,620 |  | 93,620 |  | 93,620 |
Investment, Identifier [Axis]: Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 307,000 | [2] | $ 307,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |
Acquisition date |  | Jan. 18, 2013 | [3] | Jan. 18, 2013 | [40] |  |  |  |
Shares | shares |  | 190 |  | 190 |  | 190 |  | 190 |
Investment, Identifier [Axis]: Equity Investments Software and Leapwork ApS., Equity, Acquisition Date 8/25/2023, Series Preferred Series B2 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[26],[27] | $ 250,000 |  |  |  |  |  |  |
Investments, at fair value: | [26],[27] | $ 231,000 |  |  |  |  |  |  |
Acquisition date | [3],[26],[27] | Aug. 25, 2023 |  |  |  |  |  |  |
Shares | shares | [26],[27] | 183,073 |  |  |  | 183,073 |  |  |
Investment, Identifier [Axis]: Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 265,000 | [2] | $ 265,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 23,000 |  | $ 24,000 |  |  |  |  |
Acquisition date |  | Dec. 04, 2020 | [3] | Dec. 04, 2020 | [40] |  |  |  |
Shares | shares |  | 38,461 |  | 38,461 |  | 38,461 |  | 38,461 |
Investment, Identifier [Axis]: Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 4,854,000 | [2],[3] | $ 4,854,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 1,927,000 | [3] | $ 2,100,000 | [40] |  |  |  |
Acquisition date |  | Aug. 01, 2018 | [3] | Aug. 01, 2018 | [40] |  |  |  |
Shares | shares |  | 1,019,255 | [3] | 1,019,255 | [40] | 1,019,255 | [3] | 1,019,255 | [40]
Investment, Identifier [Axis]: Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 3,474,000 | [2],[3] | $ 8,670,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 9,758,000 | [3] | $ 9,106,000 | [40] |  |  |  |
Acquisition date |  | Sep. 23, 2020 | [3] | Sep. 23, 2020 | [40] |  |  |  |
Shares | shares |  | 568,337 | [3] | 1,418,337 | [40] | 568,337 | [3] | 1,418,337 | [40]
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,000,000 | [2] | $ 2,000,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 1,721,000 |  | $ 1,940,000 |  |  |  |  |
Acquisition date |  | Nov. 25, 2020 | [3] | Nov. 25, 2020 | [40] |  |  |  |
Shares | shares |  | 580,983 |  | 580,983 |  | 580,983 |  | 580,983 |
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 280,000 | [2] | $ 280,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 196,000 |  | $ 221,000 |  |  |  |  |
Acquisition date |  | Aug. 12, 2021 | [3] | Aug. 12, 2021 | [40] |  |  |  |
Shares | shares |  | 52,956 |  | 52,956 |  | 52,956 |  | 52,956 |
Investment, Identifier [Axis]: Equity Investments Software and Sprinklr, Inc., Equity, Acquisition Date 3/22/2017, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 3,748,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 5,719,000 |  |  |  |  |
Acquisition date | [40] |  |  | Mar. 22, 2017 |  |  |  |  |
Shares | shares | [40] |  |  | 700,000 |  |  |  | 700,000 |
Investment, Identifier [Axis]: Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,000,000 | [2] | $ 2,000,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 422,000 |  | $ 1,023,000 |  |  |  |  |
Acquisition date |  | Jul. 08, 2021 | [3] | Jul. 08, 2021 | [40] |  |  |  |
Shares | shares |  | 952,562 |  | 952,562 |  | 952,562 |  | 952,562 |
Investment, Identifier [Axis]: Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 101,000 | [2],[3] | $ 101,000 | [6],[40],[43] |  |  |  |
Investments, at fair value: |  | $ 252,000 | [3] | $ 1,382,000 | [40],[43] |  |  |  |
Acquisition date |  | May 07, 2020 | [3] | May 07, 2020 | [40],[43] |  |  |  |
Shares | shares |  | 289,992 | [3] | 289,992 | [40],[43] | 289,992 | [3] | 289,992 | [40],[43]
Investment, Identifier [Axis]: Equity Investments Software, Contentful Global, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 638,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 990,000 |  |  |  |  |
Shares | shares |  |  |  | 149,500 |  |  |  | 149,500 |
Investment, Identifier [Axis]: Equity Investments Software, Druva Holdings, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 1,300,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 2,159,000 |  |  |  |  |
Shares | shares |  |  |  | 552,461 |  |  |  | 552,461 |
Investment, Identifier [Axis]: Equity Investments Software, SingleStore, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 2,280,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 2,161,000 |  |  |  |  |
Shares | shares |  |  |  | 633,939 |  |  |  | 633,939 |
Investment, Identifier [Axis]: Equity Investments Software, Total Contentful Global, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 638,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 1,145,000 |  |  |  |  |  |  |
Shares | shares |  | 149,500 |  |  |  | 149,500 |  |  |
Investment, Identifier [Axis]: Equity Investments Software, Total Druva Holdings, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 1,300,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 3,339,000 |  |  |  |  |  |  |
Shares | shares |  | 552,461 |  |  |  | 552,461 |  |  |
Investment, Identifier [Axis]: Equity Investments Software, Total SingleStore, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 2,280,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 1,917,000 |  |  |  |  |  |  |
Shares | shares |  | 633,939 |  |  |  | 633,939 |  |  |
Investment, Identifier [Axis]: Equity Investments Surgical Devices (0.18%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.18% |  |  |  | 0.18% |
Investment cost | [6] |  |  | $ 2,479,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 2,546,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 1/18/2007, Series Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | 250,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Jan. 18, 2007 |  |  |  |  |
Shares | shares |  |  |  | 219,298 |  |  |  | 219,298 |
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 118,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Dec. 18, 2018 |  |  |  |  |
Shares | shares |  |  |  | 1,523,693 |  |  |  | 1,523,693 |
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F-1 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 150,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Dec. 18, 2018 |  |  |  |  |
Shares | shares |  |  |  | 2,418,125 |  |  |  | 2,418,125 |
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 2/8/2013, Series Preferred Series D |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 712,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Feb. 08, 2013 |  |  |  |  |
Shares | shares |  |  |  | 1,991,157 |  |  |  | 1,991,157 |
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 6/16/2010, Series Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 282,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Jun. 16, 2010 |  |  |  |  |
Shares | shares |  |  |  | 656,538 |  |  |  | 656,538 |
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 7/14/2015, Series Preferred Series E |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 429,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Jul. 14, 2015 |  |  |  |  |
Shares | shares |  |  |  | 2,786,367 |  |  |  | 2,786,367 |
Investment, Identifier [Axis]: Equity Investments Surgical Devices and TransMedics Group, Inc., Equity, Acquisition Date 11/7/2012, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 538,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 2,546,000 |  |  |  |  |
Acquisition date | [40] |  |  | Nov. 07, 2012 |  |  |  |  |
Shares | shares | [40] |  |  | 50,000 |  |  |  | 50,000 |
Investment, Identifier [Axis]: Equity Investments Surgical Devices, Gynesonics, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 1,941,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Shares | shares |  |  |  | 9,595,178 |  |  |  | 9,595,178 |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.22%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.22% |  |  |  | 0.22% |  |  |
Investment cost | [2] | $ 11,508,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 3,881,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.57%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.57% |  |  |  | 0.57% |
Investment cost | [6] |  |  | $ 11,508,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 7,984,000 |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-1 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 711,000 | [2] | 711,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 529,000 |  | $ 995,000 |  |  |  |  |
Acquisition date |  | Sep. 13, 2012 | [3] | Sep. 13, 2012 | [40] |  |  |  |
Shares | shares |  | 187,265 |  | 187,265 |  | 187,265 |  | 187,265 |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-1 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,000,000 | [2] | $ 2,000,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 479,000 |  | $ 2,173,000 |  |  |  |  |
Acquisition date |  | May 10, 2019 | [3] | May 10, 2019 | [40] |  |  |  |
Shares | shares |  | 188,611 |  | 188,611 |  | 188,611 |  | 188,611 |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 500,000 | [2] | $ 500,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |
Acquisition date |  | Jun. 01, 2015 | [3] | Jun. 01, 2015 | [40] |  |  |  |
Shares | shares |  | 1,035 |  | 1,035 |  | 1,035 |  | 1,035 |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 102,000 | [2] | $ 102,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |
Acquisition date |  | Aug. 31, 2013 | [3] | Aug. 31, 2013 | [40] |  |  |  |
Shares | shares |  | 59,665 |  | 59,665 |  | 59,665 |  | 59,665 |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 3,153,000 | [2],[3] | $ 3,153,000 | [6],[40],[43] |  |  |  |
Investments, at fair value: |  | $ 180,000 | [3] | $ 634,000 | [40],[43] |  |  |  |
Acquisition date |  | Dec. 10, 2020 | [3] | Dec. 10, 2020 | [40],[43] |  |  |  |
Shares | shares |  | 304,487 | [3] | 304,486 | [40],[43] | 304,487 | [3] | 304,486 | [40],[43]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 4,500,000 | [2] | $ 4,500,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 2,684,000 |  | $ 2,456,000 |  |  |  |  |
Acquisition date |  | Jun. 28, 2021 | [3] | Jun. 28, 2021 | [40] |  |  |  |
Shares | shares |  | 593,080 |  | 593,080 |  | 593,080 |  | 593,080 |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Proterra, Inc., Equity, Acquisition Date 5/28/2015, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 542,000 | [2],[3] | $ 542,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 9,000 | [3] | $ 1,726,000 | [40] |  |  |  |
Acquisition date |  | May 28, 2015 | [3] | May 28, 2015 | [40] |  |  |  |
Shares | shares |  | 457,841 | [3] | 457,841 | [40] | 457,841 | [3] | 457,841 | [40]
Investment, Identifier [Axis]: Equity Investments and Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 2,255,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 1,763,000 |  |  |  |  |
Acquisition date | [40] |  |  | Jun. 21, 2018 |  |  |  |  |
Shares | shares | [40] |  |  | 231,329 |  |  |  | 231,329 |
Investment, Identifier [Axis]: Equity Investments and Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[34] |  |  | $ 250,000 |  |  |  |  |
Investments, at fair value: | [34] |  |  | $ 313,000 |  |  |  |  |
Acquisition date | [34],[40] |  |  | Oct. 15, 2021 |  |  |  |  |
Shares | shares | [34] |  |  | 5,000,000 |  |  |  | 5,000,000 |
Investment, Identifier [Axis]: Investment Fund After Cash & Cash Equivalents (183.28%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 183.28% |  |  |  | 183.28% |  |  |
Investment cost | [2] | $ 3,303,033,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 3,304,046,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Fund Cash & Cash Equivalent and GS Financial Square Government Fund, FGTXX/38141W273 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | 56,000,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 56,000,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Fund In Cash & Cash Equivalents (3.11%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 3.11% |  |  |  | 3.11% |  |  |
Investment cost | [2] | $ 56,000,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 56,000,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.26%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.26% |  |  |  | 0.26% |  |  |
Investment cost | [2] | $ 4,483,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 4,608,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.28%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.28% |  |  |  | 0.28% |
Investment cost | [6] |  |  | $ 3,499,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 3,893,000 |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.23%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.23% |  |  |  | 0.23% |  |  |
Investment cost | [2] | $ 4,102,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 4,230,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.25%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.25% |  |  |  | 0.25% |
Investment cost | [6] |  |  | $ 3,118,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 3,518,000 |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/2020 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 3,783,000 | [2],[22],[26],[27] | 2,699,000 | [6],[7],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 3,619,000 | [22],[26],[27] | $ 3,080,000 | [7],[24],[25] |  |  |  |
Acquisition date |  | Nov. 16, 2020 | [3],[22],[26],[27] | Nov. 16, 2020 | [7],[24],[25],[40] |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/2022 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 319,000 | [2],[22],[26],[27] | $ 419,000 | [6],[7],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 611,000 | [22],[26],[27] | $ 438,000 | [7],[24],[25] |  |  |  |
Acquisition date |  | Jun. 23, 2022 | [3],[22],[26],[27] | Jun. 23, 2022 | [7],[24],[25],[40] |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software (0.02%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.02% |  |  |  | 0.02% |  |  |
Investment cost | [2] | $ 381,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 378,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software (0.03%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.03% |  |  |  | 0.03% |
Investment cost | [6] |  |  | $ 381,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 375,000 |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 381,000 | [2],[26],[27] | 381,000 | [6],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 378,000 | [26],[27] | $ 375,000 | [24],[25] |  |  |  |
Acquisition date |  | Jul. 21, 2022 | [3],[26],[27] | Jul. 21, 2022 | [24],[25],[40] |  |  |  |
Investment, Identifier [Axis]: Investments (180.18%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 180.18% |  |  |  | 180.18% |  |  |
Investment cost | [2] | $ 3,247,033,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 3,248,046,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investments (211.49%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 211.49% |  |  |  | 211.49% |
Investment cost | [6] |  |  | $ 3,005,696,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 2,963,955,000 |  |  |  |  |
Investment, Identifier [Axis]: Investments in Securities (179.92%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 179.92% |  |  |  | 179.92% |  |  |
Investment cost | [2] | $ 3,242,550,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 3,243,438,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investments in Securities (211.21%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 211.21% |  |  |  | 211.21% |
Investment cost | [6] |  |  | $ 3,002,197,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 2,960,062,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments (1.88%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 1.88% |  |  |  | 1.88% |  |  |
Investment cost | [2] | $ 28,954,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 33,969,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments (2.19%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 2.19% |  |  |  | 2.19% |
Investment cost | [6] |  |  | $ 30,964,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 30,646,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools (0.02%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.02% |  |  |  | 0.02% |  |  |
Investment cost | [2] | $ 496,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 354,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools (0.03%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.03% |  |  |  | 0.03% |
Investment cost | [6] |  |  | $ 485,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 486,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 36,000 | [2] | 24,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 20,000 |  | $ 23,000 |  |  |  |  |
Acquisition date |  | Jun. 21, 2022 | [3] | Jun. 21, 2022 | [40] |  |  |  |
Shares | shares |  | 46,197 |  | 15,399 |  | 46,197 |  | 15,399 |
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 460,000 | [2],[12] | $ 461,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 334,000 | [12] | $ 463,000 |  |  |  |  |
Acquisition date |  | Dec. 23, 2022 | [3],[12] | Dec. 23, 2022 | [40] |  |  |  |
Shares | shares |  | 53,418 | [12] | 53,418 |  | 53,418 | [12] | 53,418 |
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking (0.01%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.01% |  | 0.01% | [5] | 0.01% |  | 0.01% | [5]
Investment cost |  | $ 123,000 | [2] | $ 541,000 | [6] |  |  |  |
Investments, at fair value: |  | 128,000 |  | 99,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 123,000 | [2],[12] | 123,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 128,000 | [12] | $ 99,000 |  |  |  |  |
Acquisition date |  | Jun. 28, 2022 | [3],[12] | Jun. 28, 2022 | [40] |  |  |  |
Shares | shares |  | 229,611 | [12] | 229,611 |  | 229,611 | [12] | 229,611 |
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Spring Mobile Solutions, Inc., Warrant, Acquisition Date 4/19/2013, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 418,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Apr. 19, 2013 |  |  |  |  |
Shares | shares |  |  |  | 2,834,375 |  |  |  | 2,834,375 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products (0.02%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.02% |  |  |  | 0.02% |  |  |
Investment cost | [2] | $ 611,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 325,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products (0.17%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.17% |  |  |  | 0.17% |
Investment cost | [6] |  |  | $ 1,712,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 2,323,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 228,000 | [2] | 228,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |
Acquisition date |  | Jun. 03, 2014 | [3] | Jun. 03, 2014 | [40] |  |  |  |
Shares | shares |  | 1,662,441 |  | 1,662,441 |  | 1,662,441 |  | 1,662,441 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Savage X Holding, LLC, Warrant, Acquisition Date 6/27/2014, Class A Units |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 0 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 1,103,000 |  |  |  |  |
Acquisition date | [40] |  |  | Jun. 27, 2014 |  |  |  |  |
Shares | shares |  |  |  | 206,185 |  |  |  | 206,185 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and TFG Holding, Inc., Warrant, Acquisition Date 6/27/2014, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 0 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Jun. 27, 2014 |  |  |  |  |
Shares | shares |  |  |  | 206,185 |  |  |  | 206,185 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and TechStyle, Inc., Warrant, Acquisition Date 7/16/2013, Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 1,101,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 745,000 |  |  |  |  |
Acquisition date | [40] |  |  | Jul. 16, 2013 |  |  |  |  |
Shares | shares |  |  |  | 206,185 |  |  |  | 206,185 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 365,000 | [2] | $ 365,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |
Acquisition date |  | Aug. 13, 2014 | [3] | Aug. 13, 2014 | [40] |  |  |  |
Shares | shares |  | 54,054 |  | 54,054 |  | 54,054 |  | 54,054 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 18,000 | [2] | $ 18,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 325,000 |  | $ 475,000 |  |  |  |  |
Acquisition date |  | Jun. 27, 2018 | [3] | Jun. 27, 2018 | [40] |  |  |  |
Shares | shares |  | 686,270 |  | 686,270 |  | 686,270 |  | 686,270 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.19%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.19% |  |  |  | 0.19% |
Investment cost | [6] |  |  | $ 4,248,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 2,639,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.23%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.23% |  |  |  | 0.23% |  |  |
Investment cost | [2] | $ 4,208,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 4,217,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 164,000 | [2],[26],[27] | 164,000 | [6],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 75,000 | [26],[27] | $ 34,000 | [24],[25] |  |  |  |
Acquisition date |  | Dec. 14, 2021 | [3],[26],[27] | Dec. 14, 2021 | [24],[25],[40] |  |  |  |
Shares | shares |  | 174,163 | [26],[27] | 174,163 | [24],[25] | 174,163 | [26],[27] | 174,163 | [24],[25]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 20,000 | [2] | $ 20,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |
Acquisition date |  | Oct. 29, 2019 | [3] | Oct. 29, 2019 | [40] |  |  |  |
Shares | shares |  | 529,661 |  | 529,661 |  | 529,661 |  | 529,661 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 116,000 | [1],[2] | $ 116,000 | [6],[30] |  |  |  |
Investments, at fair value: |  | $ 298,000 | [1] | $ 127,000 | [30] |  |  |  |
Acquisition date |  | Mar. 12, 2021 | [1],[3] | Mar. 12, 2021 | [30],[40] |  |  |  |
Shares | shares |  | 11,806 | [1] | 11,806 | [30] | 11,806 | [1] | 11,806 | [30]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Preferred Series D |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 39,000 | [2] | $ 39,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 33,000 |  | $ 19,000 |  |  |  |  |
Acquisition date |  | Mar. 29, 2019 | [3] | Mar. 29, 2019 | [40] |  |  |  |
Shares | shares |  | 127,032 |  | 127,032 |  | 127,032 |  | 127,032 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Ordinary shares |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[26],[27] | $ 48,000 |  |  |  |  |  |  |
Investments, at fair value: | [26],[27] | $ 51,000 |  |  |  |  |  |  |
Acquisition date | [3],[26],[27] | Oct. 03, 2023 |  |  |  |  |  |  |
Shares | shares | [26],[27] | 19,499 |  |  |  | 19,499 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 166,000 | [1],[2] | $ 166,000 | [6],[30] |  |  |  |
Investments, at fair value: |  | $ 74,000 | [1] | $ 155,000 | [30] |  |  |  |
Acquisition date |  | Dec. 22, 2022 | [1],[3] | Dec. 22, 2022 | [30],[40] |  |  |  |
Shares | shares |  | 117,042 | [1] | 117,042 | [30] | 117,042 | [1] | 117,042 | [30]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 470,000 | [1],[2] | $ 470,000 | [6],[30] |  |  |  |
Investments, at fair value: |  | $ 4,000 | [1] | $ 308,000 | [30] |  |  |  |
Acquisition date |  | Mar. 12, 2021 | [1],[3] | Mar. 12, 2021 | [30],[40] |  |  |  |
Shares | shares |  | 13,106 | [1] | 13,106 | [30] | 13,106 | [1] | 13,106 | [30]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and RumbleON, Inc., Warrant, Acquisition Date 4/30/2018, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 88,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Apr. 30, 2018 |  |  |  |  |
Shares | shares | [40] |  |  | 5,139 |  |  |  | 5,139 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 842,000 | [2],[31] | $ 842,000 | [6],[18],[19] |  |  |  |
Investments, at fair value: |  | $ 3,065,000 | [31] | $ 1,332,000 | [18],[19] |  |  |  |
Acquisition date |  | Jun. 12, 2019 | [3],[31] | Jun. 12, 2019 | [18],[19],[40] |  |  |  |
Shares | shares |  | 1,379,761 | [31] | 1,379,761 | [18],[19] | 1,379,761 | [31] | 1,379,761 | [18],[19]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 140,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 43,000 |  |  |  |  |
Shares | shares |  |  |  | 2,051,587 |  |  |  | 2,051,587 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 57,000 | [2] | $ 57,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 58,000 |  | $ 43,000 |  |  |  |  |
Acquisition date |  | Nov. 14, 2022 | [3] | Nov. 14, 2022 | [40] |  |  |  |
Shares | shares |  | 1,607,143 |  | 1,607,143 |  | 1,607,143 |  | 1,607,143 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 83,000 | [2] | $ 83,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 5,000 |  | $ 0 |  |  |  |  |
Acquisition date |  | Aug. 23, 2019 | [3] | Aug. 23, 2019 | [40] |  |  |  |
Shares | shares |  | 444,444 |  | 444,444 |  | 444,444 |  | 444,444 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 860,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 118,000 |  |  |  |  |
Shares | shares |  |  |  | 3,611,537 |  |  |  | 3,611,537 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 16,000 | [2] | $ 16,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 43,000 |  |  |  |  |
Acquisition date |  | Apr. 20, 2020 | [3] | Apr. 20, 2020 | [40] |  |  |  |
Shares | shares |  | 600,000 |  | 600,000 |  | 600,000 |  | 600,000 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Preferred Series A |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 782,000 | [2] | $ 782,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 50,000 |  |  |  |  |
Acquisition date |  | Jun. 30, 2016 | [3] | Jun. 30, 2016 | [40] |  |  |  |
Shares | shares |  | 1,800,000 |  | 1,800,000 |  | 1,800,000 |  | 1,800,000 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 62,000 | [2] | $ 62,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 25,000 |  |  |  |  |
Acquisition date |  | Aug. 01, 2018 | [3] | Aug. 01, 2018 | [40] |  |  |  |
Shares | shares |  | 1,211,537 |  | 1,211,537 |  | 1,211,537 |  | 1,211,537 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 844,000 | [2],[12] | $ 844,000 | [6],[18] |  |  |  |
Investments, at fair value: |  | $ 515,000 | [12] | $ 280,000 | [18] |  |  |  |
Acquisition date |  | May 01, 2018 | [3],[12] | May 01, 2018 | [18],[40] |  |  |  |
Shares | shares |  | 267,225 | [12] | 267,225 | [18] | 267,225 | [12] | 267,225 | [18]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Skyword, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 140,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 63,000 |  |  |  |  |  |  |
Shares | shares |  | 2,051,587 |  |  |  | 2,051,587 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Snagajob.com, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 860,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  |  |  |  |  |  |
Shares | shares |  | 3,611,537 |  |  |  | 3,611,537 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Worldremit Group Limited |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 155,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 23,000 |  |  |  |  |  |  |
Shares | shares |  | 79,083 |  |  |  | 79,083 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 218,000 | [2],[12] | $ 218,000 | [6],[18] |  |  |  |
Investments, at fair value: |  | $ 0 | [12] | $ 4,000 | [18] |  |  |  |
Acquisition date |  | Sep. 25, 2020 | [3],[12] | Sep. 25, 2020 | [18],[40] |  |  |  |
Shares | shares |  | 486,359 | [12] | 486,359 | [18] | 486,359 | [12] | 486,359 | [18]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 126,000 | [2],[12] | $ 126,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 16,000 | [12] | $ 25,000 |  |  |  |  |
Acquisition date |  | Mar. 31, 2022 | [3],[12] | Mar. 31, 2022 | [40] |  |  |  |
Shares | shares |  | 98,428 | [12] | 98,428 |  | 98,428 | [12] | 98,428 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 155,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 194,000 |  |  |  |  |
Shares | shares |  |  |  | 79,083 |  |  |  | 79,083 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Preferred Series D |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 129,000 | [2],[12],[26],[27],[31] | $ 129,000 | [6],[18],[19],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 23,000 | [12],[26],[27],[31] | $ 192,000 | [18],[19],[24],[25] |  |  |  |
Acquisition date |  | Feb. 11, 2021 | [3],[12],[26],[27],[31] | Feb. 11, 2021 | [18],[19],[24],[25],[40] |  |  |  |
Shares | shares |  | 77,215 | [12],[26],[27],[31] | 77,215 | [18],[19],[24],[25] | 77,215 | [12],[26],[27],[31] | 77,215 | [18],[19],[24],[25]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Preferred Series E |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 26,000 | [2],[26],[27],[31] | $ 26,000 | [6],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 0 | [26],[27],[31] | $ 2,000 | [24],[25] |  |  |  |
Acquisition date |  | Aug. 27, 2021 | [3],[26],[27],[31] | Aug. 27, 2021 | [24],[25],[40] |  |  |  |
Shares | shares |  | 1,868 | [26],[27],[31] | 1,868 | [24],[25] | 1,868 | [26],[27],[31] | 1,868 | [24],[25]
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services (0.03%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.03% |  |  |  | 0.03% |  |  |
Investment cost | [2] | $ 214,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 554,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | 214,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 554,000 |  |  |  |  |  |  |
Acquisition date | [3] | Feb. 03, 2023 |  |  |  |  |  |  |
Shares | shares |  | 522,930 |  |  |  | 522,930 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery (0.00%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.00% | [4] | 0.00% | [5] | 0.00% | [4] | 0.00% | [5]
Investment cost |  | $ 392,000 | [2] | $ 465,000 | [6] |  |  |  |
Investments, at fair value: |  | 0 |  | 1,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 6/1/2016, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | 0 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  |  |  |  |  |  |
Acquisition date | [3] | Jun. 01, 2016 |  |  |  |  |  |  |
Shares | shares |  | 67,069 |  |  |  | 67,069 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 9/30/2015, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | 74,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Sep. 30, 2015 |  |  |  |  |
Shares | shares |  |  |  | 110,882 |  |  |  | 110,882 |
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,000 | [2] | $ 1,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |
Acquisition date |  | Oct. 27, 2014 | [3] | Oct. 27, 2014 | [40] |  |  |  |
Shares | shares |  | 459,183 |  | 459,183 |  | 459,183 |  | 459,183 |
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 390,000 | [2],[3] | $ 390,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 0 | [3] | $ 1,000 | [40] |  |  |  |
Acquisition date |  | Aug. 28, 2014 | [3] | Aug. 28, 2014 | [40] |  |  |  |
Shares | shares |  | 3,929 | [3] | 3,929 | [40] | 3,929 | [3] | 3,929 | [40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.46%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.46% |  |  |  | 0.46% |  |  |
Investment cost | [2] | $ 7,517,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 8,302,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.60%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.60% |  |  |  | 0.60% |
Investment cost | [6] |  |  | $ 7,466,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 8,444,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and ADMA Biologics, Inc., Warrant, Acquisition Date 2/24/2014, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 166,000 | [2],[3] | 166,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 11,000 | [3] | $ 10,000 | [40] |  |  |  |
Acquisition date |  | Feb. 24, 2014 | [3] | Feb. 24, 2014 | [40] |  |  |  |
Shares | shares |  | 58,000 | [3] | 58,000 | [40] | 58,000 | [3] | 58,000 | [40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Acacia Pharma Inc., Warrant, Acquisition Date 6/29/2018, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[24],[25] |  |  | $ 304,000 |  |  |  |  |
Investments, at fair value: | [24],[25] |  |  | $ 0 |  |  |  |  |
Acquisition date | [24],[25],[40] |  |  | Jun. 29, 2018 |  |  |  |  |
Shares | shares | [24],[25] |  |  | 201,330 |  |  |  | 201,330 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 175,000 | [2],[3],[26] | $ 56,000 | [6],[24],[40] |  |  |  |
Investments, at fair value: |  | $ 335,000 | [3],[26] | $ 674,000 | [24],[40] |  |  |  |
Acquisition date |  | Jun. 15, 2022 | [3],[26] | Jun. 15, 2022 | [24],[40] |  |  |  |
Shares | shares |  | 22,949 | [3],[26] | 18,360 | [24],[40] | 22,949 | [3],[26] | 18,360 | [24],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Albireo Pharma, Inc., Warrant, Acquisition Date 6/8/2020, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[24],[40] |  |  | $ 61,000 |  |  |  |  |
Investments, at fair value: | [24],[40] |  |  | $ 31,000 |  |  |  |  |
Acquisition date | [24],[40] |  |  | Jun. 08, 2020 |  |  |  |  |
Shares | shares | [24],[40] |  |  | 5,311 |  |  |  | 5,311 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[30] |  |  | $ 238,000 |  |  |  |  |
Investments, at fair value: | [30] |  |  | $ 256,000 |  |  |  |  |
Acquisition date | [30],[40] |  |  | Dec. 27, 2022 |  |  |  |  |
Shares | shares | [30] |  |  | 69,239 |  |  |  | 69,239 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,290,000 | [2],[3],[12],[26],[31] | $ 880,000 | [6],[18],[19],[24],[40] |  |  |  |
Investments, at fair value: |  | $ 1,657,000 | [3],[12],[26],[31] | $ 1,590,000 | [18],[19],[24],[40] |  |  |  |
Acquisition date |  | Sep. 25, 2020 | [3],[12],[26],[31] | Sep. 25, 2020 | [18],[19],[24],[40] |  |  |  |
Shares | shares |  | 61,004 | [3],[12],[26],[31] | 40,396 | [18],[19],[24],[40] | 61,004 | [3],[12],[26],[31] | 40,396 | [18],[19],[24],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Ordinary Shares |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[26],[27] | $ 278,000 |  |  |  |  |  |  |
Investments, at fair value: | [3],[26],[27] | $ 285,000 |  |  |  |  |  |  |
Acquisition date | [3],[26],[27] | Jun. 30, 2023 |  |  |  |  |  |  |
Shares | shares | [3],[26],[27] | 75,376 |  |  |  | 75,376 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 287,000 | [1],[2] | $ 287,000 | [6],[30] |  |  |  |
Investments, at fair value: |  | $ 201,000 | [1] | $ 318,000 | [30] |  |  |  |
Acquisition date |  | Dec. 08, 2021 | [1],[3] | Dec. 08, 2021 | [30],[40] |  |  |  |
Shares | shares |  | 100,000 | [1] | 100,000 | [30] | 100,000 | [1] | 100,000 | [30]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 37,000 | [2],[3] | $ 37,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 1,000 | [3] | $ 3,000 | [40] |  |  |  |
Acquisition date |  | Sep. 14, 2020 | [3] | Sep. 14, 2020 | [40] |  |  |  |
Shares | shares |  | 16,112 | [3] | 16,112 | [40] | 16,112 | [3] | 16,112 | [40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Curevo, Inc., Warrant, Acquisition Date 6/9/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [1],[2] | $ 233,000 |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 251,000 |  |  |  |  |  |  |
Acquisition date | [1],[3] | Jun. 09, 2023 |  |  |  |  |  |  |
Shares | shares | [1] | 95,221 |  |  |  | 95,221 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 101,000 | [2],[26],[27] | $ 101,000 | [6],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 7,000 | [26],[27] | $ 199,000 | [24],[25] |  |  |  |
Acquisition date |  | May 31, 2019 | [3],[26],[27] | May 31, 2019 | [24],[25],[40] |  |  |  |
Shares | shares |  | 223,642 | [26],[27] | 223,642 | [24],[25] | 223,642 | [26],[27] | 223,642 | [24],[25]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 266,000 | [2],[3] | $ 266,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 0 | [3] | $ 0 | [40] |  |  |  |
Acquisition date |  | Jun. 11, 2014 | [3] | Jun. 11, 2014 | [40] |  |  |  |
Shares | shares |  | 3 | [3] | 520 | [40] | 3 | [3] | 520 | [40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 119,000 | [2],[3] | $ 119,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 0 | [3] | $ 0 | [40] |  |  |  |
Acquisition date |  | Feb. 18, 2016 | [3] | Feb. 18, 2016 | [40] |  |  |  |
Shares | shares |  | 201 | [3] | 200 | [40] | 201 | [3] | 200 | [40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[3] | $ 228,000 |  |  |  |  |  |  |
Investments, at fair value: | [1],[3] | $ 223,000 |  |  |  |  |  |  |
Acquisition date | [1],[3] | Aug. 09, 2023 |  |  |  |  |  |  |
Shares | shares | [1],[3] | 238,095 |  |  |  | 238,095 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 110,000 | [2],[3] | $ 110,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 0 | [3] | $ 0 | [40] |  |  |  |
Acquisition date |  | Dec. 20, 2019 | [3] | Dec. 20, 2019 | [40] |  |  |  |
Shares | shares |  | 2,202 | [3] | 2,202 | [40] | 2,202 | [3] | 2,202 | [40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 88,000 | [1],[2],[3],[26] | $ 88,000 | [24],[30],[40] |  |  |  |
Investments, at fair value: |  | $ 63,000 | [1],[3],[26] | $ 59,000 | [24],[30],[40] |  |  |  |
Acquisition date |  | Nov. 02, 2022 | [1],[3],[26] | Nov. 02, 2022 | [24],[30],[40] |  |  |  |
Shares | shares |  | 14,342 | [1],[3],[26] | 14,342 | [24],[30],[40] | 14,342 | [1],[3],[26] | 14,342 | [24],[30],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 570,000 | [2],[3],[26] | $ 177,000 | [6],[24],[40] |  |  |  |
Investments, at fair value: |  | $ 1,842,000 | [3],[26] | $ 1,977,000 | [24],[40] |  |  |  |
Acquisition date |  | May 09, 2022 | [3],[26] | May 09, 2022 | [24],[40] |  |  |  |
Shares | shares |  | 13,229 | [3],[26] | 10,131 | [24],[40] | 13,229 | [3],[26] | 10,131 | [24],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Myovant Sciences, Ltd., Warrant, Acquisition Date 10/16/2017, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[24],[25],[40] |  |  | $ 460,000 |  |  |  |  |
Investments, at fair value: | [24],[25],[40] |  |  | $ 958,000 |  |  |  |  |
Acquisition date | [24],[25],[40] |  |  | Oct. 16, 2017 |  |  |  |  |
Shares | shares | [24],[25],[40] |  |  | 73,710 |  |  |  | 73,710 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Warrant, Acquisition Date 8/1/2018, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 520,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 34,000 |  |  |  |  |
Acquisition date | [40] |  |  | Aug. 01, 2018 |  |  |  |  |
Shares | shares | [40] |  |  | 426,866 |  |  |  | 426,866 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 848,000 | [1],[2],[3],[12],[26],[31] | $ 848,000 | [6],[18],[19],[24],[30],[40] |  |  |  |
Investments, at fair value: |  | $ 68,000 | [1],[3],[12],[26],[31] | $ 101,000 | [18],[19],[24],[30],[40] |  |  |  |
Acquisition date |  | Sep. 17, 2021 | [1],[3],[12],[26],[31] | Sep. 17, 2021 | [18],[19],[24],[30],[40] |  |  |  |
Shares | shares |  | 64,687 | [1],[3],[12],[26],[31] | 64,687 | [18],[19],[24],[30],[40] | 64,687 | [1],[3],[12],[26],[31] | 64,687 | [18],[19],[24],[30],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Provention Bio, Inc., Warrant, Acquisition Date 9/15/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 281,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 677,000 |  |  |  |  |
Acquisition date | [40] |  |  | Sep. 15, 2022 |  |  |  |  |
Shares | shares | [40] |  |  | 111,934 |  |  |  | 111,934 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Preferred Series E |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 20,000 | [1],[2] | $ 20,000 | [6],[30] |  |  |  |
Investments, at fair value: |  | $ 6,000 | [1] | $ 21,000 | [30] |  |  |  |
Acquisition date |  | Mar. 23, 2022 | [1],[3] | Mar. 23, 2022 | [30],[40] |  |  |  |
Shares | shares |  | 475,510 | [1] | 475,510 | [30] | 475,510 | [1] | 475,510 | [30]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 296,000 | [2],[3] | $ 296,000 | [6],[18],[40] |  |  |  |
Investments, at fair value: |  | $ 28,000 | [3] | $ 15,000 | [18],[40] |  |  |  |
Acquisition date |  | May 14, 2021 | [3] | May 14, 2021 | [18],[40] |  |  |  |
Shares | shares |  | 106,035 | [3] | 106,035 | [18],[40] | 106,035 | [3] | 106,035 | [18],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,284,000 | [2],[3],[12],[26] | $ 1,033,000 | [6],[18],[24],[40] |  |  |  |
Investments, at fair value: |  | $ 2,583,000 | [3],[12],[26] | $ 1,084,000 | [18],[24],[40] |  |  |  |
Acquisition date |  | Feb. 28, 2019 | [3],[12],[26] | Feb. 28, 2019 | [18],[24],[40] |  |  |  |
Shares | shares |  | 264,226 | [3],[12],[26] | 231,613 | [18],[24],[40] | 264,226 | [3],[12],[26] | 231,613 | [18],[24],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Tricida, Inc., Warrant, Acquisition Date 3/27/2019, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 280,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 1,000 |  |  |  |  |
Acquisition date | [40] |  |  | Mar. 27, 2019 |  |  |  |  |
Shares | shares | [40] |  |  | 31,352 |  |  |  | 31,352 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Common Units |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 256,000 | [2] | $ 256,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 153,000 |  | $ 127,000 |  |  |  |  |
Acquisition date |  | Jun. 15, 2020 | [3] | Jun. 15, 2020 | [40] |  |  |  |
Shares | shares |  | 102,216 |  | 102,216 |  | 102,216 |  | 102,216 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 12/9/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 510,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 281,000 |  |  |  |  |
Acquisition date | [40] |  |  | Dec. 09, 2022 |  |  |  |  |
Shares | shares | [40] |  |  | 1,392,787 |  |  |  | 1,392,787 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 510,000 |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 225,000 |  |  |  |  |  |  |
Acquisition date | [3] | Mar. 18, 2019 |  |  |  |  |  |  |
Shares | shares | [3] | 1,392,787 |  |  |  | 1,392,787 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/30/2021, Preferred Series 3 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[18],[24],[25] |  |  | $ 72,000 |  |  |  |  |
Investments, at fair value: | [18],[24],[25] |  |  | $ 28,000 |  |  |  |  |
Acquisition date | [18],[24],[25],[40] |  |  | Dec. 30, 2021 |  |  |  |  |
Shares | shares | [18],[24],[25] |  |  | 133,692 |  |  |  | 133,692 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene,Inc, Warrant, Acquisition Date 12/22/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[26],[27] | $ 118,000 |  |  |  |  |  |  |
Investments, at fair value: | [3],[26],[27] | $ 179,000 |  |  |  |  |  |  |
Acquisition date | [3],[26],[27] | Dec. 22, 2023 |  |  |  |  |  |  |
Shares | shares | [3],[26],[27] | 43,689 |  |  |  | 43,689 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware (0.02%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.02% |  |  |  | 0.02% |  |  |
Investment cost | [2] | $ 692,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 391,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware (0.09%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.09% |  |  |  | 0.09% |
Investment cost | [6] |  |  | $ 692,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 1,273,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 101,000 | [2],[3] | 101,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 175,000 | [3] | $ 86,000 | [40] |  |  |  |
Acquisition date |  | Mar. 15, 2017 | [3] | Mar. 15, 2017 | [40] |  |  |  |
Shares | shares |  | 49,078 | [3] | 49,078 | [40] | 49,078 | [3] | 49,078 | [40]
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 34,000 | [2] | $ 34,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 102,000 |  | $ 212,000 |  |  |  |  |
Acquisition date |  | Jun. 21, 2022 | [3] | Jun. 21, 2022 | [40] |  |  |  |
Shares | shares |  | 8,503 |  | 8,511 |  | 8,503 |  | 8,511 |
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 557,000 | [2] | $ 557,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 114,000 |  | $ 975,000 |  |  |  |  |
Acquisition date |  | Nov. 08, 2021 | [3] | Nov. 08, 2021 | [40] |  |  |  |
Shares | shares |  | 622,255 |  | 622,255 |  | 622,255 |  | 622,255 |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other (0.00%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.00% |  |  |  | 0.00% |
Investment cost | [6] |  |  | $ 114,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 14,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other (0.03%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.03% |  |  |  | 0.03% |  |  |
Investment cost | [2] | $ 750,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 596,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Modern Life, Inc., Warrant, Acquisition Date 3/30/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | 164,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 165,000 |  |  |  |  |  |  |
Acquisition date | [3] | Mar. 30, 2023 |  |  |  |  |  |  |
Shares | shares |  | 37,618 |  |  |  | 37,618 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Recover Together, Inc.., Warrant, Acquisition Date 7/3/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 382,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 327,000 |  |  |  |  |  |  |
Acquisition date | [3] | Jul. 03, 2023 |  |  |  |  |  |  |
Shares | shares |  | 194,830 |  |  |  | 194,830 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC., Warrant, Acquisition Date 9/28/2023, Common Units |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [1],[2] | $ 83,000 |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 95,000 |  |  |  |  |  |  |
Acquisition date | [1],[3] | Sep. 28, 2023 |  |  |  |  |  |  |
Shares | shares | [1] | 51,760 |  |  |  | 51,760 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 121,000 | [2] | 114,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 9,000 |  | $ 14,000 |  |  |  |  |
Acquisition date |  | Mar. 28, 2022 | [3] | Mar. 28, 2022 | [40] |  |  |  |
Shares | shares |  | 192,431 |  | 100,618 |  | 192,431 |  | 100,618 |
Investment, Identifier [Axis]: Warrant Investments and Information Services (0.03%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.03% |  |  |  | 0.03% |  |  |
Investment cost | [2] | $ 694,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 486,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Information Services (0.04%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.04% |  |  |  | 0.04% |
Investment cost | [6] |  |  | $ 680,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 509,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 207,000 | [1],[2] | 207,000 | [6],[30] |  |  |  |
Investments, at fair value: |  | $ 33,000 | [1] | $ 114,000 | [30] |  |  |  |
Acquisition date |  | Oct. 21, 2021 | [1],[3] | Oct. 21, 2021 | [30],[40] |  |  |  |
Shares | shares |  | 176,200 | [1] | 176,200 | [30] | 176,200 | [1] | 176,200 | [30]
Investment, Identifier [Axis]: Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 82,000 | [2],[26],[27] | $ 82,000 | [6],[24] |  |  |  |
Investments, at fair value: |  | $ 0 | [26],[27] | $ 0 | [24] |  |  |  |
Acquisition date |  | Nov. 19, 2014 | [3],[26],[27] | Nov. 19, 2014 | [24],[40] |  |  |  |
Shares | shares |  | 65,587 | [26],[27] | 65,587 | [24] | 65,587 | [26],[27] | 65,587 | [24]
Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Solutions, Inc., Warrant, Acquisition Date 8/22/2017, Preferred Series 1 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 356,000 | [2] | $ 356,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 362,000 |  | $ 380,000 |  |  |  |  |
Acquisition date |  | Aug. 22, 2017 | [3] | Aug. 22, 2017 | [40] |  |  |  |
Shares | shares |  | 60,000 |  | 60,000 |  | 60,000 |  | 60,000 |
Investment, Identifier [Axis]: Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 49,000 | [2],[26],[27] | $ 35,000 | [6],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 91,000 | [26],[27] | $ 15,000 | [24],[25] |  |  |  |
Acquisition date |  | Jun. 29, 2022 | [3],[26],[27] | Jun. 29, 2022 | [24],[25],[40] |  |  |  |
Shares | shares |  | 113,828 | [26],[27] | 94,857 | [24],[25] | 113,828 | [26],[27] | 94,857 | [24],[25]
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.17%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.17% |  |  |  | 0.17% |  |  |
Investment cost | [2] | $ 1,112,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 3,000,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.30%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.30% |  |  |  | 0.30% |
Investment cost | [6] |  |  | $ 1,112,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 4,156,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 537,000 | [2] | 537,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 279,000 |  | $ 1,154,000 |  |  |  |  |
Acquisition date |  | Mar. 31, 2022 | [3] | Mar. 31, 2022 | [40] |  |  |  |
Shares | shares |  | 392,308 |  | 392,308 |  | 392,308 |  | 392,308 |
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 528,000 | [2] | $ 528,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 677,000 |  | $ 1,202,000 |  |  |  |  |
Acquisition date |  | Mar. 23, 2022 | [3] | Mar. 23, 2022 | [40] |  |  |  |
Shares | shares |  | 1,111,111 |  | 1,111,111 |  | 1,111,111 |  | 1,111,111 |
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 47,000 | [2],[3] | $ 47,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 2,044,000 | [3] | $ 1,800,000 | [40] |  |  |  |
Acquisition date |  | May 09, 2018 | [3] | May 09, 2018 | [40] |  |  |  |
Shares | shares |  | 87,784 | [3] | 87,784 | [40] | 87,784 | [3] | 87,784 | [40]
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info (0.00%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.00% |  |  |  | 0.00% |
Investment cost | [6] |  |  | $ 35,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 35,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info (0.01%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.01% |  |  |  | 0.01% |  |  |
Investment cost | [2] | $ 67,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 235,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Preferred Series E-1 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 67,000 | [2] | 35,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 235,000 |  | $ 35,000 |  |  |  |  |
Acquisition date |  | Dec. 30, 2022 | [3] | Dec. 30, 2022 | [40] |  |  |  |
Shares | shares |  | 369,370 |  | 221,622 |  | 369,370 |  | 221,622 |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.01%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.01% |  |  |  | 0.01% |  |  |
Investment cost | [2] | $ 956,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 262,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.07%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.07% |  |  |  | 0.07% |
Investment cost | [6] |  |  | $ 2,034,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 919,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Aspire Bariatrics, Inc., Warrant, Acquisition Date 1/28/2015, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | 455,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Jan. 28, 2015 |  |  |  |  |
Shares | shares |  |  |  | 22,572 |  |  |  | 22,572 |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 713,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Shares | shares |  |  |  | 836,752 |  |  |  | 836,752 |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 11/3/2014, Preferred Series AA |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 362,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Nov. 03, 2014 |  |  |  |  |
Shares | shares |  |  |  | 110,946 |  |  |  | 110,946 |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 9/21/2018, Preferred Series BB |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 351,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Sep. 21, 2018 |  |  |  |  |
Shares | shares |  |  |  | 725,806 |  |  |  | 725,806 |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Preferred Series B-1 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 294,000 | [2] | $ 294,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 54,000 |  |  |  |  |
Acquisition date |  | Dec. 29, 2017 | [3] | Dec. 29, 2017 | [40] |  |  |  |
Shares | shares |  | 3,076,323 |  | 3,076,323 |  | 3,076,323 |  | 3,076,323 |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Lucira Health, Inc., Warrant, Acquisition Date 2/4/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[40] |  |  | $ 110,000 |  |  |  |  |
Investments, at fair value: | [40] |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Feb. 04, 2022 |  |  |  |  |
Shares | shares | [40] |  |  | 59,642 |  |  |  | 59,642 |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 401,000 | [2],[3] | $ 401,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 78,000 | [3] | $ 864,000 | [40] |  |  |  |
Acquisition date |  | Sep. 27, 2013 | [3] | Sep. 27, 2013 | [40] |  |  |  |
Shares | shares |  | 62,794 | [3] | 62,794 | [40] | 62,794 | [3] | 62,794 | [40]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc., Warrant, Acquisition Date 9/8/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 200,000 |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 184,000 |  |  |  |  |  |  |
Acquisition date | [3] | Sep. 08, 2023 |  |  |  |  |  |  |
Shares | shares | [3] | 728,317 |  |  |  | 728,317 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 61,000 | [2],[3] | $ 61,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 0 | [3] | $ 1,000 | [40] |  |  |  |
Acquisition date |  | Mar. 31, 2017 | [3] | Mar. 31, 2017 | [40] |  |  |  |
Shares | shares |  | 15,712 | [3] | 15,712 | [40] | 15,712 | [3] | 15,712 | [40]
Investment, Identifier [Axis]: Warrant Investments and Semiconductors (0.04%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.04% |  | 0.04% | [5] | 0.04% |  | 0.04% | [5]
Investment cost |  | $ 99,000 | [2] | $ 850,000 | [6] |  |  |  |
Investments, at fair value: |  | 811,000 |  | 524,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Preferred Series D-2 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 99,000 | [2] | 99,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 811,000 |  | $ 524,000 |  |  |  |  |
Acquisition date |  | Jun. 26, 2015 | [3] | Jun. 26, 2015 | [40] |  |  |  |
Shares | shares |  | 750,000 |  | 750,000 |  | 750,000 |  | 750,000 |
Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Fungible, Inc., Warrant, Acquisition Date 12/16/2021, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[30] |  |  | $ 751,000 |  |  |  |  |
Investments, at fair value: | [30] |  |  | $ 0 |  |  |  |  |
Acquisition date | [30],[40] |  |  | Dec. 16, 2021 |  |  |  |  |
Shares | shares | [30] |  |  | 800,000 |  |  |  | 800,000 |
Investment, Identifier [Axis]: Warrant Investments and Software (0.59%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.59% |  |  |  | 0.59% |
Investment cost | [6] |  |  | $ 9,761,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 8,244,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software (0.75%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.75% |  |  |  | 0.75% |  |  |
Investment cost | [2] | $ 10,445,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 13,549,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Preferred Series G |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 74,000 | [2] | 74,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |
Acquisition date |  | May 22, 2015 | [3] | May 22, 2015 | [40] |  |  |  |
Shares | shares |  | 231,535 |  | 231,535 |  | 231,535 |  | 231,535 |
Investment, Identifier [Axis]: Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 448,000 | [2] | $ 448,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 430,000 |  | $ 365,000 |  |  |  |  |
Acquisition date |  | Sep. 23, 2022 | [3] | Sep. 23, 2022 | [40] |  |  |  |
Shares | shares |  | 254,778 |  | 254,778 |  | 254,778 |  | 254,778 |
Investment, Identifier [Axis]: Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 284,000 | [2] | $ 284,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 666,000 |  | $ 398,000 |  |  |  |  |
Acquisition date |  | Nov. 18, 2020 | [3] | Nov. 18, 2020 | [40] |  |  |  |
Shares | shares |  | 29,691 |  | 29,691 |  | 29,691 |  | 29,691 |
Investment, Identifier [Axis]: Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 165,000 | [1],[2] | $ 165,000 | [6],[30] |  |  |  |
Investments, at fair value: |  | $ 47,000 | [1] | $ 61,000 | [30] |  |  |  |
Acquisition date |  | Oct. 04, 2021 | [1],[3] | Oct. 04, 2021 | [30],[40] |  |  |  |
Shares | shares |  | 194,629 | [1] | 194,629 | [30] | 194,629 | [1] | 194,629 | [30]
Investment, Identifier [Axis]: Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 117,000 | [2] | $ 117,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 12,000 |  | $ 1,000 |  |  |  |  |
Acquisition date |  | Sep. 30, 2020 | [3] | Sep. 30, 2020 | [40] |  |  |  |
Shares | shares |  | 211,342 |  | 211,342 |  | 211,342 |  | 211,342 |
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 71,000 | [2] | $ 71,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 29,000 |  | $ 14,000 |  |  |  |  |
Acquisition date |  | Nov. 06, 2018 | [3] | Nov. 06, 2018 | [40] |  |  |  |
Shares | shares |  | 477,454 |  | 477,454 |  | 477,454 |  | 477,454 |
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 54,000 | [2],[26],[27] | $ 54,000 | [6],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 844,000 | [26],[27] | $ 400,000 | [24],[25] |  |  |  |
Acquisition date |  | Apr. 10, 2018 | [3],[26],[27] | Apr. 10, 2018 | [24],[25],[40] |  |  |  |
Shares | shares |  | 6,763 | [26],[27] | 6,763 | [24],[25] | 6,763 | [26],[27] | 6,763 | [24],[25]
Investment, Identifier [Axis]: Warrant Investments and Software and Convoy, Inc., Warrant, Acquisition Date 3/30/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[19] |  |  | $ 974,000 |  |  |  |  |
Investments, at fair value: | [19] |  |  | $ 364,000 |  |  |  |  |
Acquisition date | [19],[40] |  |  | Mar. 30, 2022 |  |  |  |  |
Shares | shares | [19] |  |  | 165,456 |  |  |  | 165,456 |
Investment, Identifier [Axis]: Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 462,000 | [2],[3] | $ 462,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 1,225,000 | [3] | $ 488,000 | [40] |  |  |  |
Acquisition date |  | Apr. 25, 2019 | [3] | Apr. 25, 2019 | [40] |  |  |  |
Shares | shares |  | 105,350 | [3] | 105,350 | [40] | 105,350 | [3] | 105,350 | [40]
Investment, Identifier [Axis]: Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 26,000 | [2],[12],[26],[27] | $ 26,000 | [6],[18],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 62,000 | [12],[26],[27] | $ 19,000 | [18],[24],[25] |  |  |  |
Acquisition date |  | Sep. 21, 2022 | [3],[12],[26],[27] | Sep. 21, 2022 | [18],[24],[25],[40] |  |  |  |
Shares | shares |  | 102,898 | [12],[26],[27] | 102,898 | [18],[24],[25] | 102,898 | [12],[26],[27] | 102,898 | [18],[24],[25]
Investment, Identifier [Axis]: Warrant Investments and Software and DNAnexus, Inc., Warrant, Acquisition Date 3/21/2014, Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 97,000 | [2] | $ 97,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 47,000 |  | $ 131,000 |  |  |  |  |
Acquisition date |  | Mar. 21, 2014 | [3] | Mar. 21, 2014 | [40] |  |  |  |
Shares | shares |  | 909,091 |  | 909,091 |  | 909,091 |  | 909,091 |
Investment, Identifier [Axis]: Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 461,000 | [2] | $ 353,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 258,000 |  | $ 168,000 |  |  |  |  |
Acquisition date |  | Mar. 11, 2019 | [3] | Mar. 11, 2019 | [40] |  |  |  |
Shares | shares |  | 770,838 |  | 453,641 |  | 770,838 |  | 453,641 |
Investment, Identifier [Axis]: Warrant Investments and Software and Delphix Corp., Warrant, Acquisition Date 10/8/2019, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,594,000 | [2] | $ 1,594,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 3,801,000 |  | $ 2,657,000 |  |  |  |  |
Acquisition date |  | Oct. 08, 2019 | [3] | Oct. 08, 2019 | [40] |  |  |  |
Shares | shares |  | 718,898 |  | 718,898 |  | 718,898 |  | 718,898 |
Investment, Identifier [Axis]: Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 545,000 | [2] | $ 545,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 396,000 |  | $ 180,000 |  |  |  |  |
Acquisition date |  | Aug. 02, 2021 | [3] | Aug. 02, 2021 | [40] |  |  |  |
Shares | shares |  | 727,047 |  | 727,047 |  | 727,047 |  | 727,047 |
Investment, Identifier [Axis]: Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 1,452,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 1,207,000 |  |  |  |  |  |  |
Acquisition date | [3] | Jun. 28, 2023 |  |  |  |  |  |  |
Shares | shares |  | 49,309 |  |  |  | 49,309 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 278,000 | [2] | $ 278,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 413,000 |  | $ 300,000 |  |  |  |  |
Acquisition date |  | Jun. 30, 2022 | [3] | Jun. 30, 2022 | [40] |  |  |  |
Shares | shares |  | 95,911 |  | 95,911 |  | 95,911 |  | 95,911 |
Investment, Identifier [Axis]: Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 8,000 | [2],[26],[27] | $ 8,000 | [6],[24],[25] |  |  |  |
Investments, at fair value: |  | $ 4,000 | [26],[27] | $ 6,000 | [24],[25] |  |  |  |
Acquisition date |  | Apr. 13, 2022 | [3],[26],[27] | Apr. 13, 2022 | [24],[25],[40] |  |  |  |
Shares | shares |  | 522 | [26],[27] | 522 | [24],[25] | 522 | [26],[27] | 522 | [24],[25]
Investment, Identifier [Axis]: Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 583,000 | [2] | $ 583,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 188,000 |  | $ 382,000 |  |  |  |  |
Acquisition date |  | Sep. 12, 2022 | [3] | Sep. 12, 2022 | [40] |  |  |  |
Shares | shares |  | 362,837 |  | 362,837 |  | 362,837 |  | 362,837 |
Investment, Identifier [Axis]: Warrant Investments and Software and Esme Learning Solutions, Inc., Warrant, Acquisition Date 1/27/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 198,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Jan. 27, 2022 |  |  |  |  |
Shares | shares |  |  |  | 56,765 |  |  |  | 56,765 |
Investment, Identifier [Axis]: Warrant Investments and Software and Evernote Corporation, Warrant, Acquisition Date 9/30/2016, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 107,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 6,000 |  |  |  |  |
Acquisition date | [40] |  |  | Sep. 30, 2016 |  |  |  |  |
Shares | shares |  |  |  | 62,500 |  |  |  | 62,500 |
Investment, Identifier [Axis]: Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 96,000 | [2] | $ 96,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 77,000 |  | $ 39,000 |  |  |  |  |
Acquisition date |  | May 10, 2018 | [3] | May 10, 2018 | [40] |  |  |  |
Shares | shares |  | 75,917 |  | 75,917 |  | 75,917 |  | 75,917 |
Investment, Identifier [Axis]: Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 325,000 | [2] | $ 325,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 456,000 |  | $ 314,000 |  |  |  |  |
Acquisition date |  | Jul. 29, 2022 | [3] | Jul. 29, 2022 | [40] |  |  |  |
Shares | shares |  | 84,995 |  | 84,995 |  | 84,995 |  | 84,995 |
Investment, Identifier [Axis]: Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 208,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 243,000 |  |  |  |  |  |  |
Acquisition date | [3] | Mar. 31, 2023 |  |  |  |  |  |  |
Shares | shares |  | 64,293 |  |  |  | 64,293 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[12],[26],[27] | $ 16,000 |  |  |  |  |  |  |
Investments, at fair value: | [12],[26],[27] | $ 35,000 |  |  |  |  |  |  |
Acquisition date | [3],[12],[26],[27] | Jan. 23, 2023 |  |  |  |  |  |  |
Shares | shares | [12],[26],[27] | 39,948 |  |  |  | 39,948 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Preferred Series D |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 131,000 | [2] | $ 131,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 49,000 |  | $ 1,000 |  |  |  |  |
Acquisition date |  | Feb. 14, 2018 | [3] | Feb. 14, 2018 | [40] |  |  |  |
Shares | shares |  | 89,685 |  | 89,685 |  | 89,685 |  | 89,685 |
Investment, Identifier [Axis]: Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 252,000 | [2] | $ 252,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 306,000 |  | $ 225,000 |  |  |  |  |
Acquisition date |  | Sep. 30, 2020 | [3] | Sep. 30, 2020 | [40] |  |  |  |
Shares | shares |  | 82,362 |  | 82,362 |  | 82,362 |  | 82,362 |
Investment, Identifier [Axis]: Warrant Investments and Software and Nuvolo Technologies Corporation, Warrant, Acquisition Date 3/29/2019, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6],[18] |  |  | $ 172,000 |  |  |  |  |
Investments, at fair value: | [18] |  |  | $ 175,000 |  |  |  |  |
Acquisition date | [18],[40] |  |  | Mar. 29, 2019 |  |  |  |  |
Shares | shares | [18] |  |  | 70,000 |  |  |  | 70,000 |
Investment, Identifier [Axis]: Warrant Investments and Software and Onna Technologies, Inc., Warrant 7/5/2023 Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Acquisition date | [3] | Jul. 05, 2023 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Onna Technologies, Inc.Warrant 7/5/2023 Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 60,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 39,000 |  |  |  |  |  |  |
Shares | shares |  | 172,867 |  |  |  | 172,867 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 0 | [2] | $ 0 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |
Acquisition date |  | May 28, 2014 | [3] | May 28, 2014 | [40] |  |  |  |
Shares | shares |  | 132,168 |  | 132,168 |  | 132,168 |  | 132,168 |
Investment, Identifier [Axis]: Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 215,000 | [2] | $ 215,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 447,000 |  | $ 298,000 |  |  |  |  |
Acquisition date |  | Jun. 30, 2020 | [3] | Jun. 30, 2020 | [40] |  |  |  |
Shares | shares |  | 69,120 |  | 69,120 |  | 69,120 |  | 69,120 |
Investment, Identifier [Axis]: Warrant Investments and Software and SignPost, Inc., Warrant, Acquisition Date 1/13/2016, Series Junior 1 Preferred |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 314,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Jan. 13, 2016 |  |  |  |  |
Shares | shares |  |  |  | 474,019 |  |  |  | 474,019 |
Investment, Identifier [Axis]: Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[12] | $ 96,000 |  |  |  |  |  |  |
Investments, at fair value: | [12] | $ 76,000 |  |  |  |  |  |  |
Acquisition date | [3],[12] | Mar. 22, 2023 |  |  |  |  |  |  |
Shares | shares | [12] | 77,934 |  |  |  | 77,934 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Preferred Series D |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 103,000 | [2] | $ 103,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 386,000 |  | $ 426,000 |  |  |  |  |
Acquisition date |  | Apr. 28, 2020 | [3] | Apr. 28, 2020 | [40] |  |  |  |
Shares | shares |  | 312,596 |  | 312,596 |  | 312,596 |  | 312,596 |
Investment, Identifier [Axis]: Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/28/2023, Ordinary Shares |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[26],[27] | $ 174,000 |  |  |  |  |  |  |
Investments, at fair value: | [26],[27] | $ 128,000 |  |  |  |  |  |  |
Acquisition date | [3],[26],[27] | Jun. 08, 2023 |  |  |  |  |  |  |
Shares | shares | [26],[27] | 321,956 |  |  |  | 321,956 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Suzy, Inc. Warrant, Acquisition Date 8/24/2023 Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [1],[2] | $ 367,000 |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 354,000 |  |  |  |  |  |  |
Acquisition date | [1],[3] | Aug. 24, 2023 |  |  |  |  |  |  |
Shares | shares | [1] | 292,936 |  |  |  | 292,936 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Tact.ai Technologies, Inc., Warrant, Acquisition Date 2/13/2020, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 206,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 69,000 |  |  |  |  |
Acquisition date | [40] |  |  | Feb. 13, 2020 |  |  |  |  |
Shares | shares |  |  |  | 1,041,667 |  |  |  | 1,041,667 |
Investment, Identifier [Axis]: Warrant Investments and Software and The Faction Group LLC, Warrant, Acquisition Date 11/3/2014, Preferred Series AA |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 234,000 | [2] | $ 234,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 904,000 |  | $ 436,000 |  |  |  |  |
Acquisition date |  | Nov. 03, 2014 | [3] | Nov. 03, 2014 | [40] |  |  |  |
Shares | shares |  | 8,076 |  | 8,076 |  | 8,076 |  | 8,076 |
Investment, Identifier [Axis]: Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Ordinary Shares |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2],[26],[27] | $ 174,000 |  |  |  |  |  |  |
Investments, at fair value: | [26],[27] | $ 234,000 |  |  |  |  |  |  |
Acquisition date | [3],[26],[27] | Mar. 22, 2023 |  |  |  |  |  |  |
Shares | shares | [26],[27] | 254,877 |  |  |  | 254,877 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,275,000 | [1],[2] | $ 1,275,000 | [6],[30] |  |  |  |
Investments, at fair value: |  | $ 186,000 | [1] | $ 321,000 | [30] |  |  |  |
Acquisition date |  | Jan. 21, 2022 | [1],[3] | Jan. 21, 2022 | [30],[40] |  |  |  |
Shares | shares |  | 152,048 | [1] | 152,048 | [30] | 152,048 | [1] | 152,048 | [30]
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices (0.04%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.04% | [4] | 0.04% | [5] | 0.04% | [4] | 0.04% | [5]
Investment cost |  | $ 39,000 | [2] | $ 46,000 | [6] |  |  |  |
Investments, at fair value: |  | 676,000 |  | 492,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices and Gynesonics, Inc., Warrant, Acquisition Date 1/16/2013, Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | 7,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Jan. 16, 2013 |  |  |  |  |
Shares | shares |  |  |  | 16,835 |  |  |  | 16,835 |
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 39,000 | [2],[3] | $ 39,000 | [6],[40] |  |  |  |
Investments, at fair value: |  | $ 676,000 | [3] | $ 492,000 | [40] |  |  |  |
Acquisition date |  | Sep. 11, 2015 | [3] | Sep. 11, 2015 | [40] |  |  |  |
Shares | shares |  | 14,440 | [3] | 14,440 | [40] | 14,440 | [3] | 14,440 | [40]
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.00%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] | 0.00% |  |  |  | 0.00% |  |  |
Investment cost | [2] | $ 539,000 |  |  |  |  |  |  |
Investments, at fair value: |  | 83,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.03%) |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [5] |  |  | 0.03% |  |  |  | 0.03% |
Investment cost | [6] |  |  | $ 723,000 |  |  |  |  |
Investments, at fair value: |  |  |  | 488,000 |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Common Stock |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | 52,000 | [2] | 52,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 36,000 |  | $ 44,000 |  |  |  |  |
Acquisition date |  | Apr. 15, 2022 | [3] | Apr. 15, 2022 | [40] |  |  |  |
Shares | shares |  | 18,472 |  | 18,472 |  | 18,472 |  | 18,472 |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Warrant, Acquisition Date 4/30/2013, Preferred Series C-1 |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 64,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 275,000 |  |  |  |  |
Acquisition date | [40] |  |  | Apr. 30, 2013 |  |  |  |  |
Shares | shares |  |  |  | 93,632 |  |  |  | 93,632 |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 218,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 169,000 |  |  |  |  |
Shares | shares |  |  |  | 456,883 |  |  |  | 456,883 |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Preferred Series A |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 155,000 | [2] | $ 155,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 36,000 |  | $ 126,000 |  |  |  |  |
Acquisition date |  | Apr. 22, 2014 | [3] | Apr. 22, 2014 | [40] |  |  |  |
Shares | shares |  | 325,000 |  | 325,000 |  | 325,000 |  | 325,000 |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Preferred Series B |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 63,000 | [2] | $ 63,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 11,000 |  | $ 43,000 |  |  |  |  |
Acquisition date |  | Apr. 07, 2015 | [3] | Apr. 07, 2015 | [40] |  |  |  |
Shares | shares |  | 131,883 |  | 131,883 |  | 131,883 |  | 131,883 |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and IngredientWerks Holdings, Inc. (p.k.a Agrivida, Inc.), Warrant, Acquisition Date 6/20/2013, Preferred Series D |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [6] |  |  | $ 120,000 |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |
Acquisition date | [40] |  |  | Jun. 20, 2013 |  |  |  |  |
Shares | shares |  |  |  | 471,327 |  |  |  | 471,327 |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Polyera Corporation, Warrant, Acquisition Date 3/24/2015, Preferred Series C |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost |  | $ 269,000 | [2] | $ 269,000 | [6] |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |
Acquisition date |  | Mar. 24, 2015 | [3] | Mar. 24, 2015 | [40] |  |  |  |
Shares | shares |  | 150,036 |  | 150,036 |  | 150,036 |  | 150,036 |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Total Halio, Inc. |  |  |  |  |  |  |  |  |
Summary of Investment Holdings |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 218,000 |  |  |  |  |  |  |
Investments, at fair value: |  | $ 47,000 |  |  |  |  |  |  |
Shares | shares |  | 456,883 |  |  |  | 456,883 |  |  |
[1] | Denotes that all or a portion of the investment in this portfolio company is held by Hercules Capital IV, L.P., the Company’s wholly owned small business investment company.
[2] | Gross unrealized appreciation, gross unrealized depreciation, and net unrealized appreciation for federal income tax purposes totaled $118.3 million, $115.9 million, and $2.4 million, respectively. The tax cost of investments is $3.2 billion.
[3] | Except for warrants in 24 publicly traded companies and common stock in 36 publicly traded companies, all investments are restricted as of December 31, 2023 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s valuation committee (the “Valuation Committee”) and approved by the board of directors (the “Board”).
[4] | Value as a percent of net assets. All amounts are stated in U.S. Dollars unless otherwise noted. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies.
[5] | Value as a percent of net assets. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies.
[6] | Gross unrealized appreciation, gross unrealized depreciation, and net unrealized depreciation for federal income tax purposes totaled $72.2 million, $112.0 million, and $39.8 million, respectively. The tax cost of investments is $3.0 billion.
[7] | Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of December 31, 2022. Refer to “Note 11 — Commitments and Contingencies”.
[8] | Interest rate PRIME represents 7.50% as of December 31, 2022. 1-month LIBOR, 3-month LIBOR, and 6-month LIBOR represent, 4.40%, 4.77%, and 5.14%, respectively, as of December 31, 2022.
[9] | Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments.
[10] | Denotes that all or a portion of the debt investment secures the 2031 Asset-Backed Notes (as defined in “Note 5 — Debt”).
[11] | Interest rate PRIME represents 8.50% as of December 31, 2023. 1-month SOFR, 3-month SOFR, and 6-month SOFR represent 5.34%, 5.36%, and 5.35%, respectively, as of December 31, 2023.
[12] | Denotes that all or a portion of the investment is pledged as collateral under the MUFG Bank Facility (as defined in “Note 5 — Debt”).
[13] | Denotes second lien senior secured debt.
[14] | Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments.
[15] | Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”).
[16] | Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition.
[17] | Denotes that all or a portion of the debt investment secures the 2031 Asset-Backed Notes (as defined in “Note 5 — Debt”).
[18] | Denotes that all or a portion of the investment is pledged as collateral under the MUFG Bank Facility (as defined in “Note 5 — Debt”).
[19] | Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of December 31, 2022.
[20] | Denotes second lien senior secured debt.
[21] | Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”).
[22] | Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of December 31, 2023 (Refer to “Note 11 — Commitments and Contingencies”).
[23] | Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition.
[24] | Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets.
[25] | Non-U.S. company or the company’s principal place of business is outside the United States.
[26] | Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets.
[27] | Non-U.S. company or the company’s principal place of business is outside the United States.
[28] | Denotes that all or a portion of the debt investment is convertible debt.
[29] | Denotes that all or a portion of the debt investment is convertible debt.
[30] | Denotes that all or a portion of the investment in this portfolio company is held by Hercules Capital IV, L.P., the Company’s wholly owned small business investment company.
[31] | Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of December 31, 2023.
[32] | Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board.
[33] | Debt is on non-accrual status as of December 31, 2022, and is therefore considered non-income producing. Note that only the PIK portion is on non-accrual for the Company’s debt investment in Tectura Corporation and Pineapple Energy LLC.
[34] | Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board.
[35] | Gibraltar Acquisition LLC is a wholly-owned subsidiary, which is the holding company for their wholly-owned affiliated portfolio companies, Gibraltar Business Capital, LLC and Gibraltar Equipment Finance, LLC.
[36] | Hercules Adviser LLC is owned by Hercules Capital Management LLC and presented with Hercules Partner Holdings, LLC which are both wholly owned by the Company. Please refer to “Note 1” for additional disclosure.
[37] | Denotes the security holds rights to royalty fee income associated with certain products of the portfolio company. The approximate cost and fair value of the royalty contract are $4.6 million and $3.4 million, respectively.
[38] | Denotes the security holds rights to royalty fee income associated with certain products of the portfolio company. The approximate cost and fair value of the royalty contract are $12.0 million and $9.4 million, respectively.
[39] | Debt is on non-accrual status as of December 31, 2023, and is therefore considered non-income producing.
[40] | Except for warrants in 27 publicly traded companies and common stock in 43 publicly traded companies, all investments are restricted as of December 31, 2022 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s Board.
[41] | Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of Common Stock for Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of December 31, 2023, the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $2.4 million.
[42] | Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of Common Stock in portfolio company Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of December 31, 2022, the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $3.0 million.
[43] | Denotes all or a portion of the public equity or warrant investment was acquired in a transaction exempt from registration under the Securities Act of 1933 (“Securities Act”) and may be deemed to be “restricted securities” under the Securities Act.

X
- Definition Investment exit fee + References No definition available. + Details
Name: | htgc_InvestmentExitFee
Namespace Prefix: | htgc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Investment Interest Rate Cap + References No definition available. + Details
Name: | htgc_InvestmentInterestRateCap
Namespace Prefix: | htgc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Investments Maturity Month and Year. + References No definition available. + Details
Name: | htgc_InvestmentsMaturityMonthAndYear
Namespace Prefix: | htgc_
Data Type: | xbrli:gYearMonthItemType
Balance Type: | na
Period Type: | instant

X
- Definition Investments owned acquisition date. + References No definition available. + Details
Name: | htgc_InvestmentsOwnedAcquisitionDate
Namespace Prefix: | htgc_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage added to reference rate used to compute variable rate on investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentBasisSpreadVariableRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Minimum rate of interest on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRateFloor
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Rate of interest paid in cash on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRatePaidInCash
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Rate of interest paid in kind on investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRatePaidInKind
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Cost of the investment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 19 -Subparagraph (3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of investment in security owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-2 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12 Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(11)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of principal of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of shares of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of investment owned to net assets. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column D)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedPercentOfNetAssets
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480990/946-20-50-9 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (g)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (g)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483580/946-220-50-3 + Details
Name: | us-gaap_SummaryOfInvestmentHoldingsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis= Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments (169.59%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments (199.47%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Biotechnology Tools (2.02%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Biotechnology Tools (2.31%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Biotechnology Tools (2.66%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Biotechnology Tools and Alamar Biosciences, Inc. Senior Secured, Maturity Date June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Biotechnology Tools and Alamar Biosciences, Inc., Senior Secured, June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, January 2027, Prime + 2.15%, Floor rate 9.15%, 9.81% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, Maturity Date January 2027, Prime + 2.15%, Floor rate 9.15%, 11.21% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Communications & Networking (7.26%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Communications & Networking and Aryaka Networks, Inc. Senior Secured, Maturity Date July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Communications & Networking and Cytracom Holdings LLC Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.31%, Floor rate 10.31%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Communications & Networking and Rocket Lab Global Services, LLC Senior Secured, Maturity Date June 2024, Prime + 4.90%, Floor rate 8.15%, PIK Interest 1.25%, 3.25% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Communications and Networking and Aryaka Networks, Inc., Senior Secured, July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Communications and Networking and Cytracom Holdings LLC, Senior Secured, February 2025, 3-month SOFR + 9.72%, Floor rate 10.62%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services (28.24%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services (30.59%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Altumint, Inc., Senior Secured, December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and AppDirect, Inc. Senior Secured, Maturity Date April 2026, Prime + 5.50%, Floor rate 8.8%, 8.29% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and AppDirect, Inc., Senior Secured, April 2026, Prime + 5.50%, Floor rate 8.75%, 7.12% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Carwow LTD Senior Secured, Maturity Date December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Carwow LTD, Senior Secured, December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 5.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Houzz, Inc., Convertible Debt, May 2028, PIK Interest 8.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date February 2025, 1-month SOFR + 8.86%, Floor rate 9.75%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Jobandtalent USA, Inc., Senior Secured, February 2025, 1-month SOFR + 8.86% Floor rate 9.75%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Plentific Ltd, Senior Secured, October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Provi, Senior Secured, December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Provi, Senior Secured, Maturity Date December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month LIBOR + 5.50%, Floor rate 6.50%, PIK Interest 4.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Rhino Labs, Inc. Senior Secured, Maturity Date March 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Rhino Labs, Inc., Senior Secured, June 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Riviera Partners LLC, Senior Secured, April 2027, 3-month SOFR + 8.26%, Floor rate 9.26%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Seat Geek, Inc., Senior Secured, July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date June 2023, Prime + 5.00%, Floor rate 10.50%, PIK Interest 0.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and SeatGeek, Inc., Senior Secured, May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Skyword, Inc. Senior Secured, Maturity Date November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Skyword, Inc., Senior Secured, November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, July 2024, FIXED 8.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 One, PIK Interest 5.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 Two, PIK Interest 5.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024, FIXED 8.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Thumbtack, Inc. Senior Secured, Maturity Date April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Thumbtack, Inc., Senior Secured, April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Total SeatGeek, Inc., Senior Secured
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Total Veem, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Total Worldremit Group Limited
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Udacity, Inc. Senior Secured, Maturity Date September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Udacity, Inc., Senior Secured, September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 1-month SOFR + 9.35%, Floor rate 10.25%, 3.20% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 3-month SOFR + 9.40%, Floor rate 10.25%, 3.20% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.25%, Floor rate 10.25%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services, SeatGeek, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services, Tectura Corporation
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services, Veem, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services (2.40%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services (3.17%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), UnSecured, Maturity Date September 2026, FIXED + 11.95%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, Maturity Date September 2026, FIXED 11.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 11.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 14.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services and Next Insurance, Inc, Senior Secured, Maturity Date February 2028, Prime + -1.50%, Floor rate 4.75%, PIK Interest 5.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services, Gibraltar Business Capital, LLC, Unsecured
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development (66.60%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development (78.59%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V. Senior Secured, Maturity Date August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date January 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 10.60% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 5.30% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc. Senior Secured, Maturity Date September 2024, Prime + 6.40%, Floor rate 9.65%, Cap rate 15.00%, 6.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date January 2028 Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 5.70%, Floor rate 8.95%, Cap rate 10.70%, 5.31% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, Maturity Date July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and BiomX, INC, Senior Secured, Maturity Date September 2025, Prime + 5.70%, Floor rate 8.95%, 6.55% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and BridgeBio Pharma, Inc. Senior Secured, Maturity Date November 2026, FIXED 9.00%, 2.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and COMPASS Pathways plc Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Cellarity, Inc. Senior Secured, Maturity Date June 2026, Prime + 5.70%, Floor rate 8.95%, 3.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Century Therapeutics, Inc. Senior Secured, Maturity Date April 2024, Prime + 6.30%, Floor rate 9.55%, 3.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Codiak Biosciences, Inc. Senior Secured, Maturity Date October 2025, Prime + 5.00%, Floor rate 8.25%, 5.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Curevo, Inc. Senior Secured, Maturity Date June 2027 Prime + 1.70%, Floor rate 9.70%, 6.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 6.55% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Finch Therapeutics Group, Inc. Senior Secured, Maturity Date November 2026, Prime + 4.05%, Floor rate 7.55%, Cap rate 8.80%, 5.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc. Senior Secured, Maturity Date November 2026, Prime + 5.90%, Floor rate 9.15%, 9.86% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc., Senior Secured, Maturity Date November 2026, Prime + 5.65%, Floor rate 9.15%, 11.41% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date April 2025, Prime + 4.50%, Floor rate 9.00%, 6.55% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date October 2024, Prime + 5.75%, Floor rate 9.00%, 6.55% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Gritstone Bio, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Gritstone Bio, Inc., Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc., Senior Secured, Maturity Date February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Hibercell, Inc. Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Hibercell, Inc., Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and HilleVax, Inc. Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and HilleVax, Inc., Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Iveric Bio, Inc. Senior Secured, Maturity Date August 2027, Prime + 4.00%, Floor rate 8.75%, Cap rate 10.25%, 4.25% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Kura Oncology, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Kura Oncology, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Locus Biosciences, Inc. Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Locus Biosciences, Inc., Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2026, Prime + 3.95%, Floor rate 7.45%, 5.35% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Senior Secured, Maturity Date May 2026, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Nabriva Therapeutics, Senior Secured, Maturity Date June 2023, Prime + 4.30%, Floor rate 9.80%, 9.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc. Senior Secured, Maturity Date October 2026, Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.35%, 7.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.15%, 7.29% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Provention Bio, Inc. Senior Secured, Maturity Date September 2027, Prime + 2.70%, Floor rate 8.20%, 6.60% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc. Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc., Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Replimune Group, Inc. Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Replimune Group, Inc., Senior Secured, Maturity Date October 2026, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Scynexis, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.80%, Floor rate 9.05%, 3.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Seres Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 6.40%, Floor rate 9.65%, 4.98% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and TG Therapeutics, Inc. Senior Secured, Maturity Date January 2026, Prime + 2.15%, Floor rate 5.40%, PIK Interest 3.45%, 5.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and TG Therapeutics, Inc., Senior Secured, Maturity Date January 2026, Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc. Senior Secured, Maturity Date February 2027, Prime + 5.20%, Floor rate 8.45%, 4.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Senior Secured, Maturity Date February 2027, Prime + 4.45%, Floor rate 8.45%, Cap rate 11.45%, 4.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Unity Biotechnology, Inc. Senior Secured, Maturity Date August 2024, Prime + 6.10%, Floor rate 9.35%, 6.25% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Valo Health, LLC, Senior Secured, Maturity Date May 2024, Prime + 6.45%, Floor rate 9.70%, 3.85% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Verona Pharma, Inc., Senior Secured, Maturity Date December 2028, 1-month SOFR + 5.85%, Floor rate 11.19%, Cap rate 13.19%, 3.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 4.76% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date July 2024, Prime + 3.75%, Floor rate 8.75%, 8.80% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Senior Secured, Maturity Date October 2026, Prime + 3.15%, Floor rate 10.15%, 3.80% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date July 2025, Prime + 5.00%, Floor rate 8.25%, 6.35% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and uniQure B.V. Senior Secured, Maturity Date December 2025, Prime + 4.70%, Floor rate 7.95%, 7.28% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and uniQure B.V., Senior Secured, Maturity Date January 2027, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Electronics & Computer Hardware (1.05%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Electronics & Computer Hardware (1.34%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Electronics & Computer Hardware and Locus Robotics Corp. Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 1.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Electronics & Computer Hardware and Locus Robotics Corp., Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 4.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other (13.98%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other (16.56%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Better Therapeutics, Inc. Senior Secured, Maturity Date August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Better Therapeutics, Inc., Senior Secured, Maturity Date August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 1-month LIBOR + 5.00%, Floor rate 6.00%, PIK Interest 4.45%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc., Senior Secured, Maturity Date November 2026, 1-month SOFR + 5.11%, Floor rate 6.00%, PIK Interest 4.45%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Senior Secured, Maturity Date March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Main Street Rural, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Modern Life, Inc., Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Oak Street Health, Inc. Senior Secured, Maturity Date October 2027, Prime + 2.45%, Floor rate 7.95%, Cap rate 9.45%, PIK Interest 1.00%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Recover Together, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Vida Health, Inc., Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Information Services (3.72%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Information Services (6.65%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Information Services and Capella Space Corp. Senior Secured, Maturity Date November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Information Services and Capella Space Corp., Senior Secured, Maturity Date November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Information Services and Checkr Group, Inc., Senior Secured, Maturity Date August 2028, Prime + 1.45%, Floor rate 8.00%, PIK Interest 2.00%, 2.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Information Services and Saama Technologies, LLC, Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Information Services and Signal Media Limited, Senior Secured, Maturity Date June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 8.45%, Floor rate 9.35%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 9.08%, Floor rate 10.08%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Manufacturing Technology (0.44%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Manufacturing Technology (2.99%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Manufacturing Technology and Bright Machines, Inc. Senior Secured, Maturity Date April 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Manufacturing Technology and Bright Machines, Inc., Senior Secured, Maturity Date May 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Manufacturing Technology and MacroFab, Inc. Senior Secured, Maturity Date March 2026, Prime + 4.35%, Floor rate 7.60%, PIK Interest 1.25%, 4.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Manufacturing Technology and Ouster, Inc. Senior Secured, Maturity Date May 2026, Prime + 6.15%, Floor rate 9.40%, 7.45% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Media/Content/Info (0.69%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date December 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date June 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date September 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date September 2026, Prime + 3.50%, Floor rate 9.00%, 4.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Media/Content/Info and Total Fever Labs, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Medical Devices & Equipment (1.20%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc. Maturity Date September 2027, Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Semiconductors (1.51%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Semiconductors and Fungible, Inc. Senior Secured, Maturity Date December 2024, Prime + 5.00%, Floor rate 8.25%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software (40.39%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software (54.28%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and 3GTMS, LLC
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 6.57%, Floor rate 7.57%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.28%, Floor rate 10.28%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 6.88%, Floor rate 7.78%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 9.70%, Floor rate 10.60%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Agilence, Inc. Senior Secured, Maturity Date October 2026, 1-month BSBY + 9.00%, Floor rate 10.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 7.89%, Floor rate 8.89%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 6-month SOFR + 7.25%, Floor rate 8.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 8.99%, Floor rate 10.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 9.41%, Floor rate 10.41%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 2.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 4.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 7.89%, Floor rate 8.89%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2025, PRIME + 3.70%, Floor rate 6.95%, PIK Interest 1.00%, 3.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2026, Prime + 3.70%, Floor rate 9.20%, PIK Interest 1.00%, 3.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.05%, Floor rate 9.90%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 6-month SOFR + 8.90%, Floor rate 9.90%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date June 2026, 3-month SOFR + 8.86%, Floor rate 9.76%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.41%, Floor rate 11.81%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 6-month LIBOR + 8.99%, Floor rate 9.89%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 6-month LIBOR + 9.67%, Floor rate 10.67%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and CloudBolt Software, Inc., Senior Secured, Maturity Date October 2024, Prime + 6.70%, Floor rate 9.95%, 3.45% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Constructor Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Constructor.io Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Convoy, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 3.96% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 4.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Cybermaxx Intermediate Holdings, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 12.36%, Floor rate 13.11%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 8.63%, Floor rate 9.38%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 9.53%, Floor rate 10.28%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date July 2025, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 7.26% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date July 2025, Prime + 3.05%, Floor rate 7.55%, PIK Interest 1.10%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Demandbase, Inc., Senior Secured, Maturity Date August 2025, Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.00%, 5.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Dispatch Technologies, Inc., Senior Secured, Maturity Date April 2028, 3-month SOFR + 8.01%, Floor rate 8.76%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and DroneDeploy, Inc., Senior Secured, Maturity Date July 2026, Prime + 4.50%, Floor rate 8.75%, 4.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Eigen Technologies Ltd., Senior Secured, Maturity Date April 2025, Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Enmark Systems, Inc., Senior Secured, Maturity Date September 2026, 3-month LIBOR + 6.77%, Floor rate 7.77%, PIK Interest 2.16%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Enmark Systems, Inc., Senior Secured, Maturity Date September 2026, 3-month SOFR + 6.73%, Floor rate 7.73%, PIK Interest 2.13%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Esentire, Inc., Senior Secured, Maturity Date May 2024, 3-month LIBOR + 9.96%, Floor rate 10.96%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Esme Learning Solutions, Inc., Senior Secured, Maturity Date February 2025, Prime + 5.50%, Floor rate 8.75%, PIK Interest 1.50%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.79%, Floor rate 8.70%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.80%, Floor rate 8.70%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 6-month SOFR + 7.64%, Floor rate 8.54%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 6-month SOFR + 7.79%, Floor rate 8.54%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Ikon Science Limited, Senior Secured, Maturity Date October 2024, 3-month Eurodollar + 9.00%, Floor rate 10.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Ikon Science Limited, Senior Secured, Maturity Date October 2024, 3-month SOFR + 9.26%, Floor rate 10.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Imperva, Inc., Senior Secured, Maturity Date January 2027, 3-month LIBOR + 7.75%, Floor rate 8.75%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.), Senior Secured, Maturity Date July 2023, 3-month SOFR + 10.14%, Floor rate 11.14%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Khoros (p.k.a Lithium Technologies), Senior Secured, Maturity Date January 2024, 3-month SOFR + 8.00%, Floor rate 9.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Khoros (p.k.a Lithium Technologies), Senior Secured, Maturity Date January 2025, 3-month SOFR + 4.50%, Floor rate 5.50%, PIK Interest 4.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Leapwork ApS., Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.25%, PIK Interest 1.95%, 2.70% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and LinenMaster, LLC., Senior Secured, Maturity Date August 2028 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and LogicSource, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.93%, Floor rate 9.93%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Logicworks, Senior Secured, Maturity Date January 2024, Prime + 7.50%, Floor rate 10.75%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 3-month LIBOR + 9.06%, Floor rate 10.06%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 3-month SOFR + 9.31%, Floor rate 10.06%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date November 2030, 3-month SOFR + 6.75%, Floor rate 7.75%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Nextroll, Inc., Senior Secured, Maturity Date July 2023, Prime + 3.75%, Floor rate 7.75%, PIK Interest 2.95%, 1.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Nuvolo Technologies Corporation, Senior Secured, Maturity Date July 2025, Prime + 5.25%, Floor rate 8.50%, 2.42% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Omeda Holdings, LLC, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.05%, Floor rate 9.05%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Onna Technologies, Inc., Senior Secured, Maturity Date March 2026, Prime + 1.35%, Floor rate 8.85%, PIK Interest, 1.75%, 4.45% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Riviera Partners LLC, Senior Secured, Maturity Date April 2027, 6-month SOFR + 7.53%, Floor rate 8.53%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Salary.com, LLC, Senior Secured, Maturity Date September 2027, 3-month SOFR + 8.00%, Floor rate 9.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Salary.com, LLC, Senior Secured, Maturity Date September 2027, 6-month SOFR + 8.00%, Floor rate 9.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 3-month LIBOR + 9.00%, Floor rate 10.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 6-month SOFR + 9.01%, Floor rate 9.91%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Simon Data, Inc., Senior Secured, Maturity Date March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.92% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Sisense Ltd., Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 1-month SOFR + 7.25%, Floor rate 8.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date May 2030, 3-month SOFR + 6.50%, Floor rate 7.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Suzy, Inc.., Senior Secured, Maturity Date August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Tact.ai Technologies, Inc., Senior Secured, Maturity Date February 2024, Prime + 4.00%, Floor rate 8.75%, PIK Interest 2.00%, 5.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 6-month LIBOR + 9.00%, Floor rate 10.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 6-month SOFR + 9.25%, Floor rate 10.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2027, Prime + 0.45%, Floor rate 7.95%, PIK Interest 2.00%, 3.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and VideoAmp, Inc., Senior Secured, Maturity Date February 2025, Prime + 3.70%, Floor rate 6.95%, PIK Interest 1.25%, 5.25% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Zappi, Inc., Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.03%, Floor rate 9.03%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Zimperium, Inc., Senior Secured, Maturity Date May 2027, 3-month SOFR + 8.31%, Floor rate 9.31%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and iGrafx,LLC, Senior Secured, Maturity Date May 2027, 1-month SOFR + 8.66%, Floor rate 9.56%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Subtotal_ Communications & Networking (1.62%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Sustainable and Renewable Technology (0.31%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Sustainable and Renewable Technology (0.50%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.78% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date December 2024, PIK Interest 10.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date June 2027, FIXED 10.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments (8.44%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments (9.56%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products (0.04%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products (0.13%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and Fabletics, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 7/16/2013, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and TechStyle, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services (0.57%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services (0.70%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-4
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Preferred Series B-2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Total OfferUp, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Total Tectura Corporation
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Uber Technologies, Inc., Equity, Acquisition Date 12/1/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services (2.49%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services (3.17%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Equity, Acquisition Date 3/1/2018, Series Member Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Preferred Series A
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services, Gibraltar Business Capital, LLC
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Delivery (0.00%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Delivery (0.01%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Delivery and AcelRx Pharmaceuticals, Inc., Equity, Acquisition Date 12/10/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Delivery and Talphera, Inc (p.k.a. AcelRx Pharmaceuticals, Inc. ), Equity, Acquisition Date 12/10/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development (2.47%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development (2.66%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 9/19/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Albireo Pharma, Inc., Equity, Acquisition Date 9/14/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Applied Molecular Transport, Equity, Acquisition Date 4/6/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, 8/19/2014, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc., Equity, Acquisition Date 7/31/2011, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, 5/9/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, 10/5/2020, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, 6/21/2018, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Concert Pharmaceuticals, Inc., Equity, Acquisition Date 2/13/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc. (p.k.a. Applied Molecular Transport), Equity, 4/6/2021, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, 1/8/2015, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, 7/22/2015, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, 10/26/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, Acquisition Date 10/26/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, 7/25/2015, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, 5/7/2021, Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and HilleVax, Inc., Equity, 5/3/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, 3/31/2021, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, Acquisition Date 3/31/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, 6/16/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, 9/29/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, 12/15/2021, Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Equity, Acquisition Date 2/26/2007, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, 6/9/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, 8/22/2007, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Savara, Inc., Equity, 8/11/2015, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, 2/2/2017, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, Acquisition Date 2/2/2017, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, 5/5/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, Acquisition Date 5/5/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Total Valo Health, LLC
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Tricida, Inc., Equity, Acquisition Date 2/28/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, 12/11/2020, Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Valo Health, LLC., Equity, 10/31/2022, Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, 9/6/2023, Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, 11/6/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, 11/26/2019, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and uniQure B.V., Equity, 1/31/2019, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development, Valo Health LLC
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Electronics & Computer Hardware (0.05%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Electronics & Computer Hardware (0.11%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Healthcare Services, Other (0.05%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Healthcare Services, Other (0.21%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Information Services (0.35%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Information Services (0.58%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Information Services and Zeta Global Corp., Equity, Acquisition Date 11/20/2007, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Medical Devices & Equipment (0.01%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Medical Devices & Equipment (0.07%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Medical Devices & Equipment and Flowonix Medical Incorporated, Equity, Acquisition Date 11/3/2014, Series Preferred Series AA
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Medical Devices & Equipment and Gelesis, Inc., Equity, Acquisition Date 11/30/2009, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Medical Devices & Equipment and ViewRay, Inc., Equity, Acquisition Date 12/16/2013, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Medical Devices & Equipment, Coronado Aesthetics, LLC
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Medical Devices & Equipment, Total Coronado Aesthetics, LLC
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Semiconductors (0.01%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Semiconductors (0.02%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software (1.27%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software (2.07%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Leapwork ApS., Equity, Acquisition Date 8/25/2023, Series Preferred Series B2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Sprinklr, Inc., Equity, Acquisition Date 3/22/2017, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software, Contentful Global, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software, Druva Holdings, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software, SingleStore, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software, Total Contentful Global, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software, Total Druva Holdings, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software, Total SingleStore, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Surgical Devices (0.18%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 1/18/2007, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F-1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 2/8/2013, Series Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 6/16/2010, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 7/14/2015, Series Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Surgical Devices and TransMedics Group, Inc., Equity, Acquisition Date 11/7/2012, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Surgical Devices, Gynesonics, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology (0.22%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology (0.57%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology and Proterra, Inc., Equity, Acquisition Date 5/28/2015, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments and Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments and Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Fund After Cash & Cash Equivalents (183.28%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Fund Cash & Cash Equivalent and GS Financial Square Government Fund, FGTXX/38141W273
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Fund In Cash & Cash Equivalents (3.11%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments (0.26%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments (0.28%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments and Drug Discovery & Development (0.23%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments and Drug Discovery & Development (0.25%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/2020
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/2022
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments and Software (0.02%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments and Software (0.03%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investments (180.18%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investments (211.49%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investments in Securities (179.92%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investments in Securities (211.21%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments (1.88%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments (2.19%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Biotechnology Tools (0.02%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Biotechnology Tools (0.03%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Communications & Networking (0.01%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Communications & Networking and Spring Mobile Solutions, Inc., Warrant, Acquisition Date 4/19/2013, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Products (0.02%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Products (0.17%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Products and Savage X Holding, LLC, Warrant, Acquisition Date 6/27/2014, Class A Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Products and TFG Holding, Inc., Warrant, Acquisition Date 6/27/2014, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Products and TechStyle, Inc., Warrant, Acquisition Date 7/16/2013, Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services (0.19%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services (0.23%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Ordinary shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and RumbleON, Inc., Warrant, Acquisition Date 4/30/2018, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Skyword, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Snagajob.com, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Preferred Series A
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Total Skyword, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Total Snagajob.com, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Total Worldremit Group Limited
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Worldremit Group Limited
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Diversified Financial Services (0.03%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Delivery (0.00%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 6/1/2016, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 9/30/2015, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development (0.46%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development (0.60%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and ADMA Biologics, Inc., Warrant, Acquisition Date 2/24/2014, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Acacia Pharma Inc., Warrant, Acquisition Date 6/29/2018, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Albireo Pharma, Inc., Warrant, Acquisition Date 6/8/2020, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Curevo, Inc., Warrant, Acquisition Date 6/9/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Myovant Sciences, Ltd., Warrant, Acquisition Date 10/16/2017, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Warrant, Acquisition Date 8/1/2018, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Provention Bio, Inc., Warrant, Acquisition Date 9/15/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Tricida, Inc., Warrant, Acquisition Date 3/27/2019, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Common Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 12/9/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/30/2021, Preferred Series 3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and enGene,Inc, Warrant, Acquisition Date 12/22/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Electronics & Computer Hardware (0.02%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Electronics & Computer Hardware (0.09%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other (0.00%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other (0.03%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Modern Life, Inc., Warrant, Acquisition Date 3/30/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Recover Together, Inc.., Warrant, Acquisition Date 7/3/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC., Warrant, Acquisition Date 9/28/2023, Common Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Information Services (0.03%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Information Services (0.04%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Information Services and NetBase Solutions, Inc., Warrant, Acquisition Date 8/22/2017, Preferred Series 1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Manufacturing Technology (0.17%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Manufacturing Technology (0.30%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Media/Content/Info (0.00%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Media/Content/Info (0.01%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Preferred Series E-1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment (0.01%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment (0.07%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Aspire Bariatrics, Inc., Warrant, Acquisition Date 1/28/2015, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 11/3/2014, Preferred Series AA
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 9/21/2018, Preferred Series BB
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Preferred Series B-1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Lucira Health, Inc., Warrant, Acquisition Date 2/4/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc., Warrant, Acquisition Date 9/8/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Semiconductors (0.04%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Preferred Series D-2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Semiconductors and Fungible, Inc., Warrant, Acquisition Date 12/16/2021, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software (0.59%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software (0.75%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Preferred Series G
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Convoy, Inc., Warrant, Acquisition Date 3/30/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and DNAnexus, Inc., Warrant, Acquisition Date 3/21/2014, Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Delphix Corp., Warrant, Acquisition Date 10/8/2019, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Esme Learning Solutions, Inc., Warrant, Acquisition Date 1/27/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Evernote Corporation, Warrant, Acquisition Date 9/30/2016, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Nuvolo Technologies Corporation, Warrant, Acquisition Date 3/29/2019, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Onna Technologies, Inc., Warrant 7/5/2023 Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Onna Technologies, Inc.Warrant 7/5/2023 Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and SignPost, Inc., Warrant, Acquisition Date 1/13/2016, Series Junior 1 Preferred
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/28/2023, Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Suzy, Inc. Warrant, Acquisition Date 8/24/2023 Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Tact.ai Technologies, Inc., Warrant, Acquisition Date 2/13/2020, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and The Faction Group LLC, Warrant, Acquisition Date 11/3/2014, Preferred Series AA
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Surgical Devices (0.04%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Surgical Devices and Gynesonics, Inc., Warrant, Acquisition Date 1/16/2013, Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology (0.00%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology (0.03%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Warrant, Acquisition Date 4/30/2013, Preferred Series C-1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology and Halio, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Preferred Series A
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology and IngredientWerks Holdings, Inc. (p.k.a Agrivida, Inc.), Warrant, Acquisition Date 6/20/2013, Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology and Polyera Corporation, Warrant, Acquisition Date 3/24/2015, Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology and Total Halio, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |